<SEC-DOCUMENT>0001193125-26-168395.txt : 20260422
<SEC-HEADER>0001193125-26-168395.hdr.sgml : 20260422
<ACCEPTANCE-DATETIME>20260422074017
ACCESSION NUMBER:		0001193125-26-168395
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		17
CONFORMED PERIOD OF REPORT:	20260421
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20260422
DATE AS OF CHANGE:		20260422

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TuHURA Biosciences, Inc./NV
		CENTRAL INDEX KEY:			0001498382
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				990360497
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37823
		FILM NUMBER:		26881299

	BUSINESS ADDRESS:	
		STREET 1:		10500 UNIVERSITY CENTER DR.
		STREET 2:		SUITE 110
		CITY:			TAMPA
		STATE:			FL
		ZIP:			33612
		BUSINESS PHONE:		813-875-6600

	MAIL ADDRESS:	
		STREET 1:		10500 UNIVERSITY CENTER DR.
		STREET 2:		SUITE 110
		CITY:			TAMPA
		STATE:			FL
		ZIP:			33612

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Kintara Therapeutics, Inc.
		DATE OF NAME CHANGE:	20200820

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DelMar Pharmaceuticals, Inc.
		DATE OF NAME CHANGE:	20130123

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Berry Only Inc.
		DATE OF NAME CHANGE:	20100805
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d139552d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-types="http://fasb.org/us-types/2025" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:hura="http://www.tuhurabio.com/20260421" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:srt="http://fasb.org/srt/2025" xmlns:stpr="http://xbrl.sec.gov/stpr/2025" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric id="Hidden_dei_EntityRegistrantName" name="dei:EntityRegistrantName" contextRef="duration_2026-04-21_to_2026-04-21">TuHURA Biosciences, Inc./NV</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_SecurityExchangeName" name="dei:SecurityExchangeName" contextRef="duration_2026-04-21_to_2026-04-21">NASDAQ</ix:nonNumeric> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2026-04-21_to_2026-04-21" id="ixv-387">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2026-04-21_to_2026-04-21">0001498382</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xlink:type="simple" xlink:href="hura-20260421.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase"/> </ix:references> <ix:resources> <xbrli:context id="duration_2026-04-21_to_2026-04-21"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001498382</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2026-04-21</xbrli:startDate> <xbrli:endDate>2026-04-21</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <div style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</div> <div style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">WASHINGTON, D.C. 20549</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2026-04-21_to_2026-04-21" id="ixv-398">8-K</ix:nonNumeric></span></p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section&#160;13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2026-04-21_to_2026-04-21" format="ixt:datemonthdayyearen" id="ixv-399">April&#160;21, 2026</ix:nonNumeric></p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"> <span style=" -sec-ix-hidden:Hidden_dei_EntityRegistrantName">TUHURA BIOSCIENCES, INC.</span> </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of Registrant as Specified in Its Charter)</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2026-04-21_to_2026-04-21" format="ixt-sec:stateprovnameen" id="ixv-400">Nevada</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2026-04-21_to_2026-04-21" id="ixv-401">001-37823</ix:nonNumeric></span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2026-04-21_to_2026-04-21" id="ixv-402">99-0360497</ix:nonNumeric></span></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top;text-align:center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or Other Jurisdiction</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">of Incorporation)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(IRS Employer</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification No.)</p></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2026-04-21_to_2026-04-21" id="ixv-403">10500 University Center Dr.</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressAddressLine2" contextRef="duration_2026-04-21_to_2026-04-21" id="ixv-404">Suite 110</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2026-04-21_to_2026-04-21" id="ixv-405">Tampa</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2026-04-21_to_2026-04-21" format="ixt-sec:stateprovnameen" id="ixv-406">Florida</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2026-04-21_to_2026-04-21" id="ixv-407">33612</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Address of Principal Executive Offices, including zip code)</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Registrant&#8217;s Telephone Number, Including Area Code: <ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2026-04-21_to_2026-04-21" id="ixv-408">(813)</ix:nonNumeric> <span style="white-space:nowrap"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2026-04-21_to_2026-04-21" id="ixv-409">875-6600</ix:nonNumeric></span></p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">N/A</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former Name or Former Address, if Changed Since Last Report)</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2026-04-21_to_2026-04-21" format="ixt-sec:boolballotbox" id="ixv-410">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2026-04-21_to_2026-04-21" format="ixt-sec:boolballotbox" id="ixv-411">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2026-04-21_to_2026-04-21" format="ixt-sec:boolballotbox" id="ixv-412">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2026-04-21_to_2026-04-21" format="ixt-sec:boolballotbox" id="ixv-413">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Securities registered pursuant to Section&#160;12(b) of the Act:</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center"><br/>Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading<br/>Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange<br/>on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2026-04-21_to_2026-04-21" id="ixv-414">Common Stock, $0.001 par value per share</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2026-04-21_to_2026-04-21" id="ixv-415">HURA</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"> <span style=" -sec-ix-hidden:Hidden_dei_SecurityExchangeName">The Nasdaq Capital Market</span> </td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;&#160;230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 <span style="white-space:nowrap">(&#167;&#160;240.12b-2</span> of this chapter).</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging growth company&#8194;<ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2026-04-21_to_2026-04-21" format="ixt-sec:boolballotbox" id="ixv-416">&#9744;</ix:nonNumeric></p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#8194;&#9744;</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</div> <div style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</div></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top;text-align:left"><span style="font-weight:bold">Item&#8201;1.01</span></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Entry into a Material Definitive Agreement. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On April&#160;21, 2026, TuHURA Biosciences, Inc. (the &#8220;Company&#8221;) entered into a Loan Agreement (the &#8220;Loan Agreement&#8221;) with Parkview Holdings One LLC, as lender (&#8220;Parkview&#8221;), under which Parkview agreed to extend a $50&#160;million revolving credit facility to the Company upon the terms and conditions set forth in the Loan Agreement. The Company intends to use borrowings under the Loan Agreement for general corporate purposes, including the funding of the Company&#8217;s ongoing clinical trials and development programs. Parkview is an affiliate of the Company&#8217;s largest stockholder, K&amp;V Investment One LLC (owned by Vijay Patel). </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Loan Agreement provides for a revolving credit facility that matures on April&#160;21, 2031, with a maximum amount of loan availability of $50&#160;million. Borrowings under the Loan Agreement are secured by substantially all of the assets of the Company and its subsidiaries and will bear interest at a rate of twelve percent (12%) per annum (plus an additional six percent (6%) if and while there is an event of default by the Company under the Loan Agreement), with interest being payable monthly in arrears. The Company is entitled to make up to one draw per month under the Loan Agreement, and such amount cannot exceed the greater of (a) $1.7&#160;million and (b)&#160;the monthly budgeted expense amount in the Company&#8217;s expense budget (which will be subject to agreement of the Company and Parkview) for the immediately subsequent month. Any unused borrowings from prior months may be added to the maximum borrowing permitted in the month in which a draw is being made by the Company. Assuming that the Company&#8217;s stockholders approve the issuance of the Loan Fee Shares (as defined below), the Company currently expects that the credit facility will provide the Company with sufficient access to capital to continue funding its operations and development programs into the first quarter of 2028 without regard to other sources of capital. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the Loan Agreement, if the Company achieves net profits in any fiscal quarter as a result of sales of pharmaceutical products for two consecutive fiscal quarters, the Company will be obligated to make repayments of principal under the Loan Agreement equal to 75% of such net profits from the previous fiscal quarter. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the Loan Agreement, the Company has also agreed to: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">pursuant to a fee letter dated April&#160;21, 2026 (the &#8220;Fee Letter&#8221;), pay a <span style="white-space:nowrap">one-time</span> loan commitment fee equal to ten percent (10%) of the total commitment under the Loan Agreement (resulting in a commitment fee of $5.0 million), which the Company has elected to pay by the issuance of an aggregate of 1,878,287 shares of Company common stock (the &#8220;Loan Fee Shares&#8221;) to Parkview based on a price equal to the average of the daily closing prices of the Company&#8217;s common stock during the ten trading days ending on (and including) April&#160;21, 2026; provided that such shares shall be issued to Parkview only after and subject to the approval of such issuance by the Company&#8217;s stockholders at the next annual meeting of the Company&#8217;s stockholders, and in the absence of such approval by August&#160;31, 2026, the commitment fee shall be due and payable in cash on September&#160;1, 2026; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">pay an annual cash facility fee, payable annually beginning on the first anniversary of the date of the Loan Agreement, equal to one and <span style="white-space:nowrap">one-half</span> percent (1.5%) of the total commitment; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">enter into two Warrant Amendment Agreements (the &#8220;Warrant Amendment Agreements&#8221;) to extend to April&#160;21, 2031, the exercise period during which 4,364,873 of the Company&#8217;s warrants held by K&amp;V Investment One, LLC, an affiliate of Parkview and Vijay Patel, may be exercised (3,049,432 of such warrants have an exercise price of $3.69 per share and 1,315,441 of such warrants have an exercise price of $5.70 per share, and such warrants constitute all of the Company warrants held by K&amp;V Investment One LLC other than warrants issued in the Company&#8217;s registered direct offering which had its first closing on December&#160;10, 2025). </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Loan Agreement contains various restrictions and covenants applicable to the Company and certain of its subsidiaries. Among other requirements, the Loan Agreement (a)&#160;limits the Company and its subsidiaries with respect to the incurrence or assumption of additional debt (subject to specified exceptions), (b) limits the Company&#8217;s permissible investments, dispositions and restricted payments, and (c)&#160;limits the Company in its ability to amend its organizational documents or material contracts. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The principal and accrued but unpaid interest in the Loan Agreement will not be convertible into common stock or other securities of the Company, other than in the case of a change of control of the Company in which a person or entity (other than Parkview, Vijay Patel, or their affiliates) acquires 51% or more of the outstanding equity interests in the Company (a &#8220;Change of Control&#8221;). Upon such a Change of Control, Parkview may, subject to the approval of such conversion right by the Company&#8217;s stockholders at a stockholder meeting prior to the Change of Control, convert all outstanding principal plus accrued and unpaid interest into shares of Company common stock (&#8220;Conversion Shares&#8221;) at a conversion price per share equal to $2.662. </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Loan Agreement also contains customary events of default, which include the occurrence of a Change of Control or the discontinuance of the Company&#8217;s development program for its <span style="white-space:nowrap">IFx-20</span> product candidate. If an event of default under the Credit Agreement occurs and is continuing, then, among other things, Parkview may declare any outstanding obligations under the Loan Agreement to be immediately due and payable. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company may at any time prepay without penalty all or any portion of the amounts outstanding under the Loan Agreement, and the Company may elect at any time to terminate the Loan Agreement or reduce the amount Parkview&#8217;s loan commitment under the Loan Agreement. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition to the foregoing, pursuant to the Loan Agreement, the Company agreed that, if requested by Parkview, the Company would permit Parkview to appoint a director to the Company&#8217;s board of directors, subject to the rules and regulations of the Securities and Exchange Commission and any national securities exchange on which the Company&#8217;s shares of common stock are then listed. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In consideration of Parkview&#8217;s obligations under the Loan Agreement, the Company entered into a Royalty Agreement, dated April&#160;21, 2026 (the &#8220;Royalty Agreement&#8221;), pursuant to which the Company granted to Parkview an annual royalty on sales by the Company and its sublicensees of products that incorporate or are based on the Company&#8217;s intellectual property covering <span style="white-space:nowrap">IFx-2.0</span> (the &#8220;Products&#8221;). The royalty will be equal to a percentage of &#8220;Net Sales&#8221; (as defined in the Royalty Agreement) of Products up to $450&#160;million in Net Sales per year, which percentage is in the low to <span style="white-space:nowrap">mid-single</span> digits range. The royalty payment obligation under the Royalty Agreement will continue through the <span style="white-space:nowrap"><span style="white-space:nowrap">last-to-expire</span></span> patent covering <span style="white-space:nowrap">IFx-2.0.</span> </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The foregoing descriptions of the Loan Agreement, Royalty Agreement, Fee Letter, and Warrant Amendment Agreements do not purport to be complete and are qualified in their entirety by reference to the full text of the Loan Agreement, Royalty Agreement, Fee Letter, and Warrant Amendment Agreements filed herewith as exhibits and incorporated herein by reference. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top;text-align:left"><span style="font-weight:bold">Item&#8201;2.03</span></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Creation of a Direct Financial Obligation or an Obligation under an <span style="white-space:nowrap">Off-Balance</span> Sheet Arrangement of a Registrant. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The information provided in Item 1.01 of this Current Report on Form <span style="white-space:nowrap">8-K</span> is hereby incorporated by reference into this Item 2.03. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top;text-align:left"><span style="font-weight:bold">Item&#8201;3.02</span></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Unregistered Sales of Equity Securities </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The disclosure in Item 1.01 of this Current Report on Form <span style="white-space:nowrap">8-K</span> is incorporated by reference into this Item 3.02. The Company claims an exemption from the registration requirements of the&#160;Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), for the private placement of the Loan Fee Shares and Conversion Shares, as the Loan Fee Shares and Conversion Shares will be issued solely to &#8220;accredited investors,&#8221; as such term is defined in the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), and in reliance on the exemption from registration afforded by Section&#160;4(a)(2) and/or Regulation D (Rule 506) under the Securities Act and corresponding provisions of state securities laws. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top;text-align:left"><span style="font-weight:bold">Item&#8201;7.01</span></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Regulation FD Disclosure. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On April&#160;22, 2026, the Company issued a press release announcing the Loan Agreement and related matters. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated hereby reference. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The information contained in this Item 7.01 and in Exhibit 99.1 of this Current Report shall not be deemed &#8220;filed&#8221; for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that section, nor shall it be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing. </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top;text-align:left"><span style="font-weight:bold">Item&#8201;9.01</span></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">(d) Exhibits </span></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0;margin:0 auto">


<tr>

<td/>

<td style="vertical-align:bottom;width:4%"/>
<td style="width:93%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap;text-align:center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;text-align:center">Exhibit<br/>No</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#8194;4.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d139552dex41.htm">Loan Agreement, dated April&#160;21, 2026, by and between TuHURA Biosciences, Inc. and Parkview Holdings One LLC. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.1*</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d139552dex101.htm">Royalty Agreement, dated April&#160;21, 2026, by and between TuHURA Biosciences, Inc. and Parkview Holdings One LLC. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.2</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d139552dex102.htm">Fee Letter, dated April&#160;21, 2026, by and between TuHURA Biosciences, Inc. and Parkview Holdings One LLC. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.3</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d139552dex103.htm">Warrant Amendment Agreement (2022 Warrants), dated April&#160;21, 2026, by and between TuHURA Biosciences, Inc. and K&amp;V Investment One LLC. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.4</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d139552dex104.htm">Warrant Amendment Agreement (2024 Warrants), dated April&#160;21, 2026, by and between TuHURA Biosciences, Inc. and K&amp;V Investment One LLC. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">99.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d139552dex991.htm">Press Release, dated April&#160;22, 2026. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the inline XBRL document)</td></tr>
</table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top;text-align:left"><span style="font-weight:bold"><span style="font-style:italic">*</span></span></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left"><span style="font-style:italic">Confidential treatment is requested for portions of this exhibit that have been marked and omitted because the omitted information is both not material and is the type of information that the registrant treats as private or confidential pursuant to Item 601(b)(10)(iv) of Regulation <span style="white-space:nowrap">S-K.</span> The registrant undertakes to promptly provide an unredacted copy of the exhibit if requested by the Securities and Exchange Commission or its staff. </span></p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Forward-Looking Statements </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This Current Report on Form <span style="white-space:nowrap">8-K</span> contains certain &#8220;forward-looking statements&#8221; within the meaning of, and subject to the safe harbor created by Section&#160;27A of the Securities Act of 1933, as amended, Section&#160;21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based only on the Company&#8217;s current beliefs, expectations and assumptions regarding the future of the Company&#8217;s business, future plans and strategies, projections, anticipated events and other future conditions. In some cases, you can identify these statements by forward-looking words such as &#8220;believe,&#8221; &#8220;may,&#8221; &#8220;will,&#8221; &#8220;estimate,&#8221; &#8220;continue,&#8221; &#8220;anticipate,&#8221; &#8220;intend,&#8221; &#8220;could,&#8221; &#8220;should,&#8221; &#8220;would,&#8221; &#8220;project,&#8221; &#8220;plan,&#8221; &#8220;expect,&#8221; &#8220;goal,&#8221; &#8220;seek,&#8221; &#8220;future,&#8221; &#8220;likely,&#8221; or the negative or plural of these words or similar expressions. Examples of such forward-looking statements include, but are not limited to, express or implied statements regarding the Company&#8217;s expectations, hopes, beliefs, or intentions regarding: the Company&#8217;s ability to draw down sufficient funds against the Loan Agreement and the Company&#8217;s needs and expectations regarding existing and future capital resources and expenses and the Company&#8217;s need for additional capital. You are cautioned that such statements are not guarantees of future performance and that actual results or developments may differ materially from those set forth in these forward-looking statements. Factors that could cause actual results to differ materially from these forward-looking statements include, among others: the risk that the Company may be unable to satisfy conditions to drawdown or maintain compliance with the terms of the Loan Agreement; the risk that funds available under the Loan Agreement may be insufficient to fund the Company&#8217;s operations and development programs to the extent anticipated; and potential conflicts of interest arising from the Loan Agreement with an affiliate of the Company&#8217;s largest stockholder; and the other risks described from time to time in detail in the Company&#8217;s Annual Report on Form <span style="white-space:nowrap">10-K</span> for the fiscal year ended December&#160;31, 2025, as filed on March&#160;31, 2026, and the Company&#8217;s other reports and filings with the SEC from time to time, which are available on the Company&#8217;s website and at&#160;www.sec.gov. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The forward-looking statements and other information contained in this Current Report on Form <span style="white-space:nowrap">8-K</span> are made as of the date hereof, and the Company does not undertake any obligation to update publicly or revise any forward-looking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws. </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0">


<tr>

<td style="width:44%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:4%"/>

<td style="vertical-align:bottom"/>
<td style="width:5%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:44%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><span style="font-weight:bold">TUHURA BIOSCIENCES, INC.</span></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">Date: April&#160;22, 2026</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">/s/ </span>Dan Dearborn</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Name:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Dan Dearborn</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Title:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Chief Financial Officer</td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>2
<FILENAME>d139552dex41.htm
<DESCRIPTION>EX-4.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-4.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 4.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B></B><B><I>Execution Version</I></B><B> </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Loan Agreement </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">between
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TUHURA BIOSCIENCES, INC., </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>as Borrower </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PARKVIEW HOLDINGS ONE LLC, </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>as Lender </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">dated as of
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">April&nbsp;21, 2026 </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TABLE OF CONTENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="11%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="85%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE I Definitions and Interpretation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.01&#8195;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Definitions</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.02</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Interpretation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE II The Commitment and Loans</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.01</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Revolving Credit Commitment</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.02</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Procedures for Revolving Credit Borrowing</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.03</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Termination or Reduction of Revolving Credit Commitments</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.04</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Repayment of Loans; Evidence of Debt</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.05</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Optional Prepayments</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.06</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>[Reserved]</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.07</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>[Reserved]</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.08</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Interest</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.09</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Fees</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.10</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Computation of Interest and Fees</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.11</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>[Reserved]</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.12</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>[Reserved]</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.13</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>[Reserved]</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.14</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>[Reserved]</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE III Taxes, Yield Protection, and Illegality</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.01</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Taxes</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.02</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>[Reserved]</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.03</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>[Reserved]</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.04</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>[Reserved]</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.05</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Mitigation Obligations; Replacement of Lender</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE IV Conditions Precedent</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.01</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Conditions Precedent to Initial Loans</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.02</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Conditions Precedent to Each Loan</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE V Representations and Warranties</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">33</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.01</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Existence; Compliance with Laws</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">33</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.02</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Power; Authorization; Enforceability</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">33</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="11%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="85%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.03&#8195;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>No Contravention</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">33</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.04</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Financial Statements</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.05</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>No Material Adverse Effect</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.06</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>No Litigation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.07</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>No Default</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.08</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Ownership of Property; Liens</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.09</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Environmental Matters</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.10</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Insurance</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.11</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Material Contracts</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.12</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Intellectual Property</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.13</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Taxes</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.14</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>ERISA</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.15</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Margin Regulations</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">38</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.16</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Investment Company Act</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">38</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.17</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Subsidiaries; Equity Interests</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">38</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.18</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Labor Matters</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.19</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Disclosure</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.20</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Security Documents</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.21</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Solvency</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.22</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>USA PATRIOT Act; OFAC and Other Regulations</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.23</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Brokers&#8217; Fees</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">41</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE VI Affirmative Covenants</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">41</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.01</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Financial Statements</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">41</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.02</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Certificates; Other Information</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.03</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Payment Obligations</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.04</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Maintenance of Existence; Conduct of Business; Compliance</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.05</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Maintenance of Property; Insurance</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.06</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Inspection of Property; Books and Records; Discussions</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.07</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Notices</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.08</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Environmental Laws</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.09</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Performance of Material Contracts</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.10</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Use of Proceeds</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="11%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="85%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.11&#8195;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Anti-Corruption, Anti-Terrorism Laws, and Sanctions</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.12</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Additional Collateral, Etc.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.13</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Further Assurances</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE VII Negative Covenants</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.01</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Limitation on Debt</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.02</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Limitation on Liens</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.03</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Mergers; Nature of Business</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.04</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Limitation on Investments</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.05</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Limitation on Dispositions</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">56</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.06</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Intentionally omitted</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">57</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.07</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Limitation on Restricted Payments</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">57</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.08</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Limitation on Prepayments of Debt and Amendments of Debt Instruments</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">58</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.09</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Limitation on Transactions with Affiliates</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">59</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.10</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Limitation on Restrictive Agreements</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">59</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.11</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Limitation on Amendments of Material Contracts</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE VIII Events of Default and Remedies</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.01</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Events of Default</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.02</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Remedies Upon Event of Default</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">64</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE IX Miscellaneous</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.01</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Notices</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.02</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Amendments and Waivers</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">67</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.03</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Expenses; Indemnity; Damage Waiver</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">67</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.04</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Successors and Assigns</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">69</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.05</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Survival</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">71</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.06</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Counterparts; Integration; Effectiveness</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">71</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.07</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Severability</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">73</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.08</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Right of Setoff</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">73</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.09</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Governing Law; Jurisdiction; Consent to Service of Process</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">73</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.10</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>WAIVER OF JURY TRIAL</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">74</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.11</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Headings</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">74</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.12</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Confidentiality</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">75</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="11%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="85%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.13&#8195;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>USA PATRIOT Act and Anti-Money Laundering Laws</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">76</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.14</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Interest Rate Limitation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">77</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.15</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>No Advisory or Fiduciary Responsibility</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">77</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>INDEX OF APPENDICES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Exhibits* </U></B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="14%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="83%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Exhibit 2.02(a)(i)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">-</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form of Borrowing Notice</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Exhibit 2.02(a)(ii)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">-</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form of Revolving Credit Note</TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Schedules* </U></B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="14%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="83%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Schedule&nbsp;5.06</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">-</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Disclosed Litigation</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Schedule&nbsp;5.08</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">-</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Ownership of Property; Liens</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Schedule&nbsp;5.09</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">-</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Environmental Matters</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Schedule&nbsp;5.10</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">-</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Insurance</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Schedule&nbsp;5.13</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">-</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Taxes</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Schedule&nbsp;5.17</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">-</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Subsidiaries; Equity Interests</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Schedule&nbsp;7.01(d)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">-</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Debt</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Schedule&nbsp;7.02(i)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">-</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Liens</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Schedule&nbsp;7.04(b)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">-</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Investments</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Schedule&nbsp;7.10</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">-</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Restrictive Agreements</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>*</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Schedules and Exhibits omitted pursuant to Item 601(a)(5) of Regulation
<FONT STYLE="white-space:nowrap">S-K.</FONT> The Company agrees to furnish supplementally a copy of any omitted schedule or exhibit to the SEC upon request. </B></P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Loan Agreement </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Loan Agreement (this &#8220;<B>Agreement</B>&#8221;), dated as of April&nbsp;21, 2026, is entered into between TUHURA BIOSCIENCES, INC.,
a Nevada corporation (the &#8220;<B>Borrower</B>&#8221;), and PARKVIEW HOLDINGS ONE LLC, a Florida limited liability company (the &#8220;<B>Lender</B>&#8221;). </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RECITALS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the
Borrower desires that the Lender extend a revolving credit facility to the Borrower to provide the Borrower with working capital; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Borrower is willing to grant to the Lender a security interest in and lien upon substantially all of its personal and real
property constituting Collateral (subject to Liens permitted under this Agreement) to secure the Obligations; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, each of the
Borrower&#8217;s Subsidiaries is willing to guaranty all of the Obligations of the Borrower and to grant to the Lender a security interest in and lien upon substantially all of its other personal and real property constituting Collateral (subject to
Liens permitted under this Agreement) to secure the Obligations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NOW, THEREFORE, in consideration of the mutual covenants and agreements
hereinafter set forth and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows: </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE I </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DEFINITIONS
AND INTERPRETATION </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;1.01</B> <B>Definitions</B><B>.</B> As used in this Agreement, the following terms
shall have the meanings set forth below: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Affiliate</B>&#8221; means, as to any Person, any other Person that, directly or
indirectly through one or more intermediaries, is in control of, is controlled by, or is under common control with, such Person. For purposes of this definition, &#8220;control&#8221; of a Person means the power, directly or indirectly, to direct or
cause the direction of the management and policies of such Person, whether by contract or otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Annual Fee</B>&#8221; has
the meaning set forth in Section&nbsp;2.09(a). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Anti-Corruption Law</B>&#8221;<B> </B>means any Requirement of Law of any
jurisdiction related to bribery or corruption, including the United States Foreign Corrupt Practices Act of 1977 (15 U.S.C. &#167;&#167; <FONT STYLE="white-space:nowrap">78dd-1</FONT> to 78qq) and the UK Bribery Act 2010, in each case as amended
from time to time.<B> </B> </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Anti-Terrorism Law</B>&#8221; means any Requirement of Law related to money
laundering or financing terrorism including the USA PATRIOT Act, The Currency and Foreign Transactions Reporting Act (also known as the &#8220;<B>Bank Secrecy Act</B>,&#8221; 31 U.S.C. &#167;&#167; 5311 to 5330 and 12 U.S.C. &#167;&#167; 1818(s),
1820(b), and 1951 to 1959), the Trading With the Enemy Act (50 U.S.C. &#167;&#167; 4301 to 4341), and Executive Order 13224 (effective September&nbsp;24, 2001), in each case as amended from time to time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Available Revolving Credit Commitment</B>&#8221; means, at any time, an amount equal to the difference between the Revolving Credit
Commitment then in effect and the aggregate principal amount of Revolving Credit Loans outstanding at such time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Bankruptcy
Code</B>&#8221; means Title 11 of the United States Code or any similar federal or state law for the relief of debtors in effect from time to time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Beneficial Ownership Certification</B>&#8221; means a certification regarding beneficial ownership as required by the Beneficial
Ownership Regulation, in form and substance reasonably satisfactory to Lender. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Blocked Person</B>&#8221; means any Person that
(a)&nbsp;is publicly identified on the most current list of &#8220;Specially Designated Nationals and Blocked Persons&#8221; published by the Office of Foreign Assets Control of the US Department of the Treasury (&#8220;<B>OFAC</B>&#8221;) or
resides, is organized or chartered, or has a place of business in a country or territory subject to OFAC sanctions or embargo programs or (b)&nbsp;is publicly identified as prohibited from doing business with the United States under the
International Emergency Economic Powers Act, the Trading With the Enemy Act, or any other Requirement of Law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Board</B>&#8221;
means the Board of Governors of the Federal Reserve System of the United States (or any successor thereto). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Borrowing
Date</B>&#8221; means any Business Day specified by the Borrower in a Borrowing Notice as a date on which the Borrower requests the Lender to make a Loan hereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Borrowing Notice</B>&#8221; means, with respect to any request for a borrowing of Loans hereunder, a notice from the Borrower,
substantially in the form, and containing the information prescribed by, Exhibit 2.02(a)(i). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Business Day</B>&#8221; means a
day other than a Saturday, Sunday, or other day on which commercial banks in New York City are authorized or required by law to close. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Capital Lease Obligations</B>,&#8221; with respect to any Person, means the obligations of such Person to pay rent or other amounts
under any lease of (or other arrangement conveying the right to use) real or personal property, or a combination thereof, which obligations are required to be classified and accounted for as capital leases under GAAP on the balance sheet of such
Person and the amount of such obligations shall be the capitalized amount thereof determined in accordance with GAAP. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Cash Equivalents</B>,&#8221; as to any Person, means (a)&nbsp;securities issued or
directly and fully guaranteed or insured by the United States or any agency or instrumentality thereof (provided that the full faith and credit of the United States is pledged in support thereof) having maturities of not more than one (1)&nbsp;year
from the date of acquisition by such Person, (b)&nbsp;time deposits and certificates of deposit of any commercial bank having, or which is the principal banking subsidiary of a bank holding company organized under the laws of the United States, any
State thereof or, the District of Columbia having capital, surplus, and undivided profits aggregating in excess of $500,000,000, having maturities of not more than one (1)&nbsp;year from the date of acquisition by such Person, (c)&nbsp;repurchase
obligations with a term of not more than ninety (90)&nbsp;days for underlying securities of the types described in clause (a)&nbsp;above entered into with any bank meeting the qualifications specified in clause (b)&nbsp;above, (d) commercial paper
issued by any issuer rated at least <FONT STYLE="white-space:nowrap">A-1</FONT> by S&amp;P or at least <FONT STYLE="white-space:nowrap">P-1</FONT> by Moody&#8217;s (or carrying an equivalent rating by a nationally recognized rating agency if both of
the two named rating agencies cease publishing ratings of commercial paper issuers generally), and in each case maturing not more than one (1)&nbsp;year after the date of acquisition by such Person, or (e)&nbsp;investments in money market funds
substantially all of whose assets are comprised of securities of the types described in clauses (a)&nbsp;through (d) above. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Change in Law</B>&#8221; means the occurrence after the date of this Agreement of (a)&nbsp;the adoption or effectiveness of any law,
rule, regulation, judicial ruling, judgment, or treaty, (b)&nbsp;any change in any law, rule, regulation, or treaty or in the administration, interpretation, implementation, or application by any Governmental Authority of any law, rule, regulation,
or treaty, or (c)&nbsp;the making or issuance by any Governmental Authority of any request, rule, guideline, or directive, whether or not having the force of law; provided that, notwithstanding anything herein to the contrary (i)&nbsp;the Dodd-Frank
Wall Street Reform and Consumer Protection Act of 2010, as amended, and all requests, rules, guidelines, or directives thereunder or issued in connection therewith and (ii)&nbsp;all requests, rules, guidelines, or directives concerning capital
adequacy promulgated by the Bank for International Settlements, the Basel Committee on Banking Supervision (or any successor or similar authority), or US or foreign regulatory authorities shall, in each case, be deemed to be a &#8220;Change in
Law,&#8221; regardless of the date enacted, adopted, or issued. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Change of Control</B>&#8221; means (a)&nbsp;any Person or group
of persons within the meaning of &#167; 13(d)(3) of the Exchange Act, other than Lender or any Affiliate of Lender, becomes the beneficial owner, directly or indirectly, of 51% or more of the outstanding Equity Interests of the Borrower or
(b)&nbsp;individuals who constitute the Continuing Directors cease for any reason to constitute at least a majority of the board of directors of the Borrower. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Closing Date</B>&#8221; means the date on which the conditions precedent set forth
in Section&nbsp;4.01 are satisfied or waived. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Code</B>&#8221; means the Internal Revenue Code of 1986 as amended from time to
time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Collateral</B>&#8221; means the property covered by the Security Agreement, Pledge Agreement and the other Security
Documents and any other property, real or personal, tangible or intangible, now existing or hereafter acquired, that may at any time be or become subject to a security interest or Lien in favor of the Lender to secure the Obligations or any portion
thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Consolidated Net Income</B>&#8221; means, for any period, the consolidated net income (or loss) of the Borrower and
its Subsidiaries for such period, determined on a consolidated basis in accordance with GAAP. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Continuing Directors</B>&#8221;
means the directors of the Borrower on the Closing Date, after giving effect to the transactions contemplated hereby, and each other director if, in each case, such other director&#8217;s nomination for election to the board of directors of the
Borrower is recommended by at least a majority of the Continuing Directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Contractual Obligation</B>&#8221; means, for any
Person, any provision of any security issued by such Person or of any agreement, instrument, or other undertaking to which such Person is a party or by which it or any of its property is bound, other than the Obligations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Debt</B>&#8221; of any Person at any date, without duplication, means (a)&nbsp;all indebtedness of such Person for borrowed money,
(b)&nbsp;all obligations of such Person for the deferred purchase price of property or services (other than (i)&nbsp;trade payables incurred in the ordinary course of business and not past due for more than one hundred twenty (120)&nbsp;days after
the later of (x)&nbsp;the date of the invoice received by such Person for each such trade payable or account payable and (y)&nbsp;the date on which payment is required pursuant to the terms of any such invoice and (ii)&nbsp;any <FONT
STYLE="white-space:nowrap">earn-out,</FONT> purchase price adjustment, or similar obligation until such obligation appears in the liabilities section of the balance sheet of such Person), (c) all obligations of such Person evidenced by notes, bonds,
debentures, or other similar instruments, (d)&nbsp;all indebtedness created or arising under any conditional sale or other title retention agreement with respect to property acquired by such Person (even though the rights and remedies of the seller
or lender under such agreement in the event of default are limited to repossession or sale of such property), (e) all obligations of such Person to purchase, redeem, retire, defease, or otherwise make any payment in respect of any Equity Interests
in such Person or any other Person, or any warrants, rights, or options to acquire such Equity Interests, valued, in the case of redeemable preferred interests, at the greater of its voluntary or involuntary liquidation preference plus accrued and
unpaid dividends, (f)&nbsp;all obligations of such Person, contingent or otherwise, as an account party or applicant under acceptance, letter of credit, or similar facilities in respect of obligations of the kind referred
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
to in subsections (a)&nbsp;through (e) of this definition, (g)&nbsp;all Guaranty Obligations of such Person in respect of obligations of the kind referred to in subsections (a)&nbsp;through (f)
above, and (h)&nbsp;all obligations of the kind referred to in subsections (a)&nbsp;through (g) above secured by (or which the holder of such obligation has an existing right, contingent or otherwise, to be secured by) any Lien on property
(including accounts and contract rights) owned by such Person, whether or not such Person has assumed or become liable for the payment of such obligation, and (i)&nbsp;all net obligations of such Person in respect of Swap Agreements valued on any
date at the Swap Termination Value thereof as of such date, and (j)&nbsp;all debt of any partnership, unlimited liability company, or unincorporated joint venture in which such Person is a general partner, member, or a joint venturer, respectively
(unless such Debt is expressly made <FONT STYLE="white-space:nowrap">non-recourse</FONT> to such Person). The amount of any Debt of any Person for purposes of clause (h)&nbsp;that is expressly made
<FONT STYLE="white-space:nowrap">non-recourse</FONT> or limited-recourse (limited solely to the assets securing such Debt) to such Person shall be deemed to be equal to the lesser of (i)&nbsp;the aggregate principal amount of such Debt and
(ii)&nbsp;the fair market value of the property encumbered thereby as determined by such Person in good faith. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Debtor Relief
Law</B>&#8221; means the Bankruptcy Code and all other liquidation, bankruptcy, assignment for the benefit of creditors, conservatorship, moratorium, receivership, insolvency, rearrangement, reorganization, or similar debtor relief laws of the US or
other applicable jurisdictions in effect from time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Default</B>&#8221; means any of the events specified in
Section&nbsp;8.01 that constitute an Event of Default or that, upon the giving of notice, the lapse of time, or both pursuant to Section&nbsp;8.01 would, unless cured or waived, become an Event of Default. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Disclosed Litigation</B>&#8221; has the meaning set forth in Section&nbsp;5.06. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Disposition</B>&#8221; or &#8220;<B>Dispose</B>&#8221; means the sale, transfer, license, lease, or other disposition (whether in
one transaction or in a series of transactions, and including any sale and leaseback transaction) of any property (including, without limitation, any Equity Interests) by any Person (or the granting of any option or other right to do any of the
foregoing), including any sale, assignment, transfer, or other disposal, with or without recourse, of any notes or accounts receivable or any rights and claims associated therewith. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Dollars</B>&#8221; means the lawful currency of the United States. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Eligible Assignee</B>&#8221; has the meaning set forth in Section&nbsp;9.04(b). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Environmental Action</B>&#8221; means any action, suit, demand, demand letter, claim, notice of violation or <FONT
STYLE="white-space:nowrap">non-compliance,</FONT> notice of liability or potential liability, investigation, proceeding, consent order, or consent agreement relating in any way to any Environmental Law, any permit issued under any Environmental Law,
or any Hazardous Material, or arising from alleged injury or threat to health, safety, or the environment including (a)&nbsp;by any Governmental Authority for enforcement, <FONT STYLE="white-space:nowrap">clean-up,</FONT> removal, response, remedial
or other actions, or damages and (b)&nbsp;any Governmental Authority or third party for damages, contribution, indemnification, cost recovery, compensation, or injunctive relief. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Environmental Law</B>&#8221; means any and all Federal, state, foreign, local or
municipal laws, rules, orders, regulations, statutes, ordinances, codes, decrees, requirements of any Governmental Authority or other Requirements of Law (including common law) as now or may at any time hereafter be in effect, and any binding
judicial or administrative interpretation thereof, including any binding judicial or administrative order, consent decree or judgment, regulating, relating to, or imposing liability or standards of conduct concerning protection of the environment
or, to the extent relating to exposure to substances that are harmful or deleterious to the environment, of human health or safety. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Environmental Liability</B>&#8221; means any liability, contingent or otherwise (including any liability for damages, costs of
environmental investigation and remediation, costs of administrative oversight, fines, natural resource damages, penalties, or indemnities), of any Loan Party or any of its Subsidiaries directly or indirectly resulting from or based upon
(a)&nbsp;any actual or alleged violation of any Environmental Law, (b)&nbsp;the generation, use, handling, transportation, storage, treatment, or disposal of any Hazardous Material, (c)&nbsp;any actual or alleged exposure to any Hazardous Material,
(d)&nbsp;the Release or threatened Release of any Hazardous Material into the environment, or (e)&nbsp;any contract, agreement, or other consensual arrangement pursuant to which liability is assumed or imposed with respect to any of the foregoing.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Equity Interests</B>&#8221; means any and all shares, interests, participations, or other equivalents (however designated) of
capital stock of a corporation, any and all equivalent ownership (or profit) interests in a Person (other than a corporation), securities convertible into or exchangeable for shares of capital stock of (or other ownership or profit interests in)
such Person, and any and all warrants, rights, or options to purchase any of the foregoing, whether voting or nonvoting, and whether or not such shares, warrants, options, rights, or other interests are authorized or otherwise existing on any date
of determination. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>ERISA</B>&#8221; means the Employee Retirement Income Security Act of 1974 (29 U.S.C. &#167;&#167; 1001 to
1191c), as amended, and the rules and regulations promulgated thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>ERISA Affiliate</B>&#8221; means an entity, whether
or not incorporated, that is under common control with the Borrower within the meaning of &#167; 4001 of ERISA or is part of a group that includes the Borrower and that is treated as a single employer under &#167; 414 of the Code. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>ERISA Event</B>&#8221; means (a)&nbsp;a Reportable Event with respect to a Pension
Plan; (b)&nbsp;the failure by the Borrower or any ERISA Affiliate to meet all applicable requirements under the Pension Funding Rules or the filing of an application for the waiver of the minimum funding standards under the Pension Funding Rules;
(c)&nbsp;the incurrence by the Borrower or any ERISA Affiliate of any liability pursuant to Section&nbsp;4063 or 4064 of ERISA or a cessation of operations with respect to a Pension Plan within the meaning of Section&nbsp;4062(e) of ERISA;
(d)&nbsp;a complete or partial withdrawal by the Borrower or any ERISA Affiliate from a Multiemployer Plan or notification that a Multiemployer Plan is insolvent (within the meaning of Title IV of ERISA); (e) the filing of a notice of intent to
terminate a Pension Plan under, or the treatment of a Pension Plan amendment as a termination under, Section&nbsp;4041 of ERISA; (f)&nbsp;the institution by the PBGC of proceedings to terminate a Pension Plan; (g)&nbsp;any event or condition that
constitutes grounds under Section&nbsp;4042 of ERISA for the termination of, or the appointment of a trustee to administer, any Pension Plan; (h)&nbsp;the determination that any Pension Plan is in <FONT STYLE="white-space:nowrap">at-risk</FONT>
status (within the meaning of Section&nbsp;430 of the Code or Section&nbsp;303 of ERISA) or that a Multiemployer Plan is in endangered or critical status (within the meaning of Section&nbsp;432 of the Code or Section&nbsp;305 of ERISA); (i) the
imposition or incurrence of any liability under Title IV of ERISA, other than for PBGC premiums due but not delinquent under Section&nbsp;4007 of ERISA, upon the Borrower or any ERISA Affiliate; (j)&nbsp;the engagement by the Borrower or any ERISA
Affiliate in a transaction that could be subject to Section&nbsp;4069 or Section&nbsp;4212(c) of ERISA; (k)&nbsp;the imposition of a lien upon the Borrower pursuant to Section&nbsp;430(k) of the Code or Section&nbsp;303(k) of ERISA; or (l)&nbsp;the
making of an amendment to a Pension Plan that could result in the posting of bond or security under Section&nbsp;436(f)(1) of the Code. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Event of Default</B>&#8221; has the meaning set forth in Section&nbsp;8.01. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Exchange Act</B>&#8221; means the Securities Exchange Act of 1934, as amended from time to time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Expense Budget</B>&#8221; means, collectively, (i)&nbsp;the Company&#8217;s 2026 expense budget and quarterly cash flow statement
for 2026 as delivered to Lender and acknowledged by Lender on the Closing Date, (the &#8220;<B>Initial Expense Budget</B>&#8221;) and (ii)&nbsp;thereafter, each updated budget delivered pursuant to Section&nbsp;6.02(d) (in each case, with such
changes as may be approved in writing by the Lender in its sole discretion (such approval not to be unreasonably withheld, conditioned or delayed)). For the avoidance of doubt, the Expense Budget is provided to Lender solely for informational
purposes, and neither the delivery of the Expense Budget nor the Lender&#8217;s approval or rejection of any changes thereto shall be deemed to confer upon the Lender any right to direct, manage, or otherwise control the Borrower&#8217;s (or any of
its Subsidiaries&#8217;) expenditures, business, or operations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Excluded Foreign Subsidiary</B>&#8221; means any Subsidiary
that is not organized and existing under the laws of the United States or any state or commonwealth thereof, or under the laws of the District of Columbia, and in respect of which either (a)&nbsp;the pledge of all the Equity Interests of such
Subsidiary as Collateral or (b)&nbsp;a guarantee by such Subsidiary of the Obligations would, in the good faith judgment of the Borrower, result in the adverse tax consequences to the Borrower. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Excluded Taxes</B>&#8221; means any of the following Taxes, imposed on or with
respect to the Lender: (a)&nbsp;Taxes imposed on or measured by net income (however denominated) and franchise Taxes, (b)&nbsp;any branch profits Taxes imposed by the United States or any similar Tax imposed by any other jurisdiction and
(c)&nbsp;any U.S. federal withholding Taxes imposed under FATCA. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Existing Warrants</B>&#8221; means the warrants to purchase up
to 4,364,873 shares of the common stock of the Borrower issued on various dates from August&nbsp;31, 2022 through September&nbsp;18, 2024 by the Borrower and held by K&amp;V Investment One, LLC; provided, for purposes of clarity, that the warrants
issued pursuant to the Borrower&#8217;s registered direct offering on December&nbsp;9, 2025 shall be excluded from the definition of Existing Warrants. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>FATCA</B>&#8221; means Sections 1471 through 1474 of the Code, as of the date of this Agreement (or any amended or successor version
that is substantively comparable and not materially more onerous to comply with), any current or future regulations or official interpretations thereof, any agreements entered into pursuant to Section&nbsp;1471(b)(1) of the Code and any fiscal or
regulatory legislation, rules or practices adopted pursuant to any intergovernmental agreement, treaty or convention among Governmental Authorities and implementing such Sections of the Code. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Federal Funds Effective Rate</B>&#8221; means, for any day, the rate calculated by the Federal Reserve Bank of New York
(&#8220;<B>FRBNY</B>&#8221;) based on such day&#8217;s federal funds transactions by depository institutions as determined in such manner as shall be set forth on the FRBNY&#8217;s website from time to time and published on the next succeeding
Business Day by the FRBNY as the effective federal funds rate; provided, however, that if such rate shall be less than zero, such rate shall be deemed to be zero for all purposes of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Fee Letter</B>&#8221; has the meaning set forth in Section&nbsp;2.09(b). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Foreign Subsidiary</B>&#8221; means any Subsidiary of the Borrower that is not a Subsidiary that is organized and existing under the
laws of the United States or any state or commonwealth thereof or under the laws of the District of Columbia. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>GAAP</B>&#8221;
means generally accepted accounting principles in the United States as in effect as of the date of determination. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Governmental
Authority</B>&#8221; means the government of any nation or any political subdivision thereof, whether at the national, state, territorial, provincial, municipal, or any other level, and any agency, authority, instrumentality, regulatory body, court,
central bank, or other entity exercising executive, legislative, judicial, taxing, regulatory, or administrative powers or functions of, or pertaining to, government. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Guarantor</B>&#8221; means any Loan Party (other than the Borrower) that has
executed and delivered the Guaranty. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Guaranty</B>&#8221; means the Guaranty of the Obligations made by each Loan Party (other
than the Borrower) in favor of the Lender, dated as of April&nbsp;21, 2026, as the same may be amended, amended and restated, supplemented, or otherwise modified from time to time to the extent permitted under the Loan Documents. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Guaranty Obligation</B>&#8221; means, as to any Person, any (a)&nbsp;obligation, contingent or otherwise, of such Person
guaranteeing or having the effect of guaranteeing any Debt or other obligation payable or performable by another Person (the &#8220;primary obligor&#8221;) in any manner, whether directly or indirectly, and including any obligation of such Person,
direct or indirect, (i)&nbsp;to purchase or pay (or advance or supply funds for the purchase or payment of) such Debt or other obligation, (ii)&nbsp;to purchase or lease property, securities, or services for the purpose of assuring the obligee in
respect of such Debt or other obligation of the payment or performance of such Debt or other obligation, (iii)&nbsp;to maintain working capital, equity capital, net worth, or solvency or liquidity, or any level of income or cash flow of the primary
obligor so as to enable the primary obligor to pay such Debt or other obligation, or (iv)&nbsp;entered into for the purpose of assuring in any other manner the obligee in respect of such Debt or other obligation of the payment or performance thereof
or to protect such obligee against loss in respect thereof (in whole or in part) or (b)&nbsp;Lien on any assets of such Person securing any Debt or other obligation of any other Person, whether or not such Debt or other obligation is assumed by such
Person (or any right, contingent or otherwise, of any holder of such Debt to obtain any such Lien). The amount of any Guaranty Obligation shall be deemed to be an amount equal to the stated or determinable amount of the related primary obligation,
or portion thereof, in respect of which such Guaranty Obligation is made or, if not stated or determinable, the maximum reasonably anticipated liability in respect thereof as determined by the guaranteeing Person in good faith. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Hazardous Materials</B>&#8221; means all explosive or radioactive substances or wastes and all hazardous or toxic substances, wastes
or other pollutants, including (a)&nbsp;any gasoline, petroleum or petroleum products or <FONT STYLE="white-space:nowrap">by-products,</FONT> radioactive materials, friable asbestos or asbestos-containing materials, urea-formaldehyde insulation,
polychlorinated biphenyls, radon gas and infectious or medical wastes, and (b)&nbsp;any other chemicals, materials, or substances designated, classified, or regulated as hazardous or toxic or as a pollutant or contaminant under any Environmental
Law. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Indemnified Taxes</B>&#8221; means (a)&nbsp;Taxes, other than Excluded Taxes,
imposed on or with respect to any payment made by any Loan Party under any Loan Document and (b)&nbsp;to the extent not otherwise described in (a), Other Taxes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Insolvency</B>,&#8221; with respect to any Multiemployer Plan, means such Plan is insolvent within the meaning of &#167; 4245 of
ERISA. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Intellectual Property</B>&#8221; means any and all intellectual property, including copyrights, copyright licenses,
patents, patent licenses, trademarks, trademark licenses, technology, <FONT STYLE="white-space:nowrap">know-how,</FONT> and processes, all rights therein, and all rights to sue at law or in equity for any past, present, or future infringement,
violation, misuse, misappropriation, or other impairment thereof, whether arising under United States, multinational, or foreign laws, or otherwise, including the right to receive injunctive relief and all proceeds and damages therefrom. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Interest Payment Date</B>&#8221; means, as to any Loan, (i)&nbsp;the first day of each month to occur while such Loan is outstanding
and (ii)&nbsp;the Maturity Date of such Loan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Interest Rate</B>&#8221; means 12% per annum, simple interest. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>IFX</B>&#8221; means the proprietary innate immune agonist for cancer being developed by Borrower and its subsidiaries under the
name <FONT STYLE="white-space:nowrap">&#8220;IFx-2.0&#8221;.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Lending Office</B>&#8221; means the office or offices of
the Lender that the Lender may from time to time notify to the Borrower. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Lien</B>&#8221; means any mortgage, pledge,
hypothecation, assignment (as security), deposit arrangement, encumbrance, lien (statutory or other), charge, or other security interest, or any preference, priority, or other security agreement or preferential arrangement of any kind or nature
whatsoever having substantially the same economic effect as any of the foregoing (including any conditional sale or other title retention agreement and any capital lease). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Loan</B>&#8221; means any Revolving Credit Loan, and &#8220;<B>Loans</B>&#8221; means Revolving Credit Loans. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Loan Documents</B>&#8221; means, collectively, this Agreement, the Security Documents, the Revolving Credit Note, the Fee Letter,
the Royalty Agreement, and all other agreements, documents, certificates, and instruments, in each case, executed by or on behalf of a Loan Party and delivered to, or in favor of, the Lender and including all other pledges, powers of attorney,
consents, assignments, contracts, notices, and all other written matter whether heretofore, now or hereafter executed by or on behalf of any Loan Party and delivered to the Lender in connection with this Agreement or the transactions contemplated
thereby. Any reference in this Agreement or any other Loan Document to a Loan Document shall include all appendices, exhibits or schedules thereto, and all amendments, restatements, supplements or other modifications thereto, and shall refer to the
Agreement or such Loan Document as the same may be in effect at any and all times such reference becomes operative. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Loan Parties</B>&#8221; means the Borrower and each Subsidiary of the Borrower
that is or becomes a party to a Loan Document. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Margin Stock</B>&#8221; has the meaning specified in Regulation U. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Material Adverse Effect</B>&#8221; means any event, condition, or occurrence that could reasonably be expected to result in a
material adverse effect on (a)&nbsp;the business, assets, properties, liabilities (actual or contingent), operations, or condition (financial or otherwise) of the Borrower and its Subsidiaries, taken as a whole, (b)&nbsp;the validity or
enforceability of any Loan Document, (c)&nbsp;the perfection or priority of any Lien purported to be created by any Loan Document, (d)&nbsp;the rights or remedies of the Lender under any Loan Document, or (e)&nbsp;the ability of any Loan Party to
perform any of its obligations under any Loan Document to which it is a party. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Material Contracts</B>&#8221; means, any
contract or agreement of any Loan Party or any of its Subsidiaries (a)&nbsp;governing any Material Debt or pursuant to which any Material Debt was incurred or (b)&nbsp;the failure to renew, the breach,
<FONT STYLE="white-space:nowrap">non-performance,</FONT> or cancellation of which could reasonably be expected to have a Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Material Debt</B>&#8221; means Debt (other than the Loans) of any one or more of the Loan Parties and their Subsidiaries in an
aggregate principal amount exceeding $200,000. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Maximum Amount</B>&#8221; has the meaning set forth in Section&nbsp;2.02. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Maturity Date</B>&#8221; means April&nbsp;21, 2031. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Moody&#8217;s</B>&#8221; means Moody&#8217;s Investors Service, Inc., and any successor thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Multiemployer Plan</B>&#8221; means a Plan which is a multiemployer plan as defined in &#167; 4001(a)(3) of ERISA to which the
Borrower or any ERISA Affiliate makes or is obligated to make contributions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Net Profits</B>&#8221; means, for any period, an
amount equal to the sum of (a)&nbsp;Consolidated Net Income, <I>plus</I> (b)&nbsp;without duplication, the sum of (i)&nbsp;income Taxes, (ii)&nbsp;depreciation, (iii) amortization and <FONT STYLE="white-space:nowrap">(iv)&nbsp;non-cash</FONT>
expenses, <I>minus</I> (c)&nbsp;revenue that does not constitute revenue from the sale of pharmaceutical products in the ordinary course of business. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Net Profits Trigger Event</B>&#8221; means the date on which the Borrower has
generated positive Net Profits from the sale of pharmaceutical products for two (2)&nbsp;consecutive fiscal quarters. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Net
Profits Trigger Event Amount</B>&#8221; has the meaning set forth in Section&nbsp;2.04(a). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Obligations</B>&#8221; means all
advances to, and debts (including principal, interest, fees, costs, and expenses), liabilities, covenants, and indemnities of, any Loan Party arising under any Loan Document or otherwise with respect to any Loan, whether direct or indirect, absolute
or contingent, due or to become due, now existing or hereafter arising. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Other Taxes</B>&#8221; means any and all present or
future stamp, court, recording, filing, intangible, documentary, or similar Taxes or any other excise or property Taxes, charges, or similar levies arising from any payment made hereunder or under any other Loan Document or from the execution,
delivery, or enforcement or registration of, or performance under, or from the receipt or perfection of a security interest under or otherwise with respect to this Agreement or any other Loan Document (other than Excluded Taxes imposed with respect
to an assignment). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Parkview Director</B>&#8221; has the meaning set forth in Section&nbsp;6.06(c). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Participant</B>&#8221; has the meaning set forth in Section&nbsp;9.04(c). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Participant Register</B>&#8221; has the meaning set forth in Section&nbsp;9.04(c). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>PBGC</B>&#8221; means the Pension Benefit Guaranty Corporation established pursuant to Subtitle A of Title IV of ERISA (or any
successor thereto). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Pension Plan</B>&#8221; means any employee pension benefit plan (excluding a Multiemployer Plan) that is
maintained or is contributed to by the Borrower or any ERISA Affiliate or which the Borrower or any ERISA Affiliate has any liability, and is either covered by Title IV of ERISA or is subject to the minimum funding standards under Section&nbsp;412
of the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Pension Funding Rules</B>&#8221; means the rules of the Code and ERISA regarding minimum required contributions
(including any installment payment thereof) to a Pension Plan and a Multiemployer Plan and set forth in Section&nbsp;412, 430, 431, 432 and 436 of the Code and Sections&nbsp;302, 303, 304 and 305 of ERISA, and any sections of the Code or ERISA
related thereto that are enacted after the Closing Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Person</B>&#8221; means any individual, corporation, limited liability
company, trust, joint venture, association, company, limited or general partnership, unincorporated organization, Governmental Authority, or other entity. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Plan</B>&#8221; means, a Pension Plan and any &#8220;employee benefit plan&#8221;
that is covered by ERISA and in respect of which the Borrower or an ERISA Affiliate is (or, if such plan were terminated at such time, would under &#167; 4062 or &#167; 4069 of ERISA be deemed to be) an &#8220;employer&#8221; as defined in &#167;
3(5) of ERISA. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Pledge Agreement</B>&#8221; means the Pledge Agreement, dated as of April&nbsp;21, 2026, made by each Loan Party
that is signatory thereto in favor of the Lender as the same may be amended, amended and restated, supplemented, or otherwise modified from time to time to the extent permitted under the Loan Documents. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Projections</B>&#8221; has the meaning set forth in Section&nbsp;6.02. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Properties</B>&#8221; has the meaning set forth in Section&nbsp;5.09(a). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Release</B>&#8221; means any release, spill, emission, leaking, dumping, injection, pouring, deposit, disposal, discharge, dispersal
or leaching into the environment (including ambient air, surface water, groundwater, land surface or subsurface strata) or within any building, structure or facility. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Regulation U</B>&#8221;<B> </B>means Regulation U of the Board as in effect from time to time and all official rulings and
interpretations thereunder or thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Related Parties</B>&#8221; means, with respect to any Person, such Person&#8217;s
Affiliates and the directors, officers, employees, partners, agents, trustees, administrators, managers, advisors, and representatives of it and its Affiliates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Reorganization</B>&#8221; with respect to any Multiemployer Plan, means that such plan is in reorganization within the meaning of
&#167; 4241 of ERISA. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Reportable Event</B>&#8221; means any of the events set forth in &#167; 4043 of ERISA or the regulations
thereunder, other than those events as to which the <FONT STYLE="white-space:nowrap">thirty-day</FONT> notice period is waived. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Requirement of Law</B>&#8221; means, as to any Person, the certificate of incorporation and
<FONT STYLE="white-space:nowrap">by-laws</FONT> or other organizational or governing documents of such Person, and any law (including common law), statute, ordinance, treaty, rule, regulation, order, decree, judgment, writ, injunction, settlement
agreement, requirement or determination of an arbitrator or a court or other Governmental Authority, in each case applicable to or binding upon such Person or any of its property or to which such Person or any of its property is subject. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Responsible Officer</B>&#8221; means, with respect to any Person, the chief executive officer, president, or chief financial officer
of such Person, except that with respect to financial matters, the Responsible Officer shall be the chief financial officer or treasurer of such Person. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Restricted Payments</B>&#8221; has the meaning set forth in Section&nbsp;7.07.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Revolving Credit Commitment</B>&#8221; means the obligation of the Lender to make Revolving Credit Loans in an aggregate
principal amount not to exceed $50,000,000.00, as the same may be changed from time to time pursuant to the terms hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Revolving Credit Commitment Period</B>&#8221; means the period from and including the Closing Date to the Termination Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Revolving Credit Loans</B>&#8221; means any revolving credit loan made by the Lender under Section&nbsp;2.01. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Revolving Credit Note</B>&#8221; means a promissory note of the Borrower payable to the Lender, in substantially the form of Exhibit
2.02(a)(ii) hereto, evidencing the aggregate indebtedness of the Borrower to the Lender resulting from Revolving Credit Loans, as the same may be amended, amended and restated, supplemented, or otherwise modified from time to time to the extent
permitted under the Loan Documents. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Royalty Agreement</B>&#8221; means that certain Royalty Agreement, dated as of
April&nbsp;21, 2026, by and between the Borrower and the Lender, as the same may be amended, amended and restated, supplemented or otherwise modified from time to time to the extent permitted under the Loan Documents. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>S&amp;P</B>&#8221; means Standard&nbsp;&amp; Poor&#8217;s Ratings Services, a division of The McGraw-Hill Companies, Inc., and any
successor thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>SEC</B>&#8221; means the Securities and Exchange Commission (or successors thereto or an analogous
Governmental Authority). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>SEC Reports</B>&#8221; means the reports, schedules, forms, statements and other documents required to
be filed by the Borrower under the Securities Act and the Exchange Act, including pursuant to Section&nbsp;13(a) or 15(d) thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Securities Act</B>&#8221;<B> </B>means, the Securities Act of 1933 (15 U.S.C. &#167;&#167; 77a to 77aa) as amended from time to
time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Security Agreement</B>&#8221; means the Security Agreement, dated as of April&nbsp;21, 2026, made by each Loan Party that
is signatory thereto in favor of the Lender as the same may be amended, amended and restated, supplemented, or otherwise modified from time to time to the extent permitted under the Loan Documents. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Security Documents</B>&#8221; means the Guaranty, Security Agreement, Pledge
Agreement, any Intellectual Property Security Agreement (as defined in the Security Agreement) and all similar agreements required by or delivered to the Lender from time to time that purport to create a Lien in favor of the Lender to secure payment
or performance of the Obligations or any portion thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Solvent</B>&#8221; means, with respect to any Person as of any date
of determination, that on such date (a)&nbsp;the present fair salable value of the property and assets of such Person exceeds the debts and liabilities, including contingent liabilities, of such Person, (b)&nbsp;the present fair salable value of the
property and assets of such Person is greater than the amount that will be required to pay the probable liability of such Person on its debts and other liabilities, including contingent liabilities, as such debts and other liabilities become
absolute and matured, (c)&nbsp;such Person does not intend to incur, or believe (nor should it reasonably believe) that it will incur, debts and liabilities, including contingent liabilities, beyond its ability to pay such debts and liabilities as
they become absolute and matured, and (d)&nbsp;such Person does not have unreasonably small capital with which to conduct the business in which it is engaged as such business is now conducted and is proposed to be conducted. The amount of contingent
liabilities at any time shall be computed as the amount that, in the light of all the facts and circumstances existing at such time, represents the amount that can reasonably be expected to become an actual or matured liability. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Subsidiary</B>&#8221; means, as to any Person, any corporation, partnership, limited liability company, joint venture, trust, or
estate of or in which more than 50% of (a)&nbsp;the issued and outstanding capital stock having ordinary voting power to elect a majority of the board of directors of such corporation (irrespective of whether at the time capital stock of any other
class of such corporation may have voting power upon the happening of a contingency), (b) the interest in the capital or profits of such partnership, limited liability company, or joint venture or, (c)&nbsp;the beneficial interest in such trust or
estate is at the time directly or indirectly owned or controlled through one or more intermediaries, or both, by such Person. Unless otherwise qualified, all references to a &#8220;Subsidiary&#8221; or to &#8220;Subsidiaries&#8221; in this Agreement
shall refer to a Subsidiary or Subsidiaries of the Borrower. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Swap Agreement</B>&#8221; means any credit, equity, commodity or
commodity-related, currency, foreign exchange, or rate swap or derivatives contract or any contract or option related to, or any transaction similar to or with similar characteristics to, any of the foregoing, including any swap or derivative
related to any index. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Swap Termination Value</B>&#8221; means, in respect of any one or more Swap Agreements, after taking into
account the effect of any legally enforceable netting agreement relating to such Swap Agreements (a)&nbsp;for any date on or after the date such Swap Agreements have been closed out and termination values determined in accordance therewith, such
termination values and (b)&nbsp;for any date prior to the date referenced in subsection (a), the amounts determined as the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">mark-to-market</FONT></FONT> values for such Swap
Agreements, as determined based upon one or more <FONT STYLE="white-space:nowrap">mid-market</FONT> or other readily available quotations provided by any recognized dealer in such Swap Agreements (which may include the Lender or any Affiliate of the
Lender). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Taxes</B>&#8221; means any and all present or future income, stamp, or other
taxes, levies, imposts, duties, deductions, charges, fees, or withholdings imposed, levied, withheld, or assessed by any Governmental Authority, together with any interest, additions to tax, or penalties imposed thereon and with respect thereto.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Termination Date</B>&#8221; means the earliest to occur of (a)&nbsp;the Maturity Date and (b)&nbsp;the date on which the
maturity of the Loans is accelerated (or deemed accelerated) pursuant to Section&nbsp;8.02, (c) the date on which the Revolving Credit Commitment is reduced to zero pursuant to Section&nbsp;2.03. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>Uniform Commercial Code</B>&#8221; means the Uniform Commercial Code as in effect in the state of Florida from time to time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<B>USA PATRIOT ACT</B>&#8221; means the Uniting and Strengthening America by Providing Appropriate Tools Required to Intercept and
Obstruct Terrorism Act of 2001 (Title III of Pub. L. <FONT STYLE="white-space:nowrap">107-56</FONT> (signed into law October&nbsp;26, 2001)). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;1.02</B> <B>Interpretation</B><B>.</B> With reference to this Agreement and each other Loan Document, unless
otherwise specified herein or in such other Loan Document: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) The definitions of terms herein shall apply equally to the
singular and plural forms of the terms defined. Whenever the context may require, any pronoun shall include the corresponding masculine, feminine, and neuter forms. The words &#8220;include,&#8221; &#8220;includes,&#8221; and &#8220;including&#8221;
shall be deemed to be followed by the phrase &#8220;without limitation.&#8221; The word &#8220;will&#8221; shall be construed to have the same meaning and effect as the word &#8220;shall.&#8221; Unless the context requires otherwise (i)&nbsp;any
definition of or reference to any agreement, instrument, or other document shall be construed as referring to such agreement, instrument, or other document as from time to time amended, supplemented, or otherwise modified (subject to any
restrictions on such amendments, supplements, or modifications set forth herein or in any other Loan Document), (ii) any reference herein to any Person shall be construed to include such Person&#8217;s successors and assigns, (iii)&nbsp;the words
&#8220;herein,&#8221; &#8220;hereof,&#8221; and &#8220;hereunder,&#8221; and words of similar import when used in any Loan Document, shall be construed to refer to such Loan Document in its entirety and not to any particular provision thereof,
(iv)&nbsp;all references in a Loan Document to Articles, Sections, Exhibits, and Schedules shall be construed to refer to Articles and Sections of, and Exhibits and Schedules to, the Loan Document in which such references appear, (v)&nbsp;any
reference to any law shall include all statutory and regulatory </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
provisions consolidating, amending, replacing, or interpreting such law and any reference to any law or regulation shall, unless otherwise specified, refer to such law or regulation as amended,
modified, or supplemented from time to time, and (vi)&nbsp;the words &#8220;asset&#8221; and &#8220;property&#8221; shall be construed to have the same meaning and effect and to refer to any and all tangible and intangible assets and properties,
including cash, securities, accounts, and contract rights. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) In the computation of periods of time from a specified date
to a later specified date, the word &#8220;from&#8221; means &#8220;from and including;&#8221; the words &#8220;to&#8221; and &#8220;until&#8221; each mean &#8220;to but excluding;&#8221; and the word &#8220;through&#8221; means &#8220;to and
including.&#8221; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Any reference herein or in any other Loan Document to the satisfaction, repayment, or payment in
full of the Obligations shall mean the repayment in Dollars in full in cash or immediately available funds (and in the case of any other contingent Obligations, providing cash collateral or other collateral as may be requested by the Lender) of all
of the Obligations other than (i)&nbsp;unasserted contingent indemnification Obligations and (ii)&nbsp;any Obligations relating to Swap Agreements that, at such time, are allowed by the applicable provider of such Swap Agreements to remain
outstanding without being required to be repaid. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) All accounting terms not specifically or completely defined herein
shall be construed in conformity with, and all financial data required to be submitted pursuant to this Agreement shall be prepared in conformity with, GAAP as in effect from time to time and applied on a consistent basis in a manner consistent with
that used in preparing the Borrower&#8217;s audited financial statements, except as otherwise specifically prescribed herein. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) For all purposes under the Loan Documents, in connection with any division or plan of division under Delaware law (or any
comparable event under a different jurisdiction&#8217;s laws): (i) if any asset, right, obligation, or liability of any Person becomes the asset, right, obligation, or liability of a different Person, then it shall be deemed to have been transferred
from the original Person to the subsequent Person, and (ii)&nbsp;if any new Person comes into existence, such new Person shall be deemed to have been organized and acquired on the first date of its existence by the holders of its equity interests at
such time. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE II </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THE COMMITMENT AND LOANS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;2.01 Revolving Credit Commitment.</B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Subject to the terms and conditions of this Agreement, the Lender agrees to make Revolving Credit Loans to the Borrower
from time to time during the Revolving Credit Commitment Period in an aggregate principal amount at any one time outstanding not exceeding the amount of the Revolving Credit Commitment. During the Revolving Credit Commitment Period the Borrower may
use the Revolving Credit Commitments by borrowing, prepaying the Revolving Credit Loans in whole or in part, and reborrowing, all in accordance with the terms and conditions hereof. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) The Borrower shall repay all outstanding Revolving Credit Loans on the Termination Date; provided, if Lender elects to
convert all or a portion of the Revolving Credit Loans in accordance with Section&nbsp;8.02(c), this requirement shall be deemed to have been satisfied with respect to the portion of the Revolving Credit Loans that have been converted. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;2.02</B> <B>Procedures for Revolving Credit Borrowing</B><B>.</B> The Borrower may borrow under the Revolving
Credit Commitments on any Business Day during the Revolving Credit Commitment Period; provided that, the Borrower shall deliver to the Lender an irrevocable Borrowing Notice (which Borrowing Notice must be received by the Lender no later than 10:00
a.m. New York City time ten (10)&nbsp;days prior to the requested Borrowing Date. Each borrowing of Revolving Credit Loans shall be in an amount not to exceed the greater of (i) $1,700,000 and (ii)&nbsp;the amount set forth in the Expense Budget for
the immediately subsequent month after such Borrowing Notice is delivered to the Lender (such amount, the &#8220;<B>Maximum Amount</B>&#8221;); provided, that, in the event the principal amount of any borrowing of Revolving Credit Loans does not
exceed the Maximum Amount, the Borrower may, at its option, roll forward an amount equal to the difference between the Maximum Amount and the amount actually funded by Lender to Borrower in such month, to the immediately subsequent month (which, for
the avoidance of doubt, shall be deemed to increase the Maximum Amount for such month). Notwithstanding anything herein to the contrary, the Borrower may submit a maximum of one (1)&nbsp;Borrowing Notice per calendar month. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;2.03</B> <B>Termination or Reduction of Revolving Credit Commitments</B><B>.</B>&nbsp;Upon not less than three
(3)&nbsp;Business Days&#8217; notice to the Lender, the Borrower shall have the right to terminate the Revolving Credit Commitment or, from time to time, to reduce the aggregate amount of the Revolving Credit Commitment; provided, that no such
termination or reduction of Revolving Credit Commitment shall be permitted if, after giving effect thereto and to any prepayments of the Revolving Credit Loans made on the effective date thereof, the aggregate principal amount then outstanding of
all Revolving Credit Loans would exceed the Revolving Credit Commitment. Any such partial reduction shall be in an increment of $1,000,000 (or such lesser amount as agreed to by Lender in its sole discretion) and shall reduce permanently the
Revolving Credit Commitment then in effect. A notice of termination of the Revolving Credit Commitment delivered by the Borrower may state that such notice is conditioned upon the occurrence of any event specified therein, in which case such notice
may be revoked by the Borrower (by notice to the Lender on or prior to one Business Day before the specified effective date) if such condition is not satisfied. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;2.04 Repayment of Loans; Evidence of Debt.</B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Upon the occurrence of a Net Profits Trigger Event, the Borrower shall pay to the Lender in full in cash an amount equal to
seventy-five percent (75%) of the Net Profits for the last fiscal quarter in which the Net Profits Trigger Event occurred (the &#8220;<U>Net Profits Trigger Event Amount</U>&#8221;), which Net Profits Trigger Event Amount shall be applied by the
Lender to the outstanding principal amount of the Revolving Credit Loans; provided, that if the Net Profits Trigger Event Amount is greater than the outstanding principal amount of the Revolving Credit Loans as of the date of the Net Profits Trigger
Event, Borrower shall only be required to pay to the Lender such outstanding principal amount. For the avoidance of doubt, each payment of the Net Profits Trigger Event Amount shall be a <FONT STYLE="white-space:nowrap">one-time</FONT> prepayment of
principal, and shall be made without application of any prepayment premium or penalty, and without the requirement to provide notice in accordance with Section&nbsp;2.05. The Borrower shall make each such payment to the Lender within ten
(10)&nbsp;days following the earlier of (i)&nbsp;the date on which the Borrower is required to deliver financial statements pursuant to Sections 6.01(a) and 6.01(b) and (ii)&nbsp;the date on which the financial statements required to be delivered
pursuant to Sections 6.01(a) and 6.01(b) are filed for public availability on the SEC&#8217;s Electronic Data Gathering and Retrieval System. The Borrower hereby unconditionally promises to pay to the Lender in full in cash, to the extent not
previously paid, the then-unpaid principal amount of all Loans on the Maturity Date. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) The Lender shall maintain in
accordance with its usual practice an account or accounts evidencing indebtedness of the Borrower to the Lender resulting from each Loan, including the amounts of principal and interest payable and paid to the Lender from time to time under this
Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Upon the request of the Lender, the Borrower will promptly execute and deliver to the Lender a Revolving
Credit Note evidencing the Revolving Credit Loans. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;2.05</B> <B>Optional Prepayments</B><B>.</B> The
Borrower may at any time and from time to time prepay the Loans, in whole or in part, without premium or penalty, upon irrevocable notice delivered to the Lender no later than 11:00 a.m. New York City time at least three (3)&nbsp;Business Days prior
thereto, which notice shall specify the date and amount of such prepayment; provided that any such prepayment shall be in a principal amount of $1,000,000 (or such lesser amount as agreed to by Lender in its sole discretion), or, if less, the entire
principal amount thereof then outstanding. If any such notice is given, the amount specified in such notice shall be due and payable on the date specified therein, together with accrued interest to such date on the amount prepaid. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;2.06 [Reserved].</B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;2.07 [Reserved].</B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;2.08 Interest.</B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Each Loan shall bear interest on the outstanding principal amount thereof from the applicable Borrowing Date at a rate per
annum equal to the Interest Rate. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) If (i)&nbsp;all or any amount of principal of any Loan is not paid when due (without
regard to any applicable grace periods), whether at stated maturity, by acceleration, or otherwise, all outstanding Loans (whether or not overdue) shall bear interest at a rate per annum equal to the rate that would otherwise be applicable thereto
pursuant to paragraph (a)&nbsp;above plus six percent (6%) and shall be payable on demand, and (ii)&nbsp;if all or any portion of any interest on any Loan or any fee or other amount payable hereunder shall not be paid when due, whether at stated
maturity, by acceleration, or otherwise, such overdue amount shall bear interest at a rate per annum equal to the Interest Rate plus six percent (6%), payable on demand, in each case, from the date of such
<FONT STYLE="white-space:nowrap">non-payment</FONT> until such amount is paid in full. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Interest on each Loan shall be
due and payable in arrears on each Interest Payment Date applicable thereto and at such other times as may be specified herein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;2.09 Fees. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) The Borrower agrees to pay the Lender a fully earned and <FONT STYLE="white-space:nowrap">non-refundable</FONT> annual fee
(the &#8220;<B>Annual Fee</B>&#8221;) in an amount equal to 1.50% of the Revolving Credit Commitment. The Annual Fee shall be due and payable within ten (10)&nbsp;Business Days following each anniversary of the Closing Date until the Termination
Date, commencing with the first anniversary of the Closing Date. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) The Borrower agrees to pay the Lender the fees
specified in that certain fee letter of even date herewith between the Borrower and the Lender (the &#8220;<B>Fee Letter</B>&#8221;), at the times specified for payment therein. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;2.10 Computation of Interest and Fees.</B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) All computations of interest for Loans shall be made on the basis of a year of 365 or 366 days, as the case may be, and the
actual number of days elapsed. All other computations of fees shall be made on the basis of a <FONT STYLE="white-space:nowrap">360-day</FONT> year, and the actual number of days elapsed. Interest shall accrue on each Loan for the day on which the
Loan is made, and shall not accrue on a Loan, or any portion thereof, for the day on which the Loan or such portion is paid. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Each reasonable and good faith determination by the Lender of an applicable interest rate or any fee due hereunder made in
accordance with the terms of this Agreement shall be conclusive and binding on the Borrower and Lender for all purposes, absent demonstrable error. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;2.11 [Reserved]. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;2.12 [Reserved].</B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;2.13 [Reserved]. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;2.14</B> <B>[Reserved]</B>. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE III </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TAXES,
YIELD PROTECTION, AND ILLEGALITY </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;3.01 Taxes.</B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Any and all payments by or on account of any obligation of any Loan Party hereunder or under any other Loan Document shall
be made free and clear of and without deduction or withholding for any Taxes except as required by applicable law. If any Loan Party is required by applicable law to deduct or withhold any Taxes from such payments, then: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) if such Tax is an Indemnified Tax, the amount payable by the applicable Loan Party shall be increased so that after all
such required deductions or withholdings are made (including deductions or withholdings applicable to additional amounts payable under this Section), the Lender receives an amount equal to the amount it would have received had no such deduction or
withholding been made; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) the Loan Parties shall make such deductions or withholdings and timely pay the full amount
deducted or withheld to the relevant Governmental Authority in accordance with applicable law. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Without limiting the provisions of Section&nbsp;3.01(a) above, the Loan
Parties shall timely pay any Other Taxes to the relevant Governmental Authority in accordance with applicable law. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) The
Loan Parties shall indemnify the Lender, within ten (10)&nbsp;days after written demand therefor, for the full amount of any Indemnified Taxes (including Indemnified Taxes imposed on or attributable to amounts payable under this Section) paid or
payable by the Lender, on or with respect to an amount payable by any Loan Party under or in respect of this Agreement or under any other Loan Document, together with any reasonable out of pocket expenses incurred by Lender in connection therewith
and with respect thereto, whether or not such Indemnified Taxes were correctly or legally imposed or asserted by the relevant Governmental Authority. A certificate from the Lender as to the amount of such payment or liability delivered to the
Borrower shall be conclusive absent manifest error. Each Loan Party hereby authorizes the Lender to set off and apply any and all amounts at any time owing to such Loan Party under any Loan Document against any amount due to the Lender under this
paragraph (c). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) As soon as practicable after any payment of Taxes by any Loan Party to a Governmental Authority
pursuant to this Section&nbsp;3.01, such Loan Party shall deliver to the Lender the original or certified copy of a receipt issued by such Governmental Authority evidencing such payment, a copy of the relevant return reporting such payment, or other
evidence of such payment reasonably satisfactory to the Lender. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) If the Lender determines, in its sole discretion
exercised in good faith, that it has received a refund of any Taxes as to which it has been indemnified by any Loan Party or with respect to which any Loan Party has paid additional amounts pursuant to this Section, it shall pay over such refund (or
the amount of any credit in lieu of refund) to the applicable Loan Party (but only to the extent of indemnity payments made, or additional amounts paid, by the Borrower under this Section with respect to the Taxes giving rise to such refund or
credit in lieu of refund), net of all <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses of the Lender and without interest (other than any interest paid by the relevant Governmental Authority with
respect to such refund or credit in lieu of refund); provided that, the applicable Loan Party, upon the request of the Lender, agrees to repay the amount paid over to the applicable Loan Party (plus any interest, penalties, or other charges imposed
by the relevant Governmental Authority) to the Lender in the event the Lender is required to repay such refund or credit in lieu of refund to such Governmental Authority. Notwithstanding anything to the contrary in this paragraph (e), in no event
will the Lender be required to pay any amount to the applicable Loan Party pursuant to this paragraph if the payment of such amount would place the Lender in a less favorable net <FONT STYLE="white-space:nowrap">after-Tax</FONT> position than it
would have been in if the Tax subject to indemnification had not been deducted, withheld, or otherwise imposed and the indemnification payments or additional amounts with respect to such Tax had never been paid. Nothing in this paragraph
(e)&nbsp;shall be construed to require the Lender to make available its tax returns or any other information relating to its taxes that it deems confidential to the Borrower or any other Person. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;3.02 [Reserved]. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;3.03 [Reserved].</B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;3.04 [Reserved].</B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;3.05</B> <B>Mitigation Obligations; Replacement of Lender</B><B>.</B> If the Borrower is required to pay any
additional amount to the Lender or any Governmental Authority for the account of the Lender pursuant to Section&nbsp;3.01, then the Lender shall use reasonable efforts to designate a different Lending Office for funding or booking its Loans
hereunder or to assign its rights and obligations hereunder to another of its offices, branches, or Affiliates, if in the judgment of the Lender, such designation or assignment (i)&nbsp;would eliminate or reduce amounts payable pursuant to
Section&nbsp;3.01 in the future and (ii)&nbsp;in each case, would not subject the Lender to any unreimbursed cost or expense and would not otherwise be disadvantageous to the Lender. The Borrower hereby agrees to pay all reasonable costs and
expenses incurred by the Lender in connection with any such designation or assignment. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE IV </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONDITIONS PRECEDENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;4.01</B> <B>Conditions Precedent to Initial Loans</B><B>.</B> The obligation of the Lender to make the initial
Loans requested to be made by it hereunder is subject to the satisfaction or the waiver by the Lender of the following conditions precedent: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) The Lender shall have received a counterpart of: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) this Agreement, duly executed and delivered by an authorized officer of the Borrower; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) the Security Documents, Revolving Credit Note, Fee Letter and Royalty Agreement, in each case executed and delivered by
each Loan Party party thereto; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) The Lender shall have received: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) audited consolidated financial statements of the Borrower and its Subsidiaries for the most recent fiscal year ended prior
to the Closing Date as to which such financial statements are available; and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) unaudited interim consolidated financial statements of the Borrower and
its Subsidiaries for each quarter ended after the date of the latest applicable financial statements delivered pursuant to clause (i)&nbsp;of this Section&nbsp;4.01(b) as to which such financial statements are available, and such financial
statements shall not, in the reasonable judgment of the Lender, reflect any material adverse change in the consolidated financial condition of the Borrower, as reflected in the unaudited consolidated financial statements described in clause
(i)&nbsp;of this Section&nbsp;4.01(b); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Documents required to be delivered pursuant to this 4.01(b) may be delivered electronically, and if
so delivered, shall be deemed to have been delivered on the date on which such documents are filed for public availability on the SEC&#8217;s Electronic Data Gathering and Retrieval System; provided that the Borrower shall, upon request, provide to
the Lender by electronic mail electronic versions (soft copies or links to access such documents) or paper copies of such documents. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) All governmental and third party approvals necessary in connection with the continuing operations of the Loan Parties and
their Subsidiaries, and the transaction contemplated by the Loan Documents shall have been obtained and be in full force and effect, and all applicable waiting periods shall have expired without any action being taken or threatened in writing by any
competent authority that would restrain, prevent, or otherwise impose adverse conditions on the financing contemplated hereby; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) The Lender shall have received satisfactory evidence that the maturity date of the Existing Warrants shall have been
extended to a date that is no earlier than the Maturity Date; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) The Lender shall have received results of a recent lien
search in each of the jurisdictions where the Loan Parties are organized and the material assets of the Loan Parties are located, and such searches reveal no liens on any of the assets of the Loan Parties, except for Liens permitted under this
Agreement or discharged on or prior to the Closing Date pursuant to documentation satisfactory to the Lender; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) The
Lender shall have received all fees and expenses due and payable in connection with this Agreement and the Loans to be provided hereunder (including all reasonable fees, charges, and disbursements of legal counsel, <I>provided</I> that such expenses
are invoiced on or before the Closing Date; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) There shall have occurred no Material Adverse Effect since
December&nbsp;31, 2025; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) The Lender shall have received, in form and substance satisfactory to
it, a certificate of each Loan Party, certified by a secretary of each such Loan Party, dated the Closing Date, that: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i)
a certificate of formation, organization, or incorporation, as applicable, of each Loan Party certified by the relevant authority of the jurisdiction of organization of such Loan Party; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) <FONT STYLE="white-space:nowrap">by-laws,</FONT> operating agreements, and partnership agreements, as applicable, for each
Loan Party as in effect on the date on which the resolutions referred to below were adopted; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) resolutions of the
governing body of each Loan Party approving the transaction and each Loan Document to which it is or is to be a party, and of all documents evidencing other necessary corporate, partnership, or limited liability company action; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) a certification that the names, titles, and signatures of the officers of each Loan Party authorized to sign each Loan
Document to which it is or is to be a party and other documents to be delivered hereunder and thereunder are true and correct; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) a good standing certificate for each Loan Party from its jurisdiction of organization. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) The Lender shall have received favorable written opinions addressed to the Lender and dated as of the Closing Date from
(i)&nbsp;Foley&nbsp;&amp; Lardner LLP, counsel to the Loan Parties, in form and substance satisfactory to the Lender, and (ii)&nbsp;Holland&nbsp;&amp; Hart LLP, special Nevada counsel to the Borrower, in form and substance satisfactory to the
Lender. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j) The Lender shall have received satisfactory evidence that each document (including any UCC financing statement
and appropriate filings with the United States Patent and Trademark Office or the United States Copyright Office) required by the Security Documents or any Requirement of Law to be filed, registered, or recorded in order to create in favor of the
Lender a perfected first priority Lien on the Collateral described therein, prior and superior in right to any other Person (other than with respect to Liens expressly permitted under this Agreement), shall be in proper form for filing,
registration, and recording; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k) The Lender shall have received evidence of insurance coverage in form, scope, and
substance satisfactory to the Lender and otherwise in compliance with the terms of Section&nbsp;5.10 and Section&nbsp;6.05 of this Agreement; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l) The Lender shall have received all documentation and other information
required by regulatory authorities under applicable &#8220;know your customer&#8221; and anti-money laundering rules and regulations, including, without limitation, the USA PATRIOT Act; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(m) The Lender shall have received, at least five (5)&nbsp;Business Days prior to the Closing Date, to the extent the Borrower
qualifies as a &#8220;legal entity customer&#8221; under 31 C.F.R. &#167; 1010.230 (the &#8220;<B>Beneficial Ownership Regulation</B>&#8221;), a Beneficial Ownership Certification in relation to the Borrower, in each case requested at least ten
(10)&nbsp;Business Days prior to the Closing Date; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(n) The Lender shall have received a Borrowing Notice with respect
to the initial Loan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;4.02</B> <B>Conditions Precedent to Each Loan</B><B>.</B> The obligation of the Lender
to make each Loan requested to be made by it hereunder (including, without limitation, its initial Loan), is subject to the satisfaction or the waiver by the Lender of the following conditions precedent: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Each of the representations and warranties made by any Loan Party in or pursuant to the Loan Documents shall be true and
correct in all material respects (or, as to any representation and warranty that is qualified by materiality or Material Adverse Effect, in all respects) on and as of the date such Loan is made as if made on and as of such date, except to the extent
such representations and warranties specifically relate to an earlier date, in which case such representations and warranties shall have been true and correct in all material respects (or, as to any representation and warranty that is qualified by
materiality or Material Adverse Effect, in all respects) on such earlier date; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) No Default or Event of Default shall
have occurred and be continuing on such date or after giving effect to the Loans requested to be made on such date; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) The Lender shall have received a Borrowing Notice with respect to such Loan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each borrowing by the Borrower hereunder shall constitute a representation and warranty by the Borrower, as of the date such Loan is made,
that the conditions contained in this Article IV have been satisfied or waived. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE V </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>REPRESENTATIONS AND WARRANTIES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To induce the Lender to enter into this Agreement and to make the Loans hereunder and except as set forth in the schedules to this Agreement,
the Borrower hereby represents and warrants to the Lender that: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;5.01</B> <B>Existence; Compliance with
Laws</B><B>.</B> Each Loan Party (a)&nbsp;is duly organized, validly existing, and in good standing under the laws of the jurisdiction of its formation, (b)&nbsp;is duly qualified as a foreign corporation or other organization and in good standing
under the laws of each jurisdiction where its ownership, lease, or operation of property or the conduct of its business requires such qualification, except to the extent that the failure to qualify in such jurisdiction would not reasonably be
expected to have a Material Adverse Effect, and (c)&nbsp;is in compliance with all Requirements of Law, except to the extent that the failure to comply therewith would not, individually or in the aggregate, reasonably be expected to have a Material
Adverse Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;5.02 Power; Authorization; Enforceability.</B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Each Loan Party has the power and authority, and the legal right, to own or lease and operate its material property, and to
carry on its business as now conducted, and to execute, deliver, and perform the Loan Documents to which it is a party and, in the case of the Borrower, to obtain Loans hereunder. Each Loan Party has taken all necessary organizational action to
authorize the execution, delivery, and performance of the Loan Documents to which it is a party and, in the case of the Borrower, to authorize the borrowing of Loans on the terms and conditions contained herein. No consent or authorization of,
filing with, notice to, or other act by, or in respect of, any Governmental Authority or any other Person is required in connection with the extensions of credit hereunder or with the execution, delivery, performance, validity, or enforceability of
this Agreement or any of the Loan Documents. Each Loan Document has been duly executed and delivered by each Loan Party party thereto. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) This Agreement constitutes, and each other Loan Document when delivered hereunder will constitute, a legal, valid, and
binding obligation of each Loan Party party thereto, enforceable against each such Loan Party in accordance with its terms, except as enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium, or similar laws
affecting the enforcement of creditors&#8217; rights generally and by general equitable principles (whether enforcement is sought by proceedings in equity or at law). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;5.03</B> <B>No Contravention</B><B>.</B> The execution, delivery, and performance of this Agreement and the
other Loan Documents, the borrowing of Loans hereunder, and the use of the proceeds thereof will not violate any Requirement of Law or any Contractual Obligation of any Loan Party and will not result in, or require, the creation or imposition of any
Lien on any of their respective properties or assets pursuant to any Requirement of Law or any such Contractual Obligation (other than the Liens created by the Loan Documents). No Contractual Obligation applicable to any Loan Party would reasonably
be expected to have a Material Adverse Effect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;5.04 Financial Statements.</B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) The audited consolidated balance sheets of the Borrower and its Subsidiaries as at December&nbsp;31, 2025, and the related
consolidated statements of income and of cash flows for the fiscal year ended on such date, accompanied by an unqualified opinion (except for a going-concern qualification) from Cherry Bekaert LLP, independent public accountants, fairly present, in
all material respects, the consolidated financial condition of the Borrower and its Subsidiaries as at such date, and the consolidated results of their operations and their consolidated cash flows for the fiscal year then ended, in accordance with
GAAP. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) The unaudited consolidated balance sheets of the Borrower and its Subsidiaries as at December&nbsp;31, 2025, and
the related unaudited consolidated statements of income and of cash flows for the twelve-month period ended on such date, duly certified by the chief financial officer of the Borrower, present fairly, in all material respects, the consolidated
financial condition of the Borrower and its Subsidiaries as at such date, and the consolidated results of their operations and their consolidated cash flows for the twelve-month period then ended, in accordance with GAAP (subject to normal <FONT
STYLE="white-space:nowrap">year-end</FONT> audit adjustments and the absence of footnotes). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;5.05</B> <B>No
Material Adverse Effect</B><B>.</B> Since December&nbsp;31, 2025, no development, circumstance, or event has occurred that has had or would reasonably be expected to have a Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;5.06</B> <B>No Litigation</B><B>.</B> No action, suit, litigation, investigation, or proceeding of or before any
arbitrator or Governmental Authority is pending or, to the knowledge of the Borrower, threatened in writing by or against any Loan Party or against any of their respective property or assets (a)&nbsp;with respect to any of the Loan Documents or any
of the transactions contemplated hereby or thereby, or (b)&nbsp;that would reasonably be expected to have a Material Adverse Effect, other than that set forth on Schedule 5.06 (the &#8220;<B>Disclosed Litigation</B>&#8221;), and there has been no
adverse change in the status, or financial effect on the Borrower or any other Loan Party, of the Disclosed Litigation from that described on Schedule 5.06. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;5.07</B> <B>No Default</B><B>.</B> No Default or Event of Default has occurred and is continuing and no default
has occurred and is continuing under or with respect to any Contractual Obligation of the Borrower or any of its Subsidiaries that would reasonably be expected to have a Material Adverse Effect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;5.08 Ownership of Property; Liens.</B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Each Loan Party has fee simple title to, or a valid leasehold interest in, all its real property and good title to, or a
valid leasehold interest in, all its other property, except where the failure to have such title or interest would not reasonably be expected to have a Material Adverse Effect, and none of such property is subject to any Lien except as permitted by
Section&nbsp;7.02. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Part A of Schedule 5.08 sets forth a complete and accurate list as of the date hereof of all Liens
on the property or assets of any Loan Party, showing as of the date hereof the lienholder thereof and the property or assets of such Loan Party subject thereto. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Part B of Schedule 5.08 sets forth a complete and accurate list as of the date hereof of all real property owned by any
Loan Party or any of its Subsidiaries, showing as of the date hereof, the street address, county or other relevant jurisdiction, state, record owner, and book value thereof. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Part C of Schedule 5.08 sets forth a complete and accurate list as of the date hereof of all leases of real property under
which any Loan Party is the lessee, showing as of the date hereof, the street address, county or other relevant jurisdiction, state, lessor and lessee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;5.09</B> <B>Environmental Matters</B><B>.</B> Except as set forth on Schedule 5.09, and except with respect to
any matters that, individually or in the aggregate, would not reasonably be expected to have a Material Adverse Effect: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) none of the facilities or properties currently or formerly owned, leased, or operated by any Loan Party (the
&#8220;<B>Properties</B>&#8221;) contain or previously contained any Hazardous Materials in amounts or concentrations or under circumstances that constitute or constituted a violation of, or could result in liability under, any Environmental Law and
the Properties have obtained, maintained and complied with all permits, licenses, authorizations and other approvals required under any applicable Environmental Laws for its business and operations; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) no Loan Party has received any notice of actual or alleged violation,
<FONT STYLE="white-space:nowrap">non-compliance,</FONT> or liability regarding compliance with Environmental Laws or other environmental matters or with respect to any of the Properties or the business operated by any Loan Party; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">35 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) the Properties and all operations at the Properties are and formerly
have been in compliance with all applicable Environmental Laws, and, to the knowledge of Borrower, there is no contamination at, under, or about the Properties or violation of any Environmental Law with respect to the Properties or the business
operated by any Loan Party; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) to the knowledge of Borrower, Hazardous Materials have not been transported or disposed of
from the Properties in violation of any Environmental Law or that could result in Environmental Liability; to the knowledge of Borrower, no Hazardous Materials have been generated, treated, stored, or disposed of at, on, or under any of the
Properties in violation of any applicable Environmental Law or that could result in any Environmental Liability; and, to the knowledge of Borrower, there has been no Release or threat of Release of Hazardous Materials at or from the Properties, or
arising from or related to the operations of any Loan Party in connection with the Properties or the business operated by any Loan Party, in violation of or in amounts or in a manner that could reasonably be expected to result in Environmental
Liability; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) no administrative or governmental action or judicial proceeding is pending or, to the knowledge of the
Borrower, threatened in writing, under any Environmental Law to which any Loan Party is or will be a party with respect to the Properties or the business operated by any Loan Party, nor are there any decrees or orders or other administrative or
judicial requirements outstanding under any Environmental Law with respect to the Properties or the business operated by any Loan Party; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) no Loan Party has assumed any liability of any other Person under Environmental Laws or is subject to any Environmental
Liability; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) no Loan Party has received notice of any alleged or threatened Environmental Liability which remains
pending or is unresolved; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) no Loan Party has knowledge of any facts or circumstances that could reasonably form the
basis for any Environmental Liability; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) the Loan Parties have provided to the Lender copies of all existing
environmental reports, reviews and audits commissioned by, and in the possession or custody of, the Loan Parties pertaining to actual or alleged Environmental Liabilities relating to any real property owned or leased by any Loan Party. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">36 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;5.10</B> <B>Insurance</B><B>.</B> The properties of the Loan
Parties are insured with financially sound and reputable insurance companies that are not Affiliates of the Borrower, in such amounts, with such deductibles, and covering such risks as are customarily carried by companies engaged in similar
businesses and owning similar properties in localities where the applicable Loan Party operates. Schedule 5.10 sets forth a description of all insurance maintained by or on behalf of the Loan Parties as of the Closing Date. Each insurance policy
listed on Schedule 5.10 is in full force and effect and all premiums in respect thereof that are due and payable have been paid. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;5.11</B> <B>Material Contracts</B><B>.</B> The Loan Parties have delivered, if requested by the Lender, true,
correct, and complete copies of the Material Contracts to the Lender on or before the Closing Date. The Loan Parties are not in breach or in default in any material respect of or under any Material Contract and have not received any notice of the
intention of any other party thereto to terminate any Material Contract. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;5.12</B> <B>Intellectual
Property</B><B>.</B> Each Loan Party owns, or is licensed to use, all Intellectual Property necessary for the conduct of its business as currently conducted. No material claim has been asserted and is pending by any Person challenging the use,
validity, or effectiveness of any Intellectual Property of any Loan Party, nor is any Loan Party aware of any valid basis for any such claim. To the knowledge of each Loan Party, the use of Intellectual Property by each Loan Party does not
materially infringe on the rights of any Person. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;5.13</B> <B>Taxes</B><B>.</B>&nbsp;Each Loan Party has
filed all Federal, state, and other tax returns that are required to be filed and has paid all taxes shown thereon to be due, together with applicable interest and penalties, and all other taxes, fees, or other charges imposed on it or any of its
property by any Governmental Authority (except those that are currently being contested in good faith by appropriate proceedings and with respect to which reserves in conformity with GAAP have been provided on the books of the relevant Loan Party).
No tax Lien has been filed, and, to the knowledge of the Loan Parties, no claim is being asserted, with respect to any such tax, fee, or other charge. Except as set forth on Schedule 5.13, no Loan Party is a party to any tax sharing agreement, tax
allocation agreement, tax indemnity obligation or similar written or unwritten agreement, arrangement, understanding or practice with respect to Taxes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;5.14</B> <B>ERISA</B><B>.</B> Each Plan is in compliance with its terms and ERISA, the Code, and any Requirement
of Law in all material respects; neither a Reportable Event nor an &#8220;accumulated funding deficiency&#8221; (within the meaning of &#167; 412 or &#167; 430 of the Code or &#167; 302 of ERISA) has occurred (or is likely to occur) with respect to
any Plan. No Pension Plan has terminated, and no Lien has been incurred in favor of the PBGC or a Plan. Based on the assumptions used to fund each Pension Plan, the present value of all accrued benefits under each such Plan did not materially exceed
the value of the assets of such Plan allocable to such accrued benefit as of the last annual valuation date prior to the date on which this representation is made. Neither any Loan Party nor any ERISA Affiliate has incurred or is reasonably expected
to incur any Withdrawal Liability that would reasonably be expected to result in a material liability under ERISA, in connection with any Multiemployer Plan. No such Multiemployer Plan is (or is reasonably expected to be) terminated, in
Reorganization, or insolvent (within the meaning of &#167; 4245 of ERISA). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">37 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;5.15</B> <B>Margin Regulations</B><B>.</B> None of the
Borrower or any Subsidiary is engaged in the business of purchasing or carrying Margin Stock, or extending credit for the purpose of purchasing or carrying Margin Stock, and following application of the proceeds of the Loan, not more than 25% of the
value of the assets (either of the Borrower only or of the Borrower and its Subsidiaries on a consolidated basis) subject to the provisions of Section&nbsp;7.02 or Section&nbsp;7.05, or subject to the restrictions contained in any agreement or
instrument between the Borrower and the Lender or any Affiliate of the Lender relating to Debt within the scope of Section&nbsp;8.01(e), will be Margin Stock. For the purposes of this section, &#8220;assets&#8221; of the Borrower or any of its
Subsidiaries includes, without limitation, treasury stock of the Borrower that has not been retired. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;5.16</B> <B>Investment Company Act</B><B>.</B> No Loan Party is or is required to be registered as an
&#8220;investment company&#8221; under the Investment Company Act of 1940, as amended. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;5.17 Subsidiaries; Equity
Interests.</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Except as disclosed to the Lender by the Borrower in writing as of the Closing Date: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) Part A of Schedule 5.17 sets forth the exact legal name, address of principal place of business, jurisdiction of formation,
and US taxpayer identification number (or in the case of a <FONT STYLE="white-space:nowrap">non-US</FONT> Subsidiary that does not have a US taxpayer identification number, its unique identification number issued to it by its jurisdiction of
formation) of each Subsidiary and, as to each such Subsidiary, the percentage of each class of Equity Interest owned by any Loan Party; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) there are no outstanding subscriptions, options, warrants, calls, rights, or other agreements or commitments (other than
stock options granted to employees or directors and directors&#8217; qualifying shares) relating to any Equity Interest of the Borrower or any Subsidiary, except as created by the Loan Documents. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) All of the outstanding Equity Interests in each Subsidiary have been validly issued, are fully paid and <FONT
STYLE="white-space:nowrap">non-assessable,</FONT> and are owned by a Loan Party in the amounts specified on Part B of Schedule 5.17 free and clear of all Liens except those created under the Loan Documents. All of the outstanding Equity Interests in
the Borrower have been validly issued and are fully paid and <FONT STYLE="white-space:nowrap">non-assessable.</FONT> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">38 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) No Loan Party has any equity investments in any other corporation or
entity other than those disclosed on Part D of Schedule 5.17. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;5.18</B> <B>Labor Matters</B><B>.</B> Except
as, individually or in the aggregate, would not reasonably be expected to have a Material Adverse Effect, (a)&nbsp;there are no strikes, lockouts, or other labor disputes pending or, to the knowledge of any Loan Party, threatened in writing against
any Loan Party, (b)&nbsp;hours worked by and wages paid to employees of the Loan Parties and their Subsidiaries have not violated the Fair Labor Standards Act or any other applicable Requirement of Law, and (c)&nbsp;all payments due in respect of
employee health and welfare insurance from any Loan Party or any Subsidiary have been paid or properly accrued on the books of such Loan Party or such Subsidiary. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;5.19</B> <B>Disclosure</B><B>.</B> The Borrower has disclosed to the Lender all agreements, instruments, and
corporate or other restrictions to which it or any of its Subsidiaries is subject, and all other matters known to it, that, individually or in the aggregate, would reasonably be expected to have a Material Adverse Effect. No statement or information
contained in this Agreement, any other Loan Document, or any other document, certificate, or written statement furnished by or on behalf of the Borrower to the Lender, for use in connection with the transactions contemplated by this Agreement or the
other Loan Documents, contained as of the date such statement, information, document, or certificate was so furnished, any untrue statement of a material fact or omitted to state a material fact necessary to make the statement contained herein or
therein, in light of the circumstances in which they were made, not materially misleading. The projections included in such materials are based upon good faith estimates and assumptions believed by the Borrower to be reasonable at the time made; it
being recognized by the Lender that such projections as to future events are not to be viewed as fact and that actual results during the period or periods covered by the projections may differ from such projected results, and such differences may be
material. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;5.20</B> <B>Security Documents</B><B>.</B>&nbsp;The provisions of the Security Documents are
effective to create in favor of the Lender a legal, valid, continuing, and enforceable security interest in the Collateral, the enforceability of which is subject to applicable bankruptcy, insolvency, reorganization, moratorium, or other laws
affecting creditors&#8217; rights generally and subject to general principles of equity, regardless of whether considered in a proceeding in equity or at law. The financing statements, releases, and other filings are in appropriate form for filing
in the offices specified in Schedule 3 of the Security Agreement. Upon such filings and/or the obtaining of &#8220;control&#8221; (as defined in the Uniform Commercial Code), the Lender will have a perfected Lien on, and security interest in, to,
and under all right, title, and interest of the grantors thereunder in all Collateral that may be perfected by filing, recording, or registering a financing statement or analogous document (including without limitation the proceeds of such
Collateral subject to the limitations relating to such proceeds in the Uniform Commercial Code) or by obtaining control, under the Uniform Commercial Code (in effect on the date this representation is made), in each case prior and superior in right
to any other Person, except for Liens permitted under Section&nbsp;7.02. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">39 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;5.21</B> <B>Solvency</B><B>.</B> As of the Closing Date, after
giving effect to the incurrence of all Debt and obligations incurred in connection herewith, the Loan Parties, taken as a whole, are Solvent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;5.22 USA PATRIOT Act; OFAC and Other Regulations.</B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) No Loan Party, any of its Subsidiaries, or, to the knowledge of each Loan Party, any of the Affiliates or respective
officers, directors, brokers, or agents of such Loan Party, Subsidiary, or Affiliate: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) has violated any Anti-Terrorism
Laws or Anti-Corruption Laws; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) has engaged in any transaction, investment, undertaking, or activity that conceals
the identity, source, or destination of the proceeds from any category of prohibited offenses designated by the Organization for Economic <FONT STYLE="white-space:nowrap">Co-operation</FONT> and Development&#8217;s Financial Action Task Force on
Money Laundering. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) No Loan Party, any of its Subsidiaries, or, to the knowledge of each Loan Party, any of the
Affiliates or respective officers, directors, brokers, or agents of such Loan Party, Subsidiary, or Affiliate that is acting or benefiting in any capacity in connection with the Loans is a Blocked Person. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) No Loan Party, any of its Subsidiaries, or, to the knowledge of each Loan Party, any of the Affiliates or respective
officers, directors, brokers, or agents of such Loan Party, Subsidiary, or Affiliate acting or benefiting in any capacity in connection with the Loans: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) conducts any business or engages in making or receiving any contribution of goods, services, or money to or for the benefit
of any Blocked Person; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) deals in, or otherwise engages in any transaction related to, any property or interests in
property blocked pursuant to any Anti-Terrorism Law or Sanction; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) engages in or conspires to engage in any
transaction that evades or avoids, or has the purpose of evading or avoiding, or attempts to violate, any of the prohibitions set forth in any Anti-Terrorism Law, Anti-Corruption Law, or Sanction. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">40 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;5.23</B> <B>Brokers&#8217; Fees</B><B>. </B>None of the Loan
Parties or their Subsidiaries has any obligation to any Person in respect of any finder&#8217;s, broker&#8217;s, investment banking, or other similar fee in connection with this Agreement or any contemporaneous transaction, other than the closing
and other fees payable pursuant to this Agreement. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE VI </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AFFIRMATIVE COVENANTS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">So
long as the Lender has any Revolving Credit Commitment hereunder, or any Loans or any other amount payable hereunder or under any other Loan Document to the Lender has not been paid in full, the Borrower shall, and shall cause each of its
Subsidiaries to (except that, in the case of the covenants set forth in Section&nbsp;6.01, Section&nbsp;6.02, and Section&nbsp;6.07, the Borrower shall furnish all applicable materials to the Lender): </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;6.01</B> <B>Financial Statements</B><B>.</B> Furnish to the Lender: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) As soon as available, but in any event within ninety (90)&nbsp;days after the end of each fiscal year of the Borrower , a
copy of its audited consolidated balance sheet and related statements of operations, stockholders&#8217; equity, and cash flows as of the end of and for such year, setting forth in each case in comparative form the figures for the previous fiscal
year, all reported on by Charry Bekaert LLP or other independent certified public accountants of nationally recognized standing, without a &#8220;going concern&#8221; or similar qualification or exception and without any qualification or exception
as to the scope of the audit (except to the extent solely due to the scheduled occurrence of a maturity date within one year from the date of such audit), to the effect that such consolidated financial statements present fairly, in all material
respects, the financial position and results of operations of the Borrower and its consolidated Subsidiaries on a consolidated basis in accordance with GAAP consistently applied, and accompanied by management&#8217;s discussion and analysis prepared
by the Borrower with respect to the performance of the Borrower and its Subsidiaries for such fiscal year; provided that, in the event of any change in generally accepted accounting principles used in the preparation of such financial statements,
the Borrower shall also provide a reconciliation of such financial statements to GAAP; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) As soon as available, but in
any event within forty-five (45)&nbsp;days after the end of each of the first three fiscal quarters of each fiscal year of the Borrower, its unaudited consolidated balance sheet and related unaudited statements of operations, stockholders&#8217;
equity, and cash flows as of the end of and for such fiscal quarter and the then elapsed portion of the fiscal year, setting forth in each case in comparative form the figures for the corresponding period or periods (or, in the case of the balance
sheet, as of the end of the previous fiscal year), all certified by a Responsible Officer as presenting fairly, in all material respects, the financial position and results of operations of the Borrower and its consolidated Subsidiaries on a
consolidated basis in accordance with GAAP consistently applied, subject to normal <FONT STYLE="white-space:nowrap">year-end</FONT> audit adjustments and the absence of footnotes. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">41 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) As soon as available, but in any event within thirty (30)&nbsp;days
after the end of each month occurring during each fiscal year of the Borrower (other than March, June, September and December), its unaudited consolidated balance sheets and related unaudited consolidated statements of operations,
stockholders&#8217; equity, and cash flows as of the end of and for such month and the then elapsed portion of the fiscal year, setting forth in each case in comparative form the figures for the corresponding period of the previous fiscal year, all
certified by a Responsible Officer as presenting fairly, in all material respects, the financial position and results of operations of the Borrower and its consolidated Subsidiaries on a consolidated basis in accordance with GAAP consistently
applied, subject to normal <FONT STYLE="white-space:nowrap">year-end</FONT> audit adjustments and the absence of footnotes. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">Documents required to be delivered pursuant to Section&nbsp;6.01, Section&nbsp;6.02(b) and Section&nbsp;6.02(c) may be
delivered electronically, and if so delivered, shall be deemed to have been delivered on the date on which such documents are filed for public availability on the SEC&#8217;s Electronic Data Gathering and Retrieval System; provided that the Borrower
shall, upon request, provide to the Lender by electronic mail electronic versions (soft copies or links to access such documents) or paper copies of such documents; provided further, that the Borrower shall notify the Lender of the posting of any
such documents. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;6.02</B> <B>Certificates; Other Information</B><B>.</B> Furnish the following to the
Lender: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) As soon as available, but in any event concurrently with the delivery of the quarterly financial statements in
Section&nbsp;6.01(b), a reasonably detailed forecast for the next fiscal quarter prepared by the management of the Borrower, in form satisfactory to the Lender, of projected consolidated balance sheets, income statements, and statements of cash
flows, projected changes in financial position, and a description of the underlying assumptions applicable thereto, and as soon as available, significant revisions, if any, of such forecasts with respect to such fiscal quarter (the
&#8220;<B>Projections</B>&#8221;), which Projections shall in each case be accompanied by a certificate of the Responsible Officer stating that such Projections are based on reasonable estimates, information, and assumptions, prepared in good faith;
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">42 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) On the same dates as delivery of the quarterly or annual financial
statements in Section&nbsp;6.01(a) and Section&nbsp;6.01(b), a compliance certificate from a Responsible Officer of the Borrower (i)&nbsp;certifying as to whether a Default has occurred and, if a Default has occurred, specifying the details thereof
and any action taken or to be taken with respect thereto, (ii)&nbsp;stating whether any change in GAAP or in the application thereof has occurred since the date of the audited financial statements referred to in Section&nbsp;5.04 and
Section&nbsp;5.05 and, if any such change has occurred, specifying the effect of such change on the financial statements accompanying such certificate, and (iii)&nbsp;setting forth a written calculation of the Net Profits for the fiscal quarter
covered by such quarterly financial statements (or, in the case of annual financial statements delivered pursuant to Section&nbsp;6.01(a), the last fiscal quarter of the fiscal year covered by such annual financial statements) and, if applicable,
the Net Profits Trigger Event Amount, which calculation shall be presented in reasonable detail and certified as correct by such Responsible Officer; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Promptly after becoming available, copies of all proxy statements, financial statements, reports, and other financial
information that any Loan Party or any of its Subsidiaries sends to any of its securities holders, and copies of all reports and registration statements that any Loan Party or any of its Subsidiaries files with the SEC or any national securities
exchange or other regulatory authority. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) As soon as available, but in any event within sixty (60)&nbsp;days after the
end of each fiscal year of the Borrower (commencing with the fiscal year ending December&nbsp;31, 2027), an updated budget for the next fiscal year prepared by the management of the Borrower, in substantially the form of the Initial Expense Budget
or any other form approved by the Lender. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) A list of all Intellectual Property owned by or licensed to or leased by any
Loan Party and any of its Subsidiaries as of the Closing Date and a list of any Intellectual Property acquired by any Loan Party since the date of the most recent report delivered under this clause (or, in the case of the first such report so
delivered, since the Closing Date), on the same dates as delivery of the compliance certificate under Section&nbsp;6.02(b); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) Promptly, and in any event within ten (10)&nbsp;days prior to the occurrence of any change in the (i)&nbsp;legal name,
(ii)&nbsp;jurisdiction of organization, or (iii)&nbsp;type of organization of any Loan Party or any of its Subsidiaries, to the extent not previously disclosed to the Lender, a description of such change, and upon request of the Lender, take all
actions and provide all documentation required to continue the perfection and the same priority in the Liens on the Collateral under the Loan Documents following any such change; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) Promptly after the same are sent, copies of any statement or report sent to any holder of debt securities of any Loan Party
or any of its Subsidiaries under the terms of any indenture, loan agreement, or similar agreement that constitutes Material Debt and not otherwise required to be furnished to the Lender under any other clause of this Section; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">43 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) Promptly upon receipt of the same, copies of all notices, requests, and
other documents received by any Loan Party or any of its Subsidiaries under any Material Contract or instrument, indenture, or loan agreement regarding or related to any breach or default by any party thereto or any other event that would reasonably
be expected to have a Material Adverse Effect and copies of the foregoing; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) As soon as available, and in any event
within thirty (30)&nbsp;days after cancellation or expiration of any insurance coverage identified on any prior report, a report summarizing the insurance coverage (specifying type, amount, and carrier) in effect for the Loan Parties and their
Subsidiaries and containing such additional information as the Lender may reasonably specify; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j) Such other information
and documentation (i)&nbsp;respecting the business, financial condition, operations, performance, properties, or prospects of any Loan Party or any of its Subsidiaries, or compliance with the terms of the Loan Documents, as the Lender may from time
to time reasonably request (it being understood and agreed that no Loan Party nor any of its Subsidiaries shall be required to disclose or discuss, or permit the inspection, examination or making of extracts of, any records, books, information or
account or other matter (A)&nbsp;in respect of which disclosure to the Lender or its representatives is then prohibited by applicable law or any agreement binding on any Loan Party or any of its Subsidiaries, (B)&nbsp;that is protected from
disclosure by the attorney-client privilege or the attorney work product privilege or (C)&nbsp;constitutes <FONT STYLE="white-space:nowrap">non-financial</FONT> trade secrets or <FONT STYLE="white-space:nowrap">non-financial</FONT> proprietary
information), and (ii)&nbsp;requested by the Lender for purposes of compliance with applicable &#8220;know your customer&#8221; and anti-money laundering rules and regulations, including the USA PATRIOT Act and the Beneficial Ownership Regulation.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;6.03</B> <B>Payment Obligations</B>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pay, discharge, or otherwise satisfy before they become delinquent all of its (i)&nbsp;material Taxes and (ii)&nbsp;material obligations of
whatever nature, except in each case where the amount or validity thereof is currently being contested in good faith by appropriate proceedings and adequate reserves, if applicable, in conformity with GAAP with respect thereto, have been provided on
its books. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">44 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;6.04 Maintenance of Existence; Conduct of Business; Compliance.</B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) (i) Preserve, renew, and maintain in full force and effect its corporate or organizational existence and (ii)&nbsp;take all
action to maintain all rights, licenses, permits, consents, privileges, and franchises necessary or desirable in the normal conduct of its business, except, in each case, as otherwise permitted under this Agreement and except, as in the case of
clause (ii)&nbsp;above, to the extent that failure to do so would not reasonably be expected to have a Material Adverse Effect. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Comply with all Contractual Obligations, Material Contracts and Requirements of Law, except to the extent that failure to
comply therewith would not, in the aggregate, reasonably be expected to have a Material Adverse Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;6.05 Maintenance
of Property; Insurance.</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Maintain and preserve all of its property necessary in its business in good working order
and condition, ordinary wear and tear excepted. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Maintain insurance with respect to its property and business
(including without limitation, property and casualty, product liability, and business interruption insurance) with financially sound and reputable insurance companies that are not Affiliates of the Borrower, in such amounts and covering such risks
as are usually insured against by similar companies engaged in the same or a similar business. In the case of liability and property insurance policies with respect to the Collateral, (i)&nbsp;the Lender shall be named as additional insured, in the
case of liability insurance, or loss payee, in the case of property insurance with respect to the Collateral, as applicable, and (ii)&nbsp;each insurance policy will provide by endorsement upon the policy or other written instrument furnished to the
Lender, that (x)&nbsp;the insurer will give the Lender thirty (30)&nbsp;days&#8217; written notice before any such policy will be changed or canceled, and (y)&nbsp;no act or default of any Loan Party or any other Person will affect the rights of the
Lender under such policy. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;6.06 Inspection of Property; Books and Records; Discussions.</B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Keep proper books of records and accounts, in which full, true, and correct entries in conformity with GAAP and all
Requirements of Law shall be made of all dealings and transactions and assets in relation to its business and activities. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Permit the Lender to visit and inspect any of its properties and examine and make abstracts from any of its books and
records at any reasonable time, with at least three (3)&nbsp;Business Days&#8217; advance notice (except no notice shall be required during the occurrence and continuance of an Event of Default), and as often as it may reasonably be desired and to
discuss its business operations, properties, and financial and other condition with its officers and employees and its independent certified public accountants. Upon the occurrence and during the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">45 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
continuance of an Event of Default, each Loan Party will, and will cause each of its Subsidiaries to, permit any representatives designated by the Lender (including any consultants, accountants,
lawyers, advisors and appraisers retained by the Lender) to conduct evaluations and appraisals of the Loan Parties&#8217; assets, including, without limitation, environmental audits and appraisals of the real property owned by the Loan Parties and
their Subsidiaries, all at such reasonable times and as often as requested. The Borrower shall only be required to pay the reasonable fees and expenses of any representatives retained by the Lender to conduct any such evaluation or appraisal if an
Event of Default has occurred and is continuing. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Permit, if requested by the Lender, (i)&nbsp;the appointment of a
director selected by the Lender to serve on the board of directors of the Borrower (the &#8220;<B>Parkview Director</B>&#8221;), which such director shall have all of the same rights as and obligations of the other members of such board of
directors, and (ii)&nbsp;subject to the rules and regulations of (A)&nbsp;the SEC and (B)&nbsp;any national securities exchange on which the Equity Interests of the Borrower are listed, any then serving Parkview Director to serve on the audit
committee of the board of directors of the Borrower. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;6.07</B> <B>Notices</B><B>.</B> Promptly, and in any
event within five (5)&nbsp;days following Borrower&#8217;s knowledge thereof, give notice to the Lender of: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) The
occurrence of any Default or Event of Default; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Any (i)&nbsp;default or event of default under any Contractual
Obligation of any Loan Party or any of its Subsidiaries, (ii)&nbsp;default or event of default under any Material Contract of any Loan Party or any of its Subsidiaries, or (iii)&nbsp;litigation, investigation, or proceeding that may exist at any
time between any Loan Party or any of its Subsidiaries and any Governmental Authority, that in each case, if not cured or if adversely determined, as the case may be, would reasonably to be expected to have a Material Adverse Effect; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Any litigation or proceeding affecting any Loan Party or any of its Subsidiaries, (i)&nbsp;that would reasonably be
expected to result in a liability of such Loan Party or any of its Subsidiaries (to the extent not paid or fully covered by insurance from a reputable and solvent independent third party insurance company as to which the relevant insurance company
has been notified and has not denied coverage,) in an amount in excess of $250,000, (ii) in which injunctive or similar relief is sought which would reasonably be expected to have a Material Adverse Effect, or (iii)&nbsp;which relates to any Loan
Document; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) The occurrence of any ERISA Event that, alone or together with any other ERISA Events that have occurred,
could reasonably be expected to have a Material Adverse Effect; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">46 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) Any change in the information provided in the Beneficial Ownership
Certification delivered to the Lender that would result in a change to the list of beneficial owners identified in such certification; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) The occurrence of any material event or any other development by which any Loan Party or any of its Subsidiaries
(i)&nbsp;fails to comply with any Environmental Law or to obtain, maintain or comply with any permit, license or other approval required under any Environmental Law, (ii)&nbsp;becomes subject to any material Environmental Liability,
(iii)&nbsp;receives notice of any material claim with respect to any Environmental Liability, or (iv)&nbsp;becomes aware of any basis for any Environmental Liability and in each of the preceding clauses, which individually or in the aggregate, would
reasonably be expected to result in a Material Adverse Effect; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) Any development or event that has had or would
reasonably be expected to have a Material Adverse Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each notice under this Section&nbsp;6.07 shall be accompanied by a statement of
a Responsible Officer of the Borrower setting forth details of the occurrence referred to therein and stating what action the relevant Loan Party or any of its Subsidiaries proposes to take with respect thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;6.08 Environmental Laws.</B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Comply and maintain in all material respects, and ensure the same in all material respects by all tenants and subtenants,
if any, with all applicable Environmental Laws in all jurisdictions in which the Loan Parties or their Subsidiaries are doing business, and obtain any and all licenses, approvals, notifications, registrations, or permits required by applicable
Environmental Laws. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Use commercially reasonable efforts to conduct and complete all investigations, studies, sampling,
and testing, and all remedial, removal, and other actions necessary to remove and clean up all Hazardous Materials from any of its properties required under Environmental Laws and promptly comply in all material respects with all lawful orders and
directives of all Governmental Authorities regarding Environmental Laws, except to the extent that the same are being contested in good faith by appropriate proceedings. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;6.09</B> <B>Performance of Material Contracts</B><B>. </B>Perform and observe all the terms and provisions of
each such Material Contract to be performed or observed by it, maintain each Material Contract in full force and effect, and enforce each such Material Contract in accordance with its terms, except, in any case, where the failure to do so, either
individually or in the aggregate, would not have a Material Adverse Effect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">47 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;6.10</B> <B>Use of Proceeds</B><B>.</B> Use the proceeds of
the Loans for working capital in the ordinary course of business and other general corporate purposes of the Borrower and its Subsidiaries to the extent not prohibited under any Requirement of Law or the Loan Documents. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;6.11 Anti-Corruption, Anti-Terrorism Laws, and Sanctions. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Borrower will maintain and enforce policies and procedures designed to ensure that it and its Subsidiaries, and their respective directors,
officers, employees, and agents comply in all material respects with applicable Anti-Corruption Laws, Anti-Terrorism Laws, and Sanctions, including the USA PATRIOT Act and the Beneficial Ownership Regulation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;6.12 Additional Collateral, Etc.</B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) With respect to any personal property, intangible property, or leasehold interests in any real property acquired after the
Closing Date by any Loan Party or any of its Subsidiaries that is intended to be subject to a Lien created by any Loan Document, other than (i)&nbsp;property described in clauses (b)&nbsp;or (c) below, and (ii)&nbsp;any property subject to a Lien
expressly permitted by this Agreement as to which the Lender does not have a perfected Lien, promptly, and in any event within thirty (30)&nbsp;days of acquiring such property: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) execute and deliver to the Lender such supplements or amendments to the Security Documents or such other documents as the
Lender deems necessary or advisable to grant to the Lender a perfected first priority security interest in such property; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) take all actions necessary or advisable to grant to the Lender a perfected first priority security interest in such
property, including the filing of <FONT STYLE="white-space:nowrap">UCC-1</FONT> financing statements in such jurisdictions as may be required by the Security Agreement or by law or as may be requested by the Lender. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) With respect to any new Subsidiary (other than an Excluded Foreign Subsidiary) created or acquired after the Closing Date
by any Loan Party or any of its Subsidiaries (which, for the purposes of this clause (b), shall include any existing Subsidiary that ceases to be an Excluded Foreign Subsidiary), promptly, and in any event within thirty (30)&nbsp;days of the
creation or acquisition of such Subsidiary: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) execute and deliver to the Lender such supplements or amendments to any
existing Guaranty, if deemed necessary or advisable in connection with the new Subsidiary, and any Loan Document acceptable to the Lender as the Lender deems necessary or advisable to grant to the Lender a perfected first priority security interest
in the Equity Interests of such new Subsidiary that are owned by any Loan Party or any of its Subsidiaries; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">48 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) deliver to the Lender the certificates representing such Equity
Interests and any other Equity Interests, owned by any such Subsidiary, together with undated stock powers, in blank, executed by a duly authorized officer of the relevant Loan Party or its Subsidiary; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) cause such new Subsidiary (x)&nbsp;to become a party to the Security Documents, and (y)&nbsp;to take all actions
necessary or desirable to grant to the Lender a perfected first priority security interest in the Collateral described in the Security Documents with respect to such new Subsidiary, including the filing of
<FONT STYLE="white-space:nowrap">UCC-1</FONT> financing statements in such jurisdictions as may be required by the Security Agreement or by law or as may be requested by the Lender, including the delivery of (A)&nbsp;any stock certificates
representing equity owned by the new Subsidiary, along with any requested stock powers for each stock certificate, or (B)&nbsp;promissory notes held by the new Subsidiary as may be requested by the Lender; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) if requested by the Lender, deliver to the Lender a secretary&#8217;s certificate of such Subsidiary, with charter
documents, <FONT STYLE="white-space:nowrap">by-laws,</FONT> and appropriate resolutions attached; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) if requested by
the Lender, deliver to the Lender (x)&nbsp;legal opinions relating to the matters described above, which opinions shall be in form and substance, and from counsel, satisfactory to the Lender, and (y)&nbsp;all documentation and other information that
the Lender reasonably requests in order to comply with its obligations under applicable &#8220;know your customer&#8221; and anti-money laundering rules and regulations, including the USA PATRIOT Act and the Beneficial Ownership Regulation </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) With respect to any new Excluded Foreign Subsidiary created or acquired after the Closing Date by any Loan Party (other
than by a Loan Party that is an Excluded Foreign Subsidiary), promptly, and in any event within thirty (30)&nbsp;days of the creation or acquisition of such Excluded Foreign Subsidiary: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) execute and deliver to the Lender such supplements or amendments to the Security Agreement as the Lender deems necessary or
advisable to grant to the Lender a perfected first priority security interest in the Equity Interests of such Subsidiary that are owned by such Loan Party, including any <FONT STYLE="white-space:nowrap">non-voting</FONT> Equity Interests, provided
that, in no event shall more than 65% of the total outstanding voting Equity Interests of any such new Excluded Foreign Subsidiary be required to be pledged; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">49 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) deliver to the Lender the certificates representing such Equity
Interests, together with undated stock powers, in blank, executed and delivered by a duly authorized officer of the relevant Loan Party or its Subsidiaries, and take such other action as may be necessary or, in the opinion of the Lender, desirable,
under the local law of the jurisdiction of organization of such Excluded Foreign Subsidiary, to create and perfect the Lender&#8217;s security interest therein; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) if requested by the Lender, deliver to the Lender (x)&nbsp;legal opinions relating to the matters described above, which
opinions shall be in form and substance, and from foreign counsel, satisfactory to the Lender, and (y)&nbsp;all documentation and other information that the Lender reasonably requests in order to comply with its obligations under applicable
&#8220;know your customer&#8221; and anti-money laundering rules and regulations, including the USA PATRIOT Act and the Beneficial Ownership Regulation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;6.13</B> <B>Further Assurances</B><B>.</B> Promptly upon the request of the Lender: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Correct any material defect or error that may be discovered in any Loan Document or in the execution, acknowledgment,
filing, or recordation thereof. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Do, execute, acknowledge, deliver, record,
<FONT STYLE="white-space:nowrap">re-record,</FONT> file, <FONT STYLE="white-space:nowrap">re-file,</FONT> register, and <FONT STYLE="white-space:nowrap">re-register</FONT> any and all such further acts, deeds, conveyances, pledge agreements,
mortgages, deeds of trust, trust deeds, assignments, financing statements and continuations thereof, termination statements, notices of assignments, transfers, certificates, assurances, and other instruments as the Lender may reasonably require from
time to time in order to: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) carry out more effectively the purposes of the Loan Documents; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) to the fullest extent permitted by applicable law, subject to any Loan Party&#8217;s or any of its Subsidiaries&#8217;
properties, assets, rights, or interests to the Liens now or hereafter intended to be covered by the Security Agreement and the other Loan Documents; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) perfect and maintain the validity, effectiveness, and priority of the Liens intended to be created under the Security
Agreement and the other Loan Documents; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) assure, convey, grant, assign, transfer, preserve, protect, and confirm
more effectively unto the Lender, the rights granted or now or hereafter intended to be granted to the Lender under any Loan Document or under any other instruments executed in connection with any Loan Document to which any Loan Party is or is to be
a party. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">50 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE VII </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NEGATIVE COVENANTS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">So
long as the Lender has any Revolving Credit Commitment hereunder, or any Loans or any other amounts payable to the Lender hereunder or under any other Loan Document have not been paid in full, the Borrower shall not, and shall not permit its
Subsidiaries to: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;7.01</B> <B>Limitation on Debt</B><B>.</B> Create, incur, assume, permit to exist, or
otherwise become liable with respect to any Debt, except: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Debt of any Loan Party existing or arising under this
Agreement and any other Loan Document; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Debt of the Borrower owed to any Subsidiary; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Debt incurred to finance the acquisition, construction, or improvement of fixed or capital assets (including Capital Lease
Obligations) secured by a Lien on such assets permitted under Section&nbsp;7.02(h); provided that (i)&nbsp;the Borrower shall deliver notice to the Lender prior to incurring Debt permitted by this Section&nbsp;7.01(c) in an amount in excess of
$250,000 during any single fiscal year of the Borrower and (ii)&nbsp;the incurrence of such Debt shall be subject to the prior written consent of the Lender (such consent not to be unreasonably withheld, conditioned or delayed); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Debt existing on the date hereof and listed on Schedule 7.01(d); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) Guaranty Obligations incurred in the ordinary course of business by any Loan Party of obligations of any other Loan Party
provided that the obligations being guaranteed are permitted pursuant to this Agreement; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) Debt as an account party or
applicant in respect of letters of credit, bank guarantees, bankers&#8217; acceptances, and similar instruments supporting trade obligations and any Guaranty Obligations with respect to such Debt in an aggregate amount not exceeding $250,000 at any
time outstanding; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) Debt with respect to letters of credit, bank guarantees, and surety, appeal, indemnity, performance,
completion, or other similar bonds or guarantees incurred in the ordinary course of business; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">51 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) Debt with respect to agreements providing for indemnification,
adjustment of purchase price, <FONT STYLE="white-space:nowrap">earn-out</FONT> payments, earnest money, or similar obligations in connection with any dispositions or acquisition permitted by Section&nbsp;7.04 or Section&nbsp;7.05, in an aggregate
amount not to exceed $250,000 at any time outstanding; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) Debt consisting of the financing of insurance premiums so long
as the amount of such Debt does not exceed the amount of such premiums and is incurred only to defer the cost of such premiums incurred in the ordinary course of business; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j) Debt from customary cash management services, overdraft facilities, or endorsement of instruments for deposit or collection
in the ordinary course of business; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k) Any other unsecured Debt of the Borrower or any of its Subsidiaries in an
aggregate principal amount not to exceed $250,000 at any time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;7.02</B> <B>Limitation on Liens</B><B>.</B>
Create, incur, assume, or permit to exist any Lien on any property or assets (including Equity Interests of any of its Subsidiaries) now owned or hereafter acquired by it or on any income or rights in respect of any thereof, except: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Liens created pursuant to or arising under any Loan Document; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Liens imposed by law for taxes, assessments, or governmental charges not yet due or which are being contested in good faith
and by appropriate proceedings diligently conducted if, unless the amount is not material with respect to it or its financial condition, adequate reserves with respect thereto are maintained in accordance with GAAP on the books of the applicable
Person; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Carriers&#8217;, warehousemen&#8217;s, mechanics&#8217;, materialmen&#8217;s, repairmen&#8217;s,
servicemen&#8217;s, landlords&#8217;, suppliers&#8217;, and other similar Liens imposed by law, arising in the ordinary course of business, and securing obligations that (i)&nbsp;are not overdue by more than sixty (60)&nbsp;days or (ii)&nbsp;if
overdue more than sixty (60)&nbsp;days, (x) are being contested in good faith and by appropriate proceedings diligently conducted, adequate reserves with respect thereto are maintained in accordance with GAAP on the books of the applicable Person,
and the failure to make payment pending such contest could not reasonably be expected to have a Material Adverse Effect, or (y)&nbsp;the failure to do so could not reasonably be expected to have a Material Adverse Effect; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">52 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) (i) Liens arising solely by virtue of any statutory or common law
provision relating to banker&#8217;s liens rights, or <FONT STYLE="white-space:nowrap">set-off,</FONT> or similar rights (x)&nbsp;on cash deposits or other funds maintained with banks or other depository institutions, or on securities accounts or
other financial assets maintained with securities intermediaries, or (y)&nbsp;securing reasonable and customary fees for services of banks, securities intermediaries, or other depository institutions; or (ii)&nbsp;contractual rights of <FONT
STYLE="white-space:nowrap">set-off</FONT> (x)&nbsp;in the ordinary course of business in an agreement not prohibited by this Agreement, or (y)&nbsp;relating to (A)&nbsp;the establishment of depository relationships with banks not given in connection
with the issuance or incurrence of Debt, (B)&nbsp;pooled deposits or sweep accounts of the Loan Parties to permit satisfaction of overdraft or similar obligations incurred in the ordinary course of business, or (C)&nbsp;purchase orders and other
agreements entered into with customers of the Loan Parties in the ordinary course of business; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) Pledges and deposits
and other Liens (i)&nbsp;made in the ordinary course of business in compliance with workers&#8217; compensation, unemployment insurance, and other social security laws or regulations, and (ii)&nbsp;securing liability for reimbursement or
indemnification obligations of (including obligations in respect of letters of credit or bank guarantees for the benefit of) insurance carriers providing property, casualty, or liability insurance to the Borrower or any other Loan Party; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) Liens (including deposits) to secure the performance of bids, tenders, trade contracts, leases, statutory obligations,
surety and appeal bonds, performance bonds, and other obligations of like nature, in each case in the ordinary course of business; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) Easements, zoning restrictions,
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">rights-of-way,</FONT></FONT> minor defects or irregularities in title, and similar encumbrances on real property imposed by law or arising in the ordinary course of business which
(i)&nbsp;do not secure any monetary obligation, and (ii)&nbsp;do not materially detract from the value of the affected property or interfere materially with the ordinary conduct of business of the Borrower or any of its Subsidiaries; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) Liens on fixed or capital assets acquired, constructed, or improved (including any assets subject to a Capital Lease
Obligation) by the Borrower or any other Loan Party after the date hereof; provided that (i)&nbsp;such security interests secure Debt permitted by Section&nbsp;7.01(c), (ii) such Liens and the Debt secured thereby are incurred simultaneously with
such acquisition or the completion of such construction or improvement, (iii)&nbsp;such Liens shall not apply to any other property or assets of the Borrower or any other Loan Party, and (iv)&nbsp;the amount of Debt initially secured thereby is not
more than 100% of the purchase price or construction or improvement cost of such fixed or capital asset; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) Liens in
existence as of the date hereof which are listed on Schedule 7.02(i), securing Debt permitted by Section&nbsp;7.01(d), and any renewals, modifications, replacements, and extensions of such Liens; provided that the aggregate principal amount of the
Debt secured by such Liens does not increase from that amount outstanding at the time of any such renewal, modification, replacement, or extension, and the Debt secured by such Lien is permitted under this Agreement; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">53 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j) To the extent such transactions create a Lien thereunder, the interest
of a lessor, sublessor, licensor, or sublicensor under a lease of real or personal property (including in connection with a sale and leaseback transaction), in each case to the extent such lease or sale and leaseback transaction is permitted under
the terms of this Agreement; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k) Any Lien existing on any property or asset prior to the acquisition thereof by the
Borrower or any other Loan Party or any Lien existing on any property or asset of any Person that becomes a Subsidiary of the Borrower or any other Loan Party at the time such Person becomes a Subsidiary of the Borrower or other Loan Party; provided
that (i)&nbsp;such Lien is not created in contemplation of, or in connection with, such acquisition or such Person becoming a Subsidiary, as the case may be, (ii)&nbsp;such Lien shall apply to the same category, type, and scope of assets, and
(iii)&nbsp;such Lien shall secure only those obligations which it secures on the date of such acquisition or the date such Person becomes a Subsidiary, as the case may be, and any refinancing, refunding, extension, renewal, or replacement thereof
that does not increase the outstanding principal amount thereof plus any accrued interest, premium, fees, and reasonable <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses payable in connection
with any such refinancing, refunding, extension, renewal, or replacement; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l) Judgments or other similar Liens in
connection with legal proceedings which, whether immediately or with the passage of time (i)&nbsp;do not give rise to an Event of Default under Section&nbsp;8.01(h), and (ii)&nbsp;are being contested in good faith by appropriate proceedings
diligently conducted; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(m) Liens securing the financing of insurance premiums to the extent such financing is permitted by
Section&nbsp;7.01(i); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(n) Liens on specific items of inventory or other goods securing obligations with respect to
documentary letters of credit or bankers&#8217; acceptances issued or created for the Borrower or any of its Subsidiaries in the ordinary course of business to facilitate the purchase, shipment, or storage of such inventory or other goods; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(o) Liens in favor of customs and revenue authorities arising as a matter of law to secure payment of customs duties from the
importation of goods in the ordinary course of business; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">54 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(p) Liens on any cash earnest money deposit made by the Borrower or any of
its Subsidiaries in connection with any letter of intent or acquisition agreement for any acquisition, Investment, or other transaction permitted by this Agreement; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(q) Liens arising from precautionary Uniform Commercial Code financing statement filings solely in connection with operating
leases or consignment of goods; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(r) Any other Liens on property not otherwise permitted by this Section&nbsp;7.02, so
long as neither (i)&nbsp;the aggregate principal amount of the Debt and other obligations secured thereby nor (ii)&nbsp;the aggregate fair market value (determined as of the date such Lien is incurred) of the assets subject thereto exceeds $250,000
at any time outstanding. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;7.03 Mergers; Nature of Business.</B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Merge into or consolidate with any other Person, or permit any other Person to merge into or consolidate with it, or
liquidate or dissolve, except that, if at the time thereof and immediately after giving effect thereto no Event of Default shall have occurred and be continuing (i)&nbsp;any Subsidiary of the Borrower that is a Loan Party may merge into the Borrower
in a transaction in which the Borrower is the surviving corporation, (ii)&nbsp;any Loan Party (other than the Borrower) may merge into any other Loan Party in a transaction in which the surviving entity is a Loan Party, and (iii)&nbsp;any Subsidiary
that is not a Loan Party may liquidate or dissolve if the Borrower determines in good faith that such liquidation or dissolution is in the best interests of the Borrower and is not materially disadvantageous to the Lender. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Engage in any business other than businesses of the type conducted by the Borrower and its Subsidiaries on the date hereof
and businesses reasonably related thereto or incidental thereto or that constitute a reasonable extension thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;7.04</B> <B>Limitation on Investments</B><B>.</B> Make any advance, loan, extension of credit (by way of
guaranty or otherwise), or capital contribution to, or purchase, hold, or acquire any Equity Interests, bonds, notes, debentures, or other debt securities of, or any assets constituting a business unit of, or make any other investment in, any Person
(all of the foregoing, &#8220;<B>Investments</B>&#8221;), except: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Investments in Cash Equivalents; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Investments existing on the date hereof and listed on Schedule 7.04(b); </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">55 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Investments in Equity Interests of its Subsidiaries existing on the date
hereof; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Guarantees permitted by Section&nbsp;7.01; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) Loans and advances to officers, directors, or employees of any Loan Party in the ordinary course of business (including for
travel, entertainment, and relocation expenses and in connection with the granting of stock options or as incentive or bonus compensation consistent with past practices) in an aggregate amount not to exceed $250,000 at any time outstanding; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) Receivables owing to the Borrower or any of its Subsidiaries and other extensions of trade credit in the ordinary course of
business (including any instrument evidencing the same and any instrument, security, or other asset acquired through bona fide collection efforts with respect to the same); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) Investments of any Person that after the date hereof becomes a Subsidiary, or consolidates or merges with the Borrower or
any Subsidiary if such merger or consolidation is permitted by Section&nbsp;7.04, provided that each such Investment (i)&nbsp;exists at the time such Person became a Subsidiary or at the time of such merger or consolidation, and (ii)&nbsp;was not
created in anticipation of such Person becoming a Subsidiary or of such merger or consolidation; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) Investments by
the Borrower or any other Loan Party not otherwise permitted by this Section&nbsp;7.01 in an amount not to exceed $250,000. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding anything to the contrary in this Section&nbsp;7.04 or the other Loan Documents, in no event shall any Loan Party convey,
exclusively license, contribute, sell, assign, dispose of, or otherwise transfer (including by transfer of Equity Interests of any Person that owns such assets) to any Subsidiary that is not a Loan Party any intellectual property or other assets
(other than cash and Cash Equivalents) that are, individually or in the aggregate, necessary or material to the conduct of the business of the Loan Parties and their Subsidiaries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;7.05</B> <B>Limitation on Dispositions</B><B>.</B> Dispose of any of its property, whether now owned or
hereafter acquired, or issue or sell any Equity Interests to any Person, except: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) the sale or Disposition of machinery
and equipment no longer used or useful in the business of any Loan Party; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) the Disposition of obsolete or <FONT
STYLE="white-space:nowrap">worn-out</FONT> equipment in the ordinary course of business; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">56 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) the sale of inventory and immaterial assets and the sale or disposition
of cash or Cash Equivalents, in each case, in the ordinary course of business; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Dispositions of property to the
Borrower; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) intentionally omitted; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) leases, subleases, rights of way, easements, licenses, and sublicenses in the ordinary course of business that,
individually and in the aggregate, do not (i)&nbsp;materially interfere with the ordinary course of business of the Borrower or its Subsidiaries or (ii)&nbsp;materially detract from the value of the Property affected thereby; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) Dispositions of other Property in any fiscal year of the Borrower, so long as (i)&nbsp;such Property, together with all
other Property Disposed of during such fiscal year, shall have a fair market value not exceeding $250,000 and (ii)&nbsp;at least 75% of the purchase price paid to the Borrower or other Loan Party for such Property shall be paid solely in cash; and
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) Disposition of any Property, interests, or assets by any Subsidiary that is not a Guarantor to any other Subsidiary
that is not a Guarantor. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding anything to the contrary in this Section&nbsp;7.05 or the other Loan Documents, in no event
shall any Loan Party convey, exclusively license, contribute, sell, assign, dispose of, or otherwise transfer (including by transfer of Equity Interests of any Person that owns such assets) to any Subsidiary that is not a Loan Party any intellectual
property or other assets (other than cash and Cash Equivalents) that are, individually or in the aggregate, necessary or material to the conduct of the business of the Loan Parties and their Subsidiaries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;7.06 Intentionally omitted. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;7.07</B> <B>Limitation on Restricted Payments</B><B>.</B> Declare or pay any dividend on, or make any payment on
account of, or set apart assets for a sinking or other analogous fund for, the purchase, redemption, retirement, or other acquisition of any Equity Interests of the Borrower or any of its Subsidiaries, whether now or hereafter outstanding, or make
any other distribution in respect thereof, either directly or indirectly, whether in cash or property or in obligations of the Borrower or any of its Subsidiaries (collectively, &#8220;<B>Restricted Payments</B>&#8221;), except that: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) A Subsidiary may make a Restricted Payment to the Borrower or any Loan Party and/or any other Persons owning Equity
Interests in such Subsidiary, so long as such Restricted Payment is made to the Borrower, such Loan Party, and/or such other Persons ratably in accordance with their Equity Interests of the same class or series therein; provided that, such
Restricted Payment to such other holders of Equity Interests in such Subsidiary is attributable only to cash flows of such Subsidiary; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">57 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) the Borrower may purchase, redeem, or otherwise acquire Equity Interests
issued by it with the proceeds received from the substantially concurrent issuance of its Equity Interests; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) The
Borrower may declare and pay dividends and make other distributions and payments with respect to its Equity Interests if payable solely in its Equity Interests; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) The Borrower or any of its Subsidiaries may make cash payments in lieu of issuing fractional shares in connection with the
conversion of any Equity Interests on the exercise of warrants or options to purchase its Equity Interests; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) The
Borrower may (i)&nbsp;make repurchases or redemptions of its Equity Interests (x)&nbsp;in connection with the exercise of stock options or restricted stock awards if such Equity Interests represent all or a portion of the exercise price thereof,
including in respect of the cashless exercise of stock options or restricted stock awards or (y)&nbsp;deemed to occur upon the withholding of a portion of such Equity Interests issued to directors, officers, or employees of the Borrower or any
Subsidiary under any stock option plan or other benefit plan or agreement for directors, officers, and employees of the Borrower and its Subsidiaries to cover withholding tax obligations of such Persons in respect of such issuance, and
(ii)&nbsp;make other Restricted Payments, not exceeding $250,000 in the aggregate for any fiscal year, pursuant to and in accordance with stock option plans or other benefit plans or agreements for directors, officers, and employees of the Borrower
and its Subsidiaries; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) So long as no Default or Event of Default has occurred and is continuing or would result
therefrom, the Borrower may make other Restricted Payments not otherwise permitted by this Section&nbsp;7.07 in an aggregate amount not to exceed $250,000 during any fiscal year of the Borrower. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;7.08 Limitation on Prepayments of Debt and Amendments of Debt Instruments.</B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Make or offer to make any optional or voluntary payment or prepayment on or redemption, defeasance, or purchase of any
amounts (whether principal or interest) payable under any Debt which is contractually subordinated in right of payment to the obligations of the Loan Parties pursuant to the Loan Documents. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">58 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Amend, modify, waive, or otherwise change, or consent or agree to any
amendment, modification, waiver, or other change to any of the terms of any Debt that is contractually subordinated to the obligations of the Loan Parties pursuant to the Loan Documents, other than any amendment, modification, waiver, or other
change which is not materially adverse to the Lender. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;7.09</B> <B>Limitation on Transactions with
Affiliates</B><B>.</B> Enter into or be a party to any transaction, including any purchase, sale, lease, or exchange of property, the rendering of any service, or the payment of any management, advisory, or similar fees, with any Affiliate unless
such transaction (i)&nbsp;is a Restricted Payment permitted by Section&nbsp;7.07 or (ii)&nbsp;is: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Otherwise permitted
by the terms of this Agreement; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) In the ordinary course of business of the Borrower or the relevant Subsidiary, as the
case may be; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) On fair and reasonable terms no less favorable to the Borrower or the relevant Subsidiary, as the
case may be, than those that would have been obtained in a comparable transaction on an arm&#8217;s length basis from an unrelated Person, which, for the avoidance of doubt, shall include the Consulting Agreement, dated March&nbsp;18, 2026, between
the Borrower and Craig Tendler. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;7.10</B> <B>Limitation on Restrictive Agreements</B><B>.</B> Enter into or
permit to exist or become effective any consensual encumbrance or restriction on the ability of any Subsidiary of the Borrower to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Make Restricted Payments in respect of any Equity Interests of such Subsidiary held by, or pay any Debt owed to, the
Borrower or any other Subsidiary; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Make loans or advances to, or Investments in, the Borrower or any other Subsidiary;
and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Transfer any of its assets to the Borrower or any other Subsidiary; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">provided, however, that </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) the foregoing shall not apply to (A)&nbsp;any prohibition, limitation, restriction, or condition imposed by law,
(B)&nbsp;any prohibition, limitation, restriction, or condition imposed by this Agreement or any other Loan Document to which it is a party or any refinancings thereof, (C)&nbsp;any prohibition, limitation, restriction, or condition in effect as of
the date hereof and set forth on Schedule 7.10 (and any amendment or modification thereof that does not materially expand the scope of any such prohibition, limitation, restriction, or condition), (D) any restriction or
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">59 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
condition in any indenture, agreement, document, instrument, or other arrangement relating to the assets or business of any Subsidiary existing prior to the acquisition of such Subsidiary if the
same was not created in contemplation of such acquisition (and any amendment or modification thereof that does not materially expand the scope of any such restriction or condition), or (E)&nbsp;customary restrictions and conditions in asset sale
agreements, purchase agreements, or acquisition agreements entered into by the Borrower or any of its Subsidiaries solely to the extent in effect pending the consummation of such transaction, if such restrictions and conditions only relate to the
subject of any such agreement; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) clause (a)&nbsp;shall not apply to (A)&nbsp;customary provisions in leases,
licenses, and other contracts restricting the assignment, sublicense, subletting, or encumbrance thereof or (B)&nbsp;any prohibition, limitation, restriction, or condition imposed by any secured Debt permitted by Section&nbsp;7.01, if such
prohibition, limitation, restriction, or condition applies only to the property or assets securing such Debt, or by any document relating to any Lien permitted by Section&nbsp;7.02, if such prohibition, limitation, restriction or condition applies
only to the property or assets subject to such Lien. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;7.11</B> <B>Limitation on Amendments of Material
Contracts</B><B>.</B> Amend, supplement, or otherwise modify (pursuant to a waiver or otherwise): </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) its articles of
incorporation, bylaws or other organizational document; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) the terms and conditions of any Material Contract; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">in each case, in any respect materially adverse to the interests of the Lender. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE VIII </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EVENTS OF
DEFAULT AND REMEDIES </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;8.01</B> <B>Events of Default</B><B>.</B> Each of the following events or
conditions shall constitute an &#8220;<B>Event of Default</B>&#8221; (whether it shall be voluntary or involuntary or come about or be affected by any Requirement of Law or otherwise): </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) the Borrower fails to pay (i)&nbsp;any principal of any Loan when due, whether at stated maturity, by acceleration, by
notice of voluntary prepayment, by mandatory prepayment, or otherwise, or (ii)&nbsp;any interest on any Loan, or any fee or other amount payable hereunder or under any other Loan Document when due and such failure remains unremedied for a period of
five (5)&nbsp;Business Days; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">60 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) any representation, warranty, certification, or other statement of fact
made or deemed made by or on behalf of any Loan Party herein or in any other Loan Document, or in any certificate, report, financial statement, or other document delivered pursuant to any Loan Document, proves to have been false or misleading in any
material respect (or in any material respect if such representation, warranty, certification or statement is not by its terms already qualified as to materiality) on or as of the date made or deemed made; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) any Loan Party fails to perform or observe any covenant, term, condition, or agreement contained in clauses (a), (b) and
(c)&nbsp;of Section&nbsp;6.01, clauses (a), (b), (d) and (e)&nbsp;of Section&nbsp;6.02, Section&nbsp;6.04(a)(i), Section&nbsp;6.05(b), Section&nbsp;6.06, clauses (a)&nbsp;and (c) of Section&nbsp;6.07, Section&nbsp;6.12 or Article 7; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) any Loan Party defaults in the performance of or compliance with any term contained in this Agreement or any other Loan
Document (other than occurrences described in other provisions of this Section&nbsp;8.01 for which a different grace or cure period is specified or for which no grace or cure period is specified and thereby constitute immediate Events of Default)
and such failure continues unremedied for a period of thirty (30)&nbsp;days after the earlier of (1)&nbsp;receipt by the Borrower of notice from the Lender of such default or (ii)&nbsp;the date on which a Responsible Officer of the Borrower obtains
actual knowledge of such failure; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) any Loan Party: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) fails to pay any principal or interest in respect of any Material Debt (other than the Obligations under the Loan
Documents) when due and such failure continues after the applicable grace period, if any, specified in the agreement or instrument relating to such Material Debt; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) fails to perform or observe any other covenant, term, condition, or agreement relating to any such Material Debt or
contained in any instrument or agreement evidencing or relating thereto, or any other event occurs or condition exists, the effect of which failure or other event or condition is to cause, or to permit the holder or beneficiary of such Material Debt
(or a trustee or agent on behalf of such holder or beneficiary) to cause, with the giving of notice, if required, such Material Debt to become due prior to its stated maturity (or, in the case of any such Material Debt constituting a Guaranty
Obligation, to become payable); or any such Material Debt is declared to be due and payable, or required to be prepaid or redeemed (other than by a regularly scheduled required prepayment or redemption or as a mandatory prepayment), purchased, or
defeased, or an offer to prepay, redeem, purchase, or defease such Material Debt shall be required to be made, in each case prior to the stated maturity thereof; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">61 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) Any Loan Party (x)&nbsp;commences any case, proceeding, or other action
under any existing or future Debtor Relief Law, seeking (A)&nbsp;to have an order for relief entered with respect to it, or (B)&nbsp;to adjudicate it as bankrupt or insolvent, or (C)&nbsp;reorganization, arrangement, adjustment, <FONT
STYLE="white-space:nowrap">winding-up,</FONT> liquidation, dissolution, composition, or other relief with respect to it or its debts, or (D)&nbsp;appointment of a receiver, trustee, custodian, conservator, or other similar official for it or for all
or any substantial part of its assets, or (y)&nbsp;makes a general assignment for the benefit of its creditors; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) there
is commenced against any Loan Party in a court of competent jurisdiction any case, proceeding, or other action of a nature referred to in clause (i)&nbsp;above which (x)&nbsp;results in the entry of an order for relief or any such adjudication or
appointment, or (y)&nbsp;remains undismissed, undischarged, unstayed, or unbonded for sixty (60)&nbsp;days; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) there is
commenced against any Loan Party any case, proceeding, or other action seeking issuance of a warrant of attachment, execution, distraint, or similar process against all or any substantial part of its assets which results in the entry of an order for
any such relief which has not been vacated, discharged, stayed, or bonded pending appeal within sixty (60)&nbsp;days from the entry thereof; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) any Loan Party shall fail generally to, or is unable to, or admits in writing its inability to, pay its debts as they
become due; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) any Loan Party takes any action in furtherance of, or indicating its consent to, approval of, or
acquiescence in, any of the acts set forth in clause (i), (ii), or (iii)&nbsp;above (provided, that that if any such Person is legally compelled in a legal proceeding to provide any information in connection with such involuntary petition, then so
providing such information to the extent required by applicable Requirements of Law shall not, on its own, be deemed to be, an action in furtherance of, consent, approval or acquiescence of such acts); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) any Person shall engage in any &#8220;prohibited transaction&#8221; (as defined in Section&nbsp;406 of ERISA or
Section&nbsp;4975 of the Code) involving any Plan; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) any failure to satisfy the minimum funding standard (within the
meaning of Sections 412 or 430 of the Code or Section&nbsp;302 of ERISA) shall exist with respect to any Plan, or any Lien in favor of the PBGC or a Plan shall arise on the assets of the Borrower or any ERISA Affiliate; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">62 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) a Reportable Event shall occur with respect to, or proceedings shall
commence to have a trustee appointed, or a trustee shall be appointed, to administer or to terminate any Pension Plan, which Reportable Event or commencement of proceedings or appointment of trustee is, in the reasonable opinion of the Lender,
reasonably likely to result in the termination of such Plan for purposes of Title IV of ERISA; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) any Pension Plan shall
terminate for purposes of Title IV of ERISA; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) the Borrower or any ERISA Affiliate shall , in the reasonable opinion of
the Lender, reasonably be likely to incur any liability in connection with a withdrawal from, or the Insolvency or Reorganization of, any Multiemployer Plan; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vi) the occurrence of an ERISA Event; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">the event or condition, whether individually or together with any other events or conditions, could result in a liability to
the Borrower or any ERISA Affiliate in an amount in excess of $250,000; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) one or more final and <FONT
STYLE="white-space:nowrap">non-appealable</FONT> judgments or decrees for the payment of money is entered against any Loan Party by a court of competent jurisdiction involving, in the aggregate, a liability (to the extent not paid or fully covered
by insurance from a reputable and solvent independent third party insurance company as to which the relevant insurance company has been notified and has not denied coverage,) in an amount in excess of $250,000, and all such judgments or decrees have
not been paid and satisfied, vacated, discharged, stayed, or bonded pending appeal within thirty (30)&nbsp;days from the entry thereof; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) the Security Documents cease for any reason to be valid, binding, and in full force and effect, or any Lien created by the
Security Documents ceases to be enforceable and of the same effect and priority purported to be created thereby as a result of the action or inaction of the Loan Parties, other than as expressly permitted hereunder or thereunder; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j) </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">63 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) any material provision of any Loan Document ceases for any reason to be
valid, binding, and in full force and effect, other than as expressly permitted hereunder or thereunder; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) any Loan
Party contests in any manner the validity or enforceability of any provision of any Loan Document; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) any Loan Party
denies that it has any or further liability or obligation under any provision of any Loan Document (except for the defense of payment in full) or purports to revoke, terminate, or rescind any provision of any Loan Document; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k) any Change of Control occurs; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l) the Borrower at any time discontinues its development program for IFX </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;8.02</B> <B>Remedies Upon Event of Default</B><B>.</B> If any Event of Default occurs and is continuing, then:
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) if such event is an Event of Default specified in Section&nbsp;8.01(f) above with respect to the Borrower, the
Revolving Credit Commitment shall automatically and immediately terminate and the Loans (with accrued interest thereon) and all other amounts owing under this Agreement and the other Loan Documents shall immediately become due and payable; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) if such event is an Event of Default (other than an Event of Default under Section&nbsp;8.01(f)), any or all of the
following actions may be taken: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) the Lender may, by notice to the Borrower, declare the Revolving Credit Commitments to
be terminated forthwith, whereupon the Revolving Credit Commitments shall immediately terminate; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) the Lender may, by
notice to the Borrower, declare the Loans (with accrued interest thereon) and all other amounts owing under this Agreement and the other Loan Documents to be due and payable forthwith, whereupon the same shall immediately become due and payable; and
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) the Lender may exercise all rights and remedies available to it under the Security Agreement and any other Loan
Document or at law or equity; and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">64 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) if such event is an Event of Default specified in Section&nbsp;8.01(k)
above and only if the Borrower&#8217;s stockholders have approved the conversion in accordance with the rules and regulations of the Nasdaq Stock Market, the Lender may, at its option, convert all or a portion of the outstanding principal amount of
the Loans (with accrued but unpaid interest thereon) to shares of common stock of the Borrower at a conversion price per share equal to $2.662, which is the average of the daily closing price of such common stock on the Nasdaq Capital Market for the
ten (10)&nbsp;trading days ending on and including the Closing Date (which amount shall be subject to adjustment for stock splits, reverse stock splits, statutory stock combinations or the like). </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE IX </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MISCELLANEOUS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;9.01 Notices.</B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Except in the case of notices and other communications expressly permitted to be given by telephone (or by <FONT
STYLE="white-space:nowrap">e-mail</FONT> as provided in paragraph (b)&nbsp;below), all notices and other communications provided for herein shall be made in writing and mailed by certified or registered mail, delivered by hand or overnight courier
service, or sent by facsimile or email as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) If to the Borrower and any other Loan Party: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">TuHURA Biosciences, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">10500
University Center Drive, Suite 110 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Tampa, FL 33612 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Attention: James Bianco, M.D.; Dan Dearborn </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Email: jbianco@tuhurabio.com; ddearborn@tuhurabio.com </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Telephone No. (813) <FONT STYLE="white-space:nowrap">875-6600,</FONT> ext 104; (813) <FONT STYLE="white-space:nowrap">875-6600,</FONT> ext 126
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">With a copy (which shall not constitute notice) to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Foley&nbsp;&amp; Lardner LLP </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">100 North Tampa Street, Suite 2700 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Tampa, FL 33602 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Attention:
Curt Creely, Esq. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Email: ccreely@foley.com </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Telephone No. (813) <FONT STYLE="white-space:nowrap">225-4122</FONT> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) If to the Lender: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Parkview Holdings One LLC </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">6135
W. Sitka Street </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Tampa, FL 33634 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Attention: Steven DiSarro </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Email: Steve@dmfunding.com </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">Telephone No. (239) <FONT STYLE="white-space:nowrap">821-0427</FONT> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">65 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">Notices mailed by certified or registered mail or sent by hand or overnight courier service
shall be deemed to have been given when received. Notices sent by facsimile during the recipient&#8217;s normal business hours shall be deemed to have been given when sent (and if sent after normal business hours shall be deemed to have been given
at the opening of the recipient&#8217;s business on the next Business Day). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Notices and other communications to any
Loan Party and the Lender hereunder may be delivered or furnished by electronic communications (including <FONT STYLE="white-space:nowrap">e-mail</FONT> and internet or intranet websites) pursuant to procedures approved by the Lender. The Lender or
the Borrower (on behalf of the Loan Parties) may, in its discretion, agree to accept notices and other communications to it hereunder by electronic communications pursuant to procedures approved by it; provided that, approval of such procedures may
be limited to particular notices or communications. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Unless the Lender specifies otherwise: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) notices and other communications sent by <FONT STYLE="white-space:nowrap">e-mail</FONT> shall be deemed received upon the
sender&#8217;s receipt of an acknowledgment from the intended recipient (such as by the &#8220;return receipt requested&#8221; function, as available, return <FONT STYLE="white-space:nowrap">e-mail,</FONT> or other written acknowledgment); and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) notices or communications posted to an Internet or intranet website shall be deemed received upon the deemed receipt by
the intended recipient, at its <FONT STYLE="white-space:nowrap">e-mail</FONT> address as described in the foregoing clause (i), of notification that such notice or communication is available and identifying the website address therefor; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">provided that, if such notice, <FONT STYLE="white-space:nowrap">e-mail,</FONT> or other communication is not sent during the
recipient&#8217;s normal business hours, such notice, <FONT STYLE="white-space:nowrap">e-mail,</FONT> or communication shall be deemed to have been sent at the recipient&#8217;s opening of business on the next Business Day. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Either party hereto may change its address, email, or facsimile number for notices and other communications hereunder by
notice to the other party. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">66 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;9.02 Amendments and Waivers.</B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) No failure to exercise and no delay in exercising, on the part of the Lender, any right, remedy, power, or privilege
hereunder or under the other Loan Documents shall operate as a waiver thereof, nor shall any single or partial exercise of any right, remedy, power, or privilege hereunder preclude any other or further exercise thereof or the exercise of any other
right, remedy, power, or privilege. The rights, remedies, powers, and privileges herein provided are cumulative and not exclusive of any rights, remedies, powers, and privileges provided by law. No waiver of any provision of any Loan Document or
consent to any departure by any Loan Party therefrom shall in any event be effective unless the same shall comply with paragraph (b)&nbsp;of this Section, and then such waiver or consent shall be effective only in the specific instance and for the
purpose for which given. Without limiting the generality of the foregoing, the making of a Loan shall not be construed as a waiver of any Default, regardless of whether the Lender may have had notice or knowledge of such Default at the time. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Neither this Agreement nor any other Loan Document nor any provision hereof or thereof may be waived, amended, or modified
except (i)&nbsp;in the case of this Agreement, pursuant to an agreement or agreements in writing entered into by the Borrower and the Lender, or (ii)&nbsp;in the case of any other Loan Document, pursuant to an agreement or agreements in writing
entered into by the Lender and the Loan Party or Loan Parties that are parties thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;9.03 Expenses; Indemnity; Damage
Waiver.</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) The Borrower agrees to pay: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) all reasonable <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses
incurred by the Lender and its Affiliates, including the reasonable fees, charges, and disbursements of counsel for the Lender in connection with the preparation, negotiation, execution, delivery, and administration of the Loan Documents and any
amendments, waivers, or other modifications of the provisions of any Loan Document (whether or not the transactions contemplated by the Loan Documents or such amendments, waivers, and other modifications are consummated) and; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) all reasonable <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses
incurred by the Lender, including the fees, charges, and disbursements of any counsel for the Lender, in connection with the enforcement or protection of its rights (i)&nbsp;in connection with the Loan Documents, including its rights under this
Section&nbsp;9.03, or (ii)&nbsp;in connection with the Loans issued under this Agreement, including all such <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses incurred in connection with any
restructuring, workout, or negotiations in respect of the Loan Documents or such Loans. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">67 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) The Borrower agrees to indemnify and hold harmless the Lender and each
of its Related Parties (each, an &#8220;<B>Indemnified Party</B>&#8221;) from and against any and all claims, damages, losses, liabilities, and related expenses (including the reasonable <FONT STYLE="white-space:nowrap">out-of-pocket</FONT> fees,
charges, and expenses of any counsel for any Indemnified Party), incurred by any Indemnified Party or asserted against any Indemnified Party by any Person (including the Borrower or any other Loan Party) other than such Indemnified Party and its
Related Parties arising out of, in connection with, or by reason of: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) the execution or delivery of any Loan Document or
any agreement or instrument contemplated in any Loan Document, the performance by the parties thereto of their respective obligations under any Loan Document, or the consummation of the transactions contemplated by the Loan Documents; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) any Loan or the actual or proposed use of the proceeds therefrom; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) any actual presence or Release of Hazardous Materials on or from any property owned by the Borrower or any of its
Subsidiaries or any Environmental Liability related in any way to the Borrower or any of its Subsidiaries; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) any
actual or prospective claim, investigation, litigation, or proceeding relating to any of the foregoing, whether based on contract, tort, or any other theory, whether brought by a third party or by the Borrower or any other Loan Party, and regardless
of whether any Indemnified Party is a party thereto; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">provided that, such indemnity shall not be available to any
Indemnified Party to the extent that such claims, damages, losses, liabilities, or related expenses (x)&nbsp;are determined by a court of competent jurisdiction by final and <FONT STYLE="white-space:nowrap">non-appealable</FONT> judgment to have
resulted from the gross negligence or willful misconduct of such Indemnified Party, or (y)&nbsp;result from a claim brought by the Borrower or any other Loan Party for material breach of such Indemnified Party&#8217;s obligations under any Loan
Document, if a court of competent jurisdiction has rendered a final and <FONT STYLE="white-space:nowrap">non-appealable</FONT> judgment in favor of the Borrower on such claim. This Section&nbsp;9.03 shall only apply to Taxes that represent losses,
claims, damages, or similar charges arising from a <FONT STYLE="white-space:nowrap">non-Tax</FONT> claim. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">68 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Each party hereto agrees, to the fullest extent permitted by applicable
law, not to assert, and hereby waives, any claim against any other party hereto, on any theory of liability, for special, indirect, consequential, or punitive damages (including any loss of profits or anticipated savings), as opposed to actual or
direct damages, resulting from this Agreement or any other Loan Document or arising out of such party&#8217;s activities in connection herewith or therewith (whether before or after the Closing Date). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) All amounts due under Section&nbsp;9.03 shall be payable not later than (ten) 10 Business Days after written demand is made
for payment by the Lender. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) The Borrower agrees that neither it nor any of its Subsidiaries will settle, compromise, or
consent to the entry of any judgment in any pending or threatened claim, action, or proceeding in respect of which indemnification or contribution could be sought under Section&nbsp;9.03 (whether or not any Indemnified Party is an actual or
potential party to such claim, action, or proceeding) without the prior written consent of the applicable Indemnified Party, unless such settlement, compromise, or consent includes an unconditional release of such Indemnified Party from all
liability arising out of such claim, action, or proceeding. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;9.04 Successors and Assigns.</B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) The provisions of this Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective
successors and assigns permitted hereby, except that the Borrower may not assign or otherwise transfer any of its rights or obligations hereunder without the prior written consent of the Lender (and any attempted assignment or transfer by the
Borrower without such consent shall be null and void). Nothing in this Agreement, expressed or implied, shall be construed to confer upon any Person (other than the parties hereto, their respective successors and assigns permitted hereby, and to the
extent expressly contemplated hereby, the Related Parties of the Lender) any legal or equitable right, remedy, or claim under or by reason of this Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) The Lender may, at any time, without the consent of the Borrower, assign to one or more Eligible Assignees (as defined
below) all or a portion of its rights and obligations under this Agreement (including all or a portion of the Revolving Credit Commitment and the Loans at the time owing to it). For purposes of this Agreement, &#8220;<B>Eligible Assignee</B>&#8221;
means any Person other than a natural Person that is (i)&nbsp;an Affiliate of the Lender and is not a competitor of Borrower, (ii)&nbsp;a commercial bank, insurance company, investment or mutual fund, or other Person that is an &#8220;accredited
investor&#8221; (as defined in Regulation D under the Securities Act), or (iii)&nbsp;a corporate entity that possesses financial sophistication and standing similar </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">69 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
to that of the Lender. Subject to notification of an assignment, the assignee shall be a party hereto, and to the extent of the interest assigned, have the rights and obligations of the Lender
under this Agreement, and the Lender shall, to the extent of the interest assigned, be released from its obligations under this Agreement (and, in the case of an assignment covering all of the Lender&#8217;s rights and obligations under this
Agreement, the Lender shall cease to be a party hereto but shall continue to be entitled to the benefits of Section&nbsp;3.01 and Section&nbsp;9.03). The Borrower hereby agrees to execute any amendment and/or any other document that may be necessary
to effectuate such an assignment, including an amendment to this Agreement to provide for multiple lenders and an administrative agent to act on behalf of such lenders. Any assignment or transfer by the Lender of rights or obligations under this
Agreement that does not comply with this paragraph shall be treated for purposes of this Agreement as a sale by the Lender of a participation in such rights and obligations in accordance with paragraph (c)&nbsp;of this Section. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) The Lender may, at any time, without the consent of the Borrower, sell participations to one or more banks or other
entities, in each case, that is not a competitor of Borrower (each, a &#8220;<B>Participant</B>&#8221;) in all or a portion of the Lender&#8217;s rights and obligations under this Agreement (including all or a portion of the Revolving Credit
Commitment and the Loans owing to it); provided that (i)&nbsp;the Lender&#8217;s obligations under this Agreement shall remain unchanged, (ii)&nbsp;the Lender shall remain solely responsible to the other parties hereto for the performance of such
obligations, and (iii)&nbsp;the Borrower shall continue to deal solely and directly with the Lender in connection with the Lender&#8217;s rights and obligations under this Agreement. The Borrower agrees that each Participant shall be entitled to the
benefits of Section&nbsp;3.01 to the same extent as if it were the Lender and had acquired its interest by assignment pursuant to paragraph (b)&nbsp;of this Section; provided that, such Participant (A)&nbsp;agrees to be subject to the provisions of
Section&nbsp;3.01 as if it were an assignee under paragraph (b)&nbsp;of this Section and (B)&nbsp;shall not be entitled to receive any greater payment under Section&nbsp;3.01, with respect to any participation, than the Lender would have been
entitled to receive, except to the extent such entitlement to receive a greater payment results from a Change in Law that occurs after the Participant acquired the applicable participation. The Lender shall, acting solely for this purpose as an
agent of the Borrower, maintain a register on which it enters the name and address of each Participant and the principal amounts (and stated interest) of each Participant&#8217;s interest in the Loans or other obligations under the Loan Documents
(the &#8220;<B>Participant Register</B>&#8221;); provided that, the Lender shall have no obligation to disclose all or any portion of the Participant Register (including the identity of any Participant or any information relating to a
Participant&#8217;s interest in the Revolving Credit Commitment, Loans, or other obligations under any Loan Document) to any Person except to the extent that such disclosure is necessary to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">70 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
establish that the Revolving Credit Commitment, any Loan, or other obligation is in registered form under <FONT STYLE="white-space:nowrap">Section&nbsp;5f.103-1(c)</FONT> of the United States
Treasury Regulations. The entries in the Participant Register shall be conclusive absent manifest error, and the Lender shall treat each Person whose name is recorded in the Participant Register as the owner of such participation for all purposes of
this Agreement notwithstanding any notice to the contrary. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) To the extent permitted by law, each Participant also shall
be entitled to the benefits of Section&nbsp;9.08 as though it were the Lender. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;9.05</B>
<B>Survival</B><B>.</B> All covenants, agreements, representations, and warranties made by any Loan Party in the Loan Documents and in the certificates or other instruments delivered in connection with or pursuant to this Agreement or any other Loan
Document shall be considered to have been relied upon by the other parties hereto and shall survive the execution and delivery of the Loan Documents and the making of any Loans, regardless of any investigation made by any such other party or on its
behalf and notwithstanding that the Lender may have notice or knowledge of any Event of Default or incorrect representation or warranty at the time any credit is extended hereunder, and shall continue in full force and effect as long as the
principal of, or any accrued interest on, any Loan or any fee or any other amount payable under this Agreement is outstanding and unpaid and so long as the Revolving Credit Commitment has not expired or terminated. The provisions of
Section&nbsp;3.01 and Article IX shall survive and remain in full force and effect regardless of the consummation of the transactions contemplated hereby, the repayment of the Loans, the expiration or termination of the Revolving Credit Commitment,
or the termination of this Agreement or any provision hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;9.06 Counterparts; Integration; Effectiveness.</B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) This Agreement and any amendments, waivers, consents, or supplements hereto may be executed in counterparts (and by
different parties hereto on different counterparts), each of which shall constitute an original, but all of which when taken together shall constitute a single contract. This Agreement, the other Loan Documents, and any separate letter agreements
with respect to fees payable to the Lender constitute the entire contract among the parties with respect to the subject matter hereof and supersede all previous agreements and understandings, oral or written, with respect to the subject matter
hereof. Except as provided in Section&nbsp;4.01, this Agreement shall become effective when it shall have been executed by the Lender and when the Lender shall have received a counterpart hereof executed by the Borrower. Delivery of an executed
counterpart of a signature page to this Agreement by facsimile or in electronic (&#8220;pdf&#8221; or &#8220;tif&#8221;) format shall be effective as delivery of a manually executed counterpart of this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">71 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) The words &#8220;execution,&#8221; &#8220;signed,&#8221;
&#8220;signature,&#8221; and words of similar import in any Loan Document shall be deemed to include electronic or digital signatures or electronic records, each of which shall be of the same effect, validity, and enforceability as manually executed
signatures or a paper-based recordkeeping system, as the case may be, to the extent and as provided for under applicable law, including the Electronic Signatures in Global and National Commerce Act of 2000 (15 U.S.C. &#167;&#167; 7001 to 7031), the
Uniform Electronic Transactions Act (UETA), or any state law based on the UETA, including the New York Electronic Signatures and Records Act (N.Y. Tech. &#167;&#167; 301 to 309), provided that notwithstanding anything contained herein to the
contrary, the Lender is under no obligation to agree to accept Electronic Signatures in any form or in any format unless expressly agreed to by the Lender pursuant to procedures approved by it; and provided, further, the Lender reserves the right to
require, at any time and at its sole discretion, the delivery of manually executed counterpart signature pages to this Agreement or any other Loan Document, and the parties hereto agree to promptly deliver such manually executed counterpart
signature pages. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Without limiting the generality of the foregoing, each of the parties (i)&nbsp;agrees that, for all
purposes, including in connection with any workout, restructuring, enforcement of remedies, bankruptcy proceedings, or litigation among the Lender and the Loan Parties, Electronic Signatures transmitted by telecopy, emailed pdf, or any other
electronic means that reproduces an image of an actual executed signature page and/or any electronic images of this Agreement or any other Loan Document shall have the same legal effect, validity, and enforceability as any paper original, and
(ii)&nbsp;waives any argument, defense, or right to contest the validity or enforceability of such Agreement or Loan Document based solely on the lack of paper original copies of such Agreement or Loan Documents, including with respect to any
signature pages thereto. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Without limiting the foregoing, to the extent the Lender has agreed to accept any Electronic
Signature, the Lender shall be entitled to rely on such Electronic Signature purportedly given by or on behalf of the Borrower or any other Loan Party without further verification thereof and without any obligation to review the appearance or form
of any such Electronic Signature. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) The Lender may, at its option, create one or more copies of this Agreement or any
other Loan Document in the form of an imaged electronic record in any format, which shall be deemed created in the ordinary course of such Person&#8217;s business, and destroy the original paper document (and all such electronic records shall be
considered an original for all purposes and shall have the same legal effect, validity, and enforceability as a paper record). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">72 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) For purposes of this Agreement, &#8220;Electronic Signature&#8221; means
an electronic sound, symbol, or process attached to or logically associated with a contract or other record and executed or adopted by a Person with the intent to sign such record, including, without limitation, facsimile, emailed pdf, or any other
electronic means that reproduces an image of an actual executed signature page. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;9.07</B>
<B>Severability</B><B>.</B> If any term or provision of any Loan Document is invalid, illegal, or unenforceable in any jurisdiction, such invalidity, illegality, or unenforceability shall not affect any other term or provision thereof or invalidate
or render unenforceable such term or provision in any other jurisdiction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;9.08</B> <B>Right of
Setoff</B><B>.</B> If an Event of Default shall have occurred and be continuing, the Lender and each of its branches and Affiliates is hereby authorized at any time and from time to time, to the fullest extent permitted by applicable law, and
without prior notice to the Borrower, any such notice being expressly waived by the Borrower, to set off and apply any and all deposits (general or special, time or demand, provisional or final, in whatever currency) at any time held and other
obligations (in whatever currency) at any time owing by the Lender, such branch, or Affiliate to or for the credit or the account of the Borrower or any Loan Party against any and all of the obligations of the Borrower or such Loan Party now or
hereafter existing under this Agreement or any other Loan Documents to the Lender or its Affiliates, whether direct or indirect, absolute or contingent, matured or unmatured, and irrespective of whether or not the Lender or any Affiliate shall have
made any demand under the Loan Documents and although such obligations of such Loan Party may be contingent or unmatured are owed to a branch, office, or Affiliate of the Lender different from the branch, office, or Affiliate holding such deposit or
obligated on such indebtedness. The Lender agrees to notify the Borrower promptly after any such setoff and application; provided that the failure to give such notice shall not affect the validity of such setoff and application. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;9.09 Governing Law; Jurisdiction; Consent to Service of Process.</B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) This Agreement and the other Loan Documents and any claim, controversy, dispute, or cause of action (whether in contract or
tort or otherwise) based upon, arising out of, or relating to this Agreement or any other Loan Document (except, as to any other Loan Document, as expressly set forth therein) and the transactions contemplated hereby and thereby shall be governed
by, and construed in accordance with, the laws of the State of Florida, without regard to conflicts of laws principles. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">73 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Each Loan Party irrevocably and unconditionally agrees that it will not
commence any action, litigation, or proceeding of any kind whatsoever, whether in law or equity, or whether in contract or tort or otherwise, against the Lender or any of its Related Parties in any way relating to this Agreement, any other Loan
Document, or the transactions contemplated hereby or thereby, in any forum other than the courts of the State of Florida sitting in Hillsborough County, and of the United States District Court of the Middle District of Florida, and any appellate
court from any thereof, and each of the parties hereto irrevocably and unconditionally submits to the exclusive jurisdiction of such courts and agrees that any such action, litigation, or proceeding may be brought in any such Florida State court or,
to the fullest extent permitted by applicable law, in such federal court. Each of the parties hereto agrees that a final judgment in any such action, litigation, or proceeding shall be conclusive and may be enforced in other jurisdictions by suit on
the judgment or in any other manner provided by law. Nothing herein or in any other Loan Document shall affect any right that the Lender may otherwise have to bring any action or proceeding relating to this Agreement or any other Loan Document
against any Loan Party or its properties in the courts of any jurisdiction. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Each Loan Party irrevocably and
unconditionally waives, to the fullest extent permitted by applicable law, (i)&nbsp;any objection that it may now or hereafter have to the laying of venue of any action or proceeding arising out of or relating to this Agreement or any other Loan
Document in any such court referred to in subsection (b)&nbsp;of this Section and (ii)&nbsp;the defense of an inconvenient forum to the maintenance of such action or proceeding in any such court. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Each party to this Agreement irrevocably consents to the service of process in the manner provided for notices in
Section&nbsp;9.01 and agrees that nothing herein will affect the right of any party hereto to serve process in any other manner permitted by applicable law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;9.10</B> <B>WAIVER OF JURY TRIAL</B><B>.</B> EACH PARTY HERETO HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT
PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN ANY LEGAL PROCEEDING DIRECTLY OR INDIRECTLY RELATING TO THIS AGREEMENT OR ANY OTHER LOAN DOCUMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY, WHETHER BASED ON CONTRACT,
TORT, OR ANY OTHER THEORY. EACH PARTY HERETO (A)&nbsp;CERTIFIES THAT NO AGENT, ATTORNEY, REPRESENTATIVE, OR ANY OTHER PERSON HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PERSON WOULD NOT SEEK TO ENFORCE THE FOREGOING WAIVER IN THE EVENT
OF LITIGATION AND (B)&nbsp;ACKNOWLEDGES THAT IT AND THE OTHER PARTIES HERETO HAVE BEEN INDUCED TO ENTER INTO THIS AGREEMENT AND THE OTHER LOAN DOCUMENTS BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;9.11</B> <B>Headings</B><B>.</B> The headings in this Agreement are for reference only and shall not affect the
interpretation of this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">74 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;9.12 Confidentiality.</B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) The Lender agrees to maintain the confidentiality of all <FONT STYLE="white-space:nowrap">non-public</FONT> information
received from or on behalf of the Borrower or any other Loan Party relating to the Borrower or its Subsidiaries, or their respective businesses, other than any such information that is available to the Lender on a nonconfidential basis prior to
disclosure by the Borrower or its Subsidiaries or pertaining to this Agreement that is routinely provided to data service providers, including league table providers that serve the lending industry; provided that, and in the case of information
received from or on behalf of the Borrower or any Loan Party after the date hereof, such information is clearly identified at the time of delivery as being confidential information (the &#8220;<B>Confidential </B><B>Information</B>&#8221;), except
that the Lender may disclose Confidential Information: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) to its Related Parties in connection with the administration of
this Agreement and the preservation, exercise, or enforcement of their rights under this Agreement (it being understood that the Persons to whom such disclosure is made will be informed of the confidential nature of the Confidential Information and
instructed to keep such Confidential Information confidential); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) to the extent required or requested by any regulatory
authority purporting to have jurisdiction over such Person or its Related Parties (including any self-regulatory authority or any securities exchange on which securities of the disclosing party or any Affiliate of the disclosing party are listed or
traded, in which case the Lender shall inform the Loan Parties prior to such disclosure to the extent permitted by the Requirements of Law); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) pursuant to any subpoena, or order of any court administrative agency, in any pending legal, judicial, or administrative
proceeding, or similar legal process, or to the extent required or requested by law, regulation, or a Governmental Authority; provided that, unless specifically prohibited by applicable law or court order, the Lender shall use reasonable efforts to
notify the Borrower of any such request by any Governmental Authority or representative thereof prior to disclosure of such Confidential Information (other than any such request in connection with an examination or audit conducted by bank
accountants or any banking regulatory authority exercising examining or regulatory authority over the Lender; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) in
connection with the exercise of any remedies hereunder or under any other Loan Document or any suit, action, or proceeding relating to this Agreement or any other Loan Document or the enforcement of its rights hereunder or thereunder; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">75 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) subject to an agreement containing provisions substantially the same as
those of this Section, to (x)&nbsp;any actual or potential pledgee, assignee, transferee, or participant in connection with the pledge, assignment, or transfer by the Lender of any Loans or any participations therein in accordance with the terms of
this Agreement or (y)&nbsp;any actual or prospective party (or its Related Parties) to any swap, derivative, or other transaction under which payments are to be made by reference to the Borrower or any other Loan Party or any Subsidiary or any of
their respective obligations, this Agreement, or payments hereunder; provided that, any such potential pledgee, assignee, transferee, Participant, swap counterparty, or advisor is advised of, and agrees to be bound by, the provisions of this
Section; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vi) for purposes of establishing a &#8220;due diligence&#8221; defense; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vii) with the written consent of the applicable Loan Party; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(viii) to the extent such Confidential Information (x)&nbsp;becomes publicly available other than as a result of a breach of
this Section, or (y)&nbsp;is available to the Lender on a <FONT STYLE="white-space:nowrap">non-confidential</FONT> basis prior to disclosure by the Borrower or any of its Subsidiaries, or (z)&nbsp;becomes available to the Lender or any of its
Affiliates on a <FONT STYLE="white-space:nowrap">non-confidential</FONT> basis from a source other than the Borrower or any other Loan Party, that is not known to be subject to a confidentiality obligation to the Borrower or any other Loan Party.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Any Person required to maintain the confidentiality of Confidential Information as provided in this Section shall be
considered to have complied with its obligation to do so if such Person has exercised the same degree of care to maintain the confidentiality of such Confidential Information as such Person would accord to its own confidential information. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;9.13</B> <B>USA PATRIOT Act and Anti-Money Laundering Laws</B><B>.</B> The Lender hereby notifies each Loan
Party that pursuant to the requirements of the USA PATRIOT Act and the Beneficial Ownership Regulation, it may be required to obtain, verify, and record information that identifies each Loan Party, which information includes the name and address of
each Loan Party and other information that will allow the Lender to identify such Loan Party in accordance with the USA PATRIOT Act and the Beneficial Ownership Regulation. Each Loan Party shall promptly, following a request by a Lender, provide all
documentation and other information that such Lender, as applicable, may request in order to comply with its ongoing obligations under applicable &#8220;know your customer&#8221; and anti- money laundering rules and regulations, including the USA
PATRIOT Act and the Beneficial Ownership Regulation. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">76 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;9.14</B> <B>Interest Rate Limitation</B><B>.</B>
Notwithstanding anything herein to the contrary, if at any time the Interest Rate applicable to any Loan, together with all fees, charges, and other amounts that are treated as interest on such Loan under applicable law (collectively the
&#8220;<B>Charges</B>&#8221;), shall exceed the maximum lawful rate (the &#8220;<B>Maximum Rate</B>&#8221;) which may be contracted for, charged, taken, received, or reserved by the Lender holding such Loan in accordance with applicable Requirements
of Law, the rate of interest payable in respect of such Loan hereunder, together with all Charges payable in respect thereof, shall be limited to the Maximum Rate and, to the extent lawful, the interest and Charges that would have been payable in
respect of such Loan but were not payable as a result of the operation of this Section shall be cumulated and the interest and Charges payable to such Lender in respect of other Loans or periods shall be increased (but not above the Maximum Rate
therefor) until such cumulated amount, together with interest thereon at the Federal Funds Effective Rate to the date of repayment, shall have been received by such Lender. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;9.15</B> <B>No Advisory or Fiduciary Responsibility</B><B>.</B> In connection with this Agreement and the Loan
Documents and the transactions contemplated hereby and thereby, each Loan Party acknowledges and agrees that: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) the
facilities provided for hereunder and any related arranging or other services in connection therewith (including in connection with any amendment, waiver, or other modification hereof or of any other Loan Document) are an <FONT
STYLE="white-space:nowrap">arm&#8217;s-length</FONT> commercial transaction between the Loan Parties and their Affiliates, on the one hand, and the Lender, on the other hand, that does not give rise directly or indirectly to, nor do the Loan Parties
rely on, any fiduciary duty to the Loan Parties or their Affiliates on the part of the Lender, and (ii)&nbsp;such Loan Party is capable of evaluating and understanding and understands and accepts the terms, risks, and conditions of the transactions
contemplated hereby and by the other Loan Documents (including any amendment, waiver, or other modification hereof or thereof); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) the Lender has not provided and will not provide any legal, accounting, regulatory, or tax advice with respect to any of
the transactions contemplated hereby (including any amendment, waiver or other modification hereof or of any other Loan Document) and the Loan Parties have consulted its own legal, accounting, regulatory, and tax advisors to the extent they have
deemed appropriate; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) in connection with the process leading to such transaction, the Lender is and has been acting
solely as a principal, and is not the financial advisor, agent, or fiduciary, for any Loan Party or any of its Affiliates, or any other Person; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">77 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) the Lender has not assumed or will not assume an advisory, agency, or
fiduciary, or other implied duty in favor of any Loan Party with respect to any of the transactions contemplated hereby or the process leading thereto, including with respect to any amendment, waiver, or other modification hereof or of any other
Loan Document (irrespective of whether the Lender has advised or is currently advising any Loan Party or any of their Affiliates on other matters) and the Lender does not have any obligation to the Borrower or any of its Affiliates with respect to
the financing transactions contemplated hereby except those obligations expressly set forth herein and in the other Loan Documents; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) the Lender and its respective Affiliates may be engaged in a broad range of transactions that involve interests that differ
from, and may conflict with, those of the Loan Parties and their Affiliates, and the Lender does not have any obligation to disclose any of such interests to any Loan Party; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) no joint venture is created by this Agreement or any other Loan Document or otherwise exists by virtue of the transactions
contemplated hereby and thereby among the Lender and the Loan Parties and their respective Affiliates; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) to the
fullest extent permitted by law, each Loan Party hereby waives and releases any claims that it may have against the Lender and their respective Affiliates with respect to any breach or alleged breach of agency or fiduciary duty in connection with
any aspect of any transaction contemplated by this Agreement or any other Loan Document. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[signature page follows] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">78 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed as of the
date first written above by their respective officers thereunto duly authorized. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="94%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">TUHURA BIOSCIENCES, INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ James Bianco, M.D.</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Name: James Bianco, M.D.</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Title:
Chief Executive Officer</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">PARKVIEW HOLDINGS ONE LLC</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Vijay Patel</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Name: Vijay Patel</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Title:
Manager</P></TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">79 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>3
<FILENAME>d139552dex101.htm
<DESCRIPTION>EX-10.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CERTAIN CONFIDENTIAL INFORMATION, IDENTIFIED BY BRACKETED ASTERISKS &#8220;[*****]&#8221;, HAS BEEN OMITTED FROM THIS EXHIBIT BECAUSE IT IS
BOTH (I)&nbsp;NOT MATERIAL AND (II)&nbsp;WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B><I>Execution Version </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ROYALTY AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>THIS</B><B> ROYALTY AGREEMENT</B> (this &#8220;<B><I>Agreement</I></B>&#8221;), dated as of April&nbsp;21, 2026 (the &#8220;<B><I>Effective
Date</I></B>&#8221;), is made and entered into by and between TuHURA Biosciences, Inc., a Nevada corporation (&#8220;<B><I>TuHURA</I></B>&#8221;) and Parkview Holdings One LLC, a Florida limited liability company
(<B><I>&#8220;</I></B><B><I>Parkview</I></B><B><I>&#8221;</I></B>). TuHURA and Parkview are referred to together as the &#8220;<B><I>Parties</I></B>&#8221; and individually as a &#8220;<B><I>Party</I></B>.&#8221; Capitalized terms used in this
Agreement and not defined herein shall have the definitions set forth in the Loan Agreement (as defined below). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RECITALS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">TuHURA and Parkview have entered into a Loan Agreement of even date herewith (the &#8220;<B><I>Loan
Agreement</I></B>&#8221;) pursuant to which Parkview has agreed to make available to TuHURA a loan facility of up to $50.0&nbsp;million upon the terms and conditions set forth in the Loan Agreement. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">B.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In partial consideration for the lending obligations undertaken by Parkview pursuant to the Loan Agreement,
TuHURA desires to pay to Parkview certain royalties based on the Net Sales of Product(s) (as those terms are defined below) on the terms and conditions set forth herein. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NOW, THEREFORE, in consideration of the mutual covenants and agreements contained in this Agreement, and for other good and valuable
consideration, the receipt and sufficiency of which is hereby acknowledged, TuHURA and Parkview agree as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AGREEMENT </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1. <U>Definitions</U>. For purposes of this Agreement: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>(i)</I> &#8220;<B><I>Affiliate(s)</I></B>&#8221; means, with respect to each Party, any other Person directly or indirectly
controlling, controlled by, or under common control with such Party. For purposes of this definition, &#8220;control,&#8221; when used with respect to any specified Person, means the power to direct the management and policies of such Person,
directly or indirectly, whether through the ownership of voting securities, by contract, or otherwise; and the terms &#8220;controlling&#8221; and &#8220;controlled&#8221; have meanings correlative to the foregoing. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>(ii)</I> &#8220;<B><I>Agreement</I></B>&#8221; shall have the meaning set forth above. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>(iii)</I> &#8220;<B><I>Buyout Consideration</I></B>&#8221; shall mean a sum to be agreed upon by TuHURA (or its successors)
and Parkview to terminate or reduce the Royalty payment obligations under this Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>(iv)</I> &#8220;<B><I>Change
of Control</I></B>&#8221; shall with respect to a Person: (a)&nbsp;an acquisition, reorganization, merger, or consolidation of such Person by or with any other Person in which the holders of the voting securities of such Person outstanding
immediately before such transaction cease to beneficially own at least fifty percent (50%) of the combined </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
voting power of the surviving entity, directly or indirectly, immediately after such transaction; (b)&nbsp;a transaction or series of related transactions in which any other Person, together with
its Affiliates (if applicable), becomes the beneficial owner of fifty percent (50%) or more of the combined voting power of the outstanding securities of such Person; or (c)&nbsp;the sale or other transfer to any other Person of all or substantially
all of such Person&#8217;s asset. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>(v)</I> &#8220;<B><I>Confidential Information</I></B>&#8221; of a Party shall mean
any and all confidential or proprietary information and materials, including all scientific, technical, financial, or business information as well as all trade secrets, patents, and ideas belonging to such Party, as well as its customers, clients,
or other Third Parties who furnished such information, materials, and/or trade secrets to such Party with expectations of confidentiality. Confidential Information does not include information that the receiving Party can demonstrate by
contemporaneous written or other contemporaneous documentary records: (a)&nbsp;was rightfully known to the receiving Party without restriction on use or disclosure prior to such information&#8217;s being disclosed or made available to the receiving
Party in connection with this Agreement; (b)&nbsp;was or becomes generally known by the public other than by the receiving Party&#8217;s or any of its Representatives&#8217; noncompliance with this Agreement; (c)&nbsp;was or is received by the
receiving Party on a <FONT STYLE="white-space:nowrap">non-confidential</FONT> basis from a Third Party that was not or is not, at the time of such receipt, under any obligation to maintain its confidentiality; or (d)&nbsp;was or is independently
developed by the receiving Party without reference to or use of any Confidential Information. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>(vi)</I>
&#8220;<B><I>Covering</I></B>&#8221; or &#8220;<B><I>Covered&#8221; </I></B>shall mean with respect to a claim of a Patent and a Product, that such claim would be infringed, absent a license, by the manufacture, use, offer for sale, or sale of such
Product (considering claims of Patent applications to be issued as then pending in the Field in the Territory). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>(vii)</I> &#8220;<B><I>Effective Date</I></B>&#8221; shall have the meaning set forth above. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>(viii)</I> &#8220;<B><I>Expert</I></B>&#8221; shall have the meaning set forth in Section&nbsp;20. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>(ix)</I> &#8220;<B><I>FDA</I></B>&#8221; shall mean the U.S. Food and Drug Administration. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>(x)</I> &#8220;<B><I>Field</I></B>&#8221; shall mean the use of <FONT STYLE="white-space:nowrap">IFx-2.0</FONT> in any
treatment or pharmaceutical application, including but not limited to treatments in the field of Merkel cell carcinoma, pancreatic cancer, ovarian cancer, and any other oncological indication or related product variant. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>(xi)</I> &#8220;<B><I>First Commercial Sale</I></B>&#8221; shall mean, with respect to any Product, in any country, the
first arm&#8217;s length sale of such Product by TuHURA or its Affiliates or Sublicensees to an unrelated Third Party for monetary value for use or consumption of such Product after regulatory approval for such Product in such country or
jurisdiction has been granted.&nbsp;Sales prior to receipt of regulatory approval for such Product, such as <FONT STYLE="white-space:nowrap">so-called</FONT> &#8220;treatment IND sales,&#8221; &#8220;named patient sales,&#8221; &#8220;compassionate
use sales,&#8221; and similar sales shall not be construed as a First Commercial Sale. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>(xii)</I>
&#8220;<B><I><FONT STYLE="white-space:nowrap">IFx-2.0</FONT></I></B>&#8221; shall mean the proprietary innate immune agonist for cancer being developed by TuHURA and its subsidiaries under the name
<FONT STYLE="white-space:nowrap">&#8220;IFx-2.0&#8221;.</FONT> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>(xiii)</I> &#8220;<B><I>Intellectual Property
Rights</I></B>&#8221; shall mean patents, utility models, rights to inventions, copyright and related rights, moral rights, trademarks and service marks, business names and domain names, rights in <FONT STYLE="white-space:nowrap">get-up,</FONT>
goodwill and the right to sue for passing off or unfair competition, rights in designs, database rights, rights to use and protect the confidentiality of, Confidential Information (including <FONT STYLE="white-space:nowrap">know-how),</FONT>
Patents, and all other intellectual property rights, in each case whether registered or unregistered and including all applications and rights to apply for and be granted renewals or extensions of, and rights to claim priority from such rights and
all similar or equivalent rights or forms of protection which subsist or will subsist now or in the future in any part of the world. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>(xiv)</I> &#8220;<B><I>Knowledge</I></B>&#8221; shall mean the actual knowledge of James Bianco or Dan Dearborn. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>(xv)</I> &#8220;<B><I>Loan Agreement</I></B>&#8221; shall have the meaning set forth above. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>(xvi)</I> &#8220;<B><I>Net Sales</I></B>&#8221; shall mean, with respect to a particular Royalty Year, the gross amount
invoiced during such Royalty Year by TuHURA, its Affiliates, or Sublicensees for the sale of Product(s) in the Field in the Territory (including all worldwide sales, regardless of where they occur) made to an unrelated Third Party; less the
following items: (A)&nbsp;normal and customary trade, quantity, prompt pay, and cash discounts, including charge-back payments, allowances, or rebates actually taken and allowed, including promotional or similar discounts or rebates, and discounts
or rebates to wholesalers or other distributors, buying groups, healthcare insurance carriers or other institutions, managed health care organizations, pharmacy benefit managers (or equivalents thereof), national, state/provincial, local, and other
governments, their agencies and purchasers and reimbursors, or to trade customers; (B)&nbsp;credits or allowances, refunds or chargebacks given or made for rejection or return of previously sold Product(s), or for defective sold Product(s); (C)
compulsory payments and rebates directly related to the sale of such Product(s) paid to a government authority pursuant to governmental regulations by reason of any national or local health insurance program or similar program; (D)&nbsp;costs of
freight, postage, shipping, insurance, handling, and other transportation charges related to the distribution of such Product(s); and (E)&nbsp;invoiced amounts that are not collected and actually written off as non collectable bad debts for the sale
of such Product(s); provided that such invoiced amounts shall be added to the Net Sales amount if collected subsequently. No deductions from Net Sales may be made for commissions paid to individuals whether they are with independent sales agencies
or regularly employed by Licensee and on its payroll, or for cost of collections. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event that the Product(s) is sold
as part of a Combination Product(s) (where &#8220;<B><I>Combination Product(s)</I></B>&#8221; means any Product consisting of one or more products covered by a Valid Claim packaged, bundled, or otherwise combined for sale with one or more other
products that is not covered by a Valid Claim (e.g., a pharmaceutical product which comprises the Product(s) and other active compound(s), ingredient(s), and/or device(s)) (each, an &#8220;<B><I>Other Product(s)</I></B>&#8221;) in a particular
country, the Net Sales of the Product(s) in </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
such country, for the purposes of determining royalty and commercial milestone payments, shall be determined on a
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">country-by-country</FONT></FONT> basis by multiplying actual Net Sales of such Combination Product(s) in such country as determined in the first paragraph of the definition of
&#8220;Net Sales&#8221; (&#8220;<B><I>Combination Product(s) Net Sales</I></B>&#8221;) by the fraction A/(A+B) where &#8220;A&#8221; is the weighted average net selling price of the Product(s) in such country when sold separately (<I>i.e.</I>,
without the Other Product(s)) and &#8220;B&#8221; is the weighted average net selling price of the Other Product(s) in such country when sold separately, in each case, during the relevant period. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event that the weighted average sale price of the Product(s) can be determined but the weighted average sale price of
the other active compound(s), ingredient(s), and/or device(s) cannot be determined, Net Sales for purposes of determining royalty payments shall be calculated by multiplying the Combination Product(s) Net Sales by the fraction A/C where A is the
weighted average net selling price of the Product(s) in such country when sold separately (<I>i.e.</I>, without the Other Product(s)) and C is the weighted average net selling price of the Combination Product(s) in such country. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">If either (a)&nbsp;the weighted average net selling price of the Product(s) in such country when sold separately (<I>i.e.</I>,
without the Other Product(s)) cannot be determined but the weighted average net selling price of the Other Product(s) in such country when sold separately can be determined or (b)&nbsp;neither the weighted average net selling price of the Other
Product(s) or the Product(s) in such country when sold separately can be determined, then with respect to sales by TuHURA or its Affiliates or Sublicensees, Combination Product(s) Net Sales in such country for purposes of determining royalty
payments will be calculated by multiplying the Combination Product(s) Net Sales by the fraction A/C where A will be a price to be negotiated and agreed upon by the Parties, reasonably and in good faith taking into account the target product profile
of such Product(s) and other relevant external factors and C is the weighted average net selling price of the Combination Product(s) in such country; <I>provided</I> that, if the Parties are unable to agree upon such price determination within sixty
(60)&nbsp;days of commencing such negotiations, then such matter shall be resolved in accordance with Section&nbsp;20 taking into account the standards set forth above. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>(xvii)</I> &#8220;<B><I>Patent(s)</I></B>&#8221; shall mean (A)&nbsp;the United States and foreign patents and/or patent
applications (and any patents issuing therefrom and all continuations, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">continuations-in-part,</FONT></FONT> divisionals, extensions, substitutions, reissues, <FONT
STYLE="white-space:nowrap">re-examinations,</FONT> and renewals of any of the foregoing) listed in Appendix A hereto and (B)&nbsp;any United States and foreign patents and/or patent applications (and any patents issuing therefrom) to the extent
claiming any use of <FONT STYLE="white-space:nowrap">IFx-2.0</FONT> in Merkel cell carcinoma, pancreatic cancer, or ovarian cancer owned or controlled by TuHURA or its Affiliates and conceived or reduced to practice prior to, or during, the Royalty
Term. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>(xviii)</I> &#8220;<B><I>Payment</I></B>&#8221; shall have the meaning set forth in Section&nbsp;2. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>(xix)</I> &#8220;<B><I>Person</I></B>&#8221; shall mean any corporation, limited or general partnership, limited liability
company, joint venture, trust, unincorporated association, governmental body, authority, bureau or agency, any other entity or body, or an individual. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>(xx)</I> &#8220;<B><I>Product(s)</I></B>&#8221; shall mean any product or
service (i)&nbsp;the manufacture, use, offer for sale, or sale of which infringes any Valid Claim of a Patent or would infringe any pending Valid Claim of a Patent if such claim were to issue or (ii)&nbsp;that otherwise constitutes the use of <FONT
STYLE="white-space:nowrap">IFx-2.0</FONT> in any pharmaceutical application. For the sake of clarity, a Product will constitute the use of <FONT STYLE="white-space:nowrap">IFx-2.0</FONT> in any indication, including Merkel cell carcinoma, pancreatic
cancer, ovarian cancer, or any other oncological indication or related product variant, if Covered and indicated therefor. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>(xxi)</I> &#8220;<B><I>Representatives</I></B>&#8221; means with respect to a Party, that Party&#8217;s employees, officers,
consultants, agents, independent contractors, and outside legal advisors. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>(xxii)</I>
&#8220;<B><I>Royalty</I></B>&#8221; shall have the meaning set forth in Section&nbsp;2. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>(xxiii)</I>
&#8220;<B><I>Royalty Payor(s)</I></B>&#8221; shall have the meaning set forth in Section&nbsp;2. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>(xxiv)</I>
&#8220;<B><I>Royalty Statement</I></B>&#8221; shall have the meaning set forth in Section&nbsp;2. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>(xxv)</I>
&#8220;<B><I>Royalty Term</I></B>&#8221; shall mean the date of the First Commercial Sale of any Product in any country and continuing until the expiration or abandonment of the
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">last-to-expire</FONT></FONT> Valid Claim in any country Covering a Product. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>(xxvi)</I> &#8220;<B><I>Royalty Year</I></B>&#8221; shall mean the twelve-month period beginning on the date of the First
Commercial Sale made by TuHURA of any Product (regardless of Product) and ending on the date that is one day before the first anniversary of such First Commercial Sale, as well as each successive consecutive twelve month period thereafter during the
Royalty Term. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>(xxvii)</I> &#8220;<B><I>Sublicensee</I></B>&#8221; shall mean a Third Party that is granted a license or
sublicense to sell Product(s) in the Field in the Territory, beyond the mere right to purchase Product(s) from TuHURA and its Affiliates or resell such Product(s), and excludes TuHURA&#8217;s Affiliates or Third Party subcontractors that act solely
for the benefit of TuHURA or its Affiliates in the supply chain or that perform discrete services (as opposed to being granted broad rights or responsibilities) on behalf of TuHURA or its Affiliates. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>(xxviii)</I> &#8220;<B><I>Term</I></B>&#8221; shall have the meaning set forth in Section&nbsp;3. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>(xxix)</I> <B><I></I></B>&#8220;<B><I>Territory</I></B>&#8221; shall mean worldwide. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>(xxx)</I> &#8220;<B><I>Third Party</I></B>&#8221; shall mean any Person other than TuHURA or Parkview. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>(xxxi)</I> &#8220;<B><I>Valid Claim</I></B>&#8221; shall mean a claim in: (A)&nbsp;an issued, unexpired, and granted Patent
owned or controlled by TuHURA or its Affiliates, which has not been held unenforceable, unpatentable, or invalid by a decision of a court or other governmental authority of competent jurisdiction or (B)&nbsp;a pending Patent application owned or
controlled by TuHURA or its Affiliates which has not been abandoned or finally rejected without the possibility of appeal or refiling and that has not been pending for greater than ten (10)&nbsp;years. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2. <U>Royalty; Material Terms</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) During each Royalty Year during the Royalty Term, as consideration for Parkview&#8217;s obligations under the Loan Agreement, TuHURA, an
applicable Third Party or Affiliate, or Sublicensee (&#8220;<B><I>Royalty Payors</I></B>&#8221;) shall pay Parkview annual royalty payments equal to (i) [*****]% of the Net Sales during such Royalty Year up to and including [*****] dollars
($[*****]) of Net Sales; (ii) [*****]% of the Net Sales during such Royalty Year for greater than [*****] dollars ($[*****]) of Net Sales up to and including [*****] dollars ($[*****]) of Net Sales; and (iii) [*****]% of the Net Sales during such
Royalty Year for greater than [*****] dollars ($[*****]) of Net Sales up to and including four hundred fifty million dollars ($450,000,000.00) of Net Sales (the &#8220;<B><I>Royalty</I></B>&#8221;). For the sake of clarity, since the use of <FONT
STYLE="white-space:nowrap">IFx-2.0</FONT> in any pharmaceutical application constitutes a Product, the thresholds for Net Sales set forth in this Section&nbsp;2(a) shall be calculated for the cumulative total of all Products taken together annually.
In no event shall the Royalty Payors pay a Royalty in excess of the amounts explicitly set forth in this Section&nbsp;2(a) for all Products combined. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Any Royalty earned hereunder on Net Sales of Product(s) shall be paid by Royalty Payors within ninety (90)&nbsp;days following the last
day of the Royalty Year in which such Net Sales were invoiced by Royalty Payors (each payment, a &#8220;<B><I>Payment</I></B>&#8221;). Each Payment shall be made in US dollars by wire transfer of immediately available funds to an account designated
by Parkview. Any Payment not made when due shall bear interest from the due date until paid at a rate equal to the lesser of (i)&nbsp;five percent (5.00%) per month or (ii)&nbsp;the maximum rate permitted by applicable law. Parkview shall pay all
applicable taxes or charges imposed by any government entity in connection with any Payment. Royalty Payors will calculate the Net Sales of Product(s) in respect of a Royalty Year in US dollars using the appropriate foreign exchange rate for the
currency quoted by the Wall Street Journal on the close of business on the last banking day of such calendar year. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Each Payment shall
be accompanied by a statement (each, a &#8220;<B><I>Royalty Statement</I></B>&#8221;) that sets forth (i)&nbsp;the gross amounts invoiced for the sale of Product(s) in the applicable Royalty Year, (ii)&nbsp;the Net Sales of the Product(s) in the
applicable Royalty Year showing the calculation of gross amounts invoiced to Net Sales on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Product-by-Product</FONT></FONT> basis, and (iii)&nbsp;a calculation of the Royalty due on
such Net Sales. Parkview may, upon reasonable notice and at Parkview&#8217;s expense and no more than once annually, audit TuHURA&#8217;s books and records for the purpose of determining the accuracy of Royalty Statements for the prior three
(3)&nbsp;Royalty Years. All audits shall be conducted on Parkview&#8217;s behalf by a certified public accountant selected by Parkview. Audits shall be conducted during regular business hours at the offices where TuHURA maintains such records.
Parkview and its auditor shall have access to all records reasonably related to the calculation of Net Sales, including records relating to deductions, discounts, returns, and Combination Products. Such auditor shall be bound by reasonable
confidentiality obligations. If such audit reveals a deficiency in any Payment, TuHURA shall pay such deficiency to Parkview within thirty (30)&nbsp;days, together with interest thereon at the rate of the lesser of (A)&nbsp;one percent (1%) per
month or (B)&nbsp;the maximum rate permitted by applicable law, from the date such payment was originally due. If such deficiency exceeds ten percent (10%) of the Payment actually made for the audited period, TuHURA shall also pay the reasonable
documented fees and expenses of the auditor. If the deficiency exceeds twenty percent (20%) for any Royalty Year, Parkview shall have the right to conduct an additional audit for the immediately preceding Royalty Year at TuHURA&#8217;s expense.
TuHURA will maintain records showing sale of the Product(s) (including sales of other goods or services sold or licensed bundled with the Product(s)) for at least five (5)&nbsp;years from the date of sale. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) If Royalty Payor(s) enters into any Third Party royalty arrangements or patent licenses
that are reasonably necessary for the exploitation of a Product, then fifty percent (50%) of the amounts actually paid to the Third Party under the Third Party royalty arrangements or patent licenses Product(s) may be offset against the Royalty that
would otherwise have been payable to Parkview, such offset to continue until all such amounts have been expended; <I>provided, however,</I> that (i)&nbsp;in no event shall the Royalty owed to Parkview be reduced by more than fifty percent (50%) and
(ii)&nbsp;Royalty Payor(s) shall provide Parkview with copies of such Third Party agreements, which may be redacted for confidential terms unrelated to royalty calculations.<I> </I> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) At any time during the Term and at the written request of TuHURA, the Parties may negotiate in good faith a termination or reduction of
TuHURA&#8217;s (or its successors&#8217;) Royalty payment obligations or other obligations under this Agreement, in accordance with a Buyout Consideration and subject to written agreement executed by both Parties. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) <U>Information Rights</U>. TuHURA shall provide Parkview with (i)&nbsp;written notice of any regulatory approval or rejection of a Product
within ten (10)&nbsp;business days of such event, (ii)&nbsp;written notice of the First Commercial Sale of any Product within ten (10)&nbsp;business days of such sale, (iii)&nbsp;quarterly reports summarizing clinical trial progress, regulatory
submissions, and commercialization activities for Products, and (iv)&nbsp;prompt written notice of any material adverse development affecting the development, regulatory status, or commercial prospects of any Product. TuHURA shall also permit
Parkview or its designee to attend, as a <FONT STYLE="white-space:nowrap">non-voting</FONT> observer, any meetings of the Board of Directors at which matters material to Product development, regulatory strategy, or commercialization are to be
discussed, subject to reasonable confidentiality restrictions and recusal for matters presenting a conflict of interest. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g)
<U>Sublicensing</U>. TuHURA shall provide Parkview with written notice within thirty (30)&nbsp;days of entering into any sublicense with a Sublicensee, including a summary of the material terms relevant to royalty calculations. Any sublicense
agreement shall include provisions requiring the Sublicensee to (i)&nbsp;report Net Sales to TuHURA in a manner consistent with this Agreement, (ii)&nbsp;maintain books and records sufficient to verify Net Sales, and (iii)&nbsp;permit audits by
TuHURA (with results available to Parkview). TuHURA shall remain responsible for all Royalty payments to Parkview arising from Royalty Payors sales, regardless of whether TuHURA receives payment from such Royalty Payors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3. <U>Term and Termination</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Unless
earlier terminated pursuant to Section&nbsp;3(b) or Section&nbsp;3(c) below, the term of this Agreement will commence on the Effective Date of this Agreement and will continue on a
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Product-by-Product</FONT></FONT> basis until the expiration of the last Royalty Term for such Product(s) (the &#8220;<B><I>Term</I></B>&#8221;). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) TuHURA may terminate this Agreement upon written notice to Parkview if Parkview shall,
and Parkview may terminate this Agreement upon written notice to TuHURA if TuHURA shall, (i)&nbsp;apply for or consent to the appointment of a receiver, trustee, liquidator, or custodian of itself or of all or a substantial part of its property,
(ii)&nbsp;make a general assignment for the benefit of its or any of its creditors, (iii)&nbsp;be dissolved or liquidated, (iv)&nbsp;commence a voluntary case or other proceeding seeking liquidation, reorganization, or other relief with respect to
itself or its debts under any bankruptcy, insolvency, or other similar law now or hereafter in effect or consent to any such relief or to the appointment of or taking possession of its property by any official in an involuntary case or other
proceeding commenced against it, or (v)&nbsp;take any action for the purpose of effecting any of the foregoing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) TuHURA may terminate
this Agreement upon written notice to Parkview if Parkview materially breaches the Loan Agreement and such breach is not cured within thirty (30)&nbsp;days of written notice of breach delivered by TuHURA to Parkview. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <U>Change of Control</U>. In connection with any Change of Control, TuHURA&#8217;s obligations under this Agreement shall be assumed by
the acquiring or surviving entity pursuant to documentation, said documentation reasonably satisfactory to Parkview and the fully executed copy thereof provided to TuHURA within thirty (30)&nbsp;days following consummation of such Change of Control.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) <U>Termination for Material Breach by TuHURA</U>. Parkview may terminate this Agreement upon written notice to TuHURA if TuHURA
(i)&nbsp;fails to make any Royalty payment when due and such failure continues for thirty (30)&nbsp;days after written notice thereof from Parkview, (ii)&nbsp;materially breaches any other provision of this Agreement and such breach is not cured
within sixty (60)&nbsp;days of written notice from Parkview, or (iii)&nbsp;materially breaches the Loan Agreement and an Event of Default (as defined therein) has occurred and is continuing. Upon any such termination, TuHURA&#8217;s Royalty
obligations that accrued prior to termination shall survive and remain payable, and Parkview shall retain all rights and remedies available at law or in equity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4. <U>Representations and Warranties of the Parties</U>. Each Party represents and warrants that (a)&nbsp;it is duly formed and in good standing under the
laws of the jurisdiction of its formation; (b)&nbsp;it has the full right, power, and authority to enter into and perform this Agreement; (c)&nbsp;it is not presently the subject of a voluntary or involuntary petition in bankruptcy, does not
presently contemplate filing any such voluntary petition, and is not aware of any intention on the part of any other Person to file such an involuntary petition against it; (d)&nbsp;the individual executing this Agreement on such Party&#8217;s
behalf has the actual authority to bind such Party to this Agreement; (e)&nbsp;the consent of any Person who is not a party to this Agreement is not necessary or required for it to carry out its obligations hereunder; and (f)&nbsp;the execution and
performance of this Agreement does not and will not violate or interfere with any other material agreement to which it is a party. TuHURA further represents and warrants to Parkview as of the Effective Date that: (g)&nbsp;TuHURA or its Affiliates
own or control all right, title, and interest in and to the Patents listed in Appendix A, free and clear of all liens, encumbrances, and adverse claims, except for Permitted Liens (as defined in the Loan Agreement); (h) the Patents listed in
Appendix A have not been the subject of any challenge, reexamination, opposition, or invalidation proceeding, and to TuHURA&#8217;s Knowledge, are valid and enforceable; (i)&nbsp;to TuHURA&#8217;s Knowledge, the manufacture, use, offer for sale, and
sale of the Product(s) in the Field in the Territory will not infringe, misappropriate, or otherwise violate any intellectual property rights of any Third Party; (j)&nbsp;TuHURA has not received any written notice alleging that the Products or the
use thereof infringes the intellectual property rights of any Third Party; (k)&nbsp;to TuHURA&#8217;s Knowledge, no Third Party is infringing the Patents; (l)&nbsp;TuHURA has disclosed to Parkview all material licenses, agreements, and encumbrances
affecting the Patents or the Products; and (m)&nbsp;TuHURA has maintained and will continue to maintain all Patents in full force and effect and will not abandon any Patent without providing Parkview with at least sixty (60)&nbsp;days&#8217; prior
written notice. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5. <U>Ownership of the Product(s)</U>. As between the Parties, (a)&nbsp;TuHURA retains any and all right,
title, and interest in and to the Product(s) and the Confidential Information, Patent(s), and Intellectual Property Rights associated with the Product(s) and (b)&nbsp;Parkview acknowledges and agrees that except as set forth in this Agreement
(i)&nbsp;it shall not have any right, title, or interest in or to the Product(s) or the Intellectual Property Rights associated with the Product(s) and (ii)&nbsp;it shall not make any claim of ownership or interest in or to such Product(s) or the
Confidential Information, Patent(s), and Intellectual Property Rights associated with the Product(s). All Confidential Information, Patent(s), and Intellectual Property Rights, including all intellectual property, designs, compilations, property,
data, documentation, and any other materials prepared, conceived, discovered, developed, or created by or on behalf of TuHURA or Parkview and relating to, comprising, or constituting, in whole or in part, the Product(s) (including the Confidential
Information, Patent(s), and Intellectual Property Rights) shall be owned solely by TuHURA, regardless of derivation or inventorship. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6. <U>Patent
Maintenance</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) TuHURA shall use commercially reasonable efforts to prosecute and maintain all Patents in the Territory during the
Term. TuHURA shall not abandon, disclaim, or otherwise permit to lapse any Patent without providing Parkview at least thirty (30)&nbsp;days&#8217; prior written notice, during which period Parkview may elect, in its sole discretion, to assume
responsibility for prosecuting or maintaining such Patent at TuHURA&#8217;s expense (which expense may be offset against future Royalty payments). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) TuHURA shall provide Parkview with prompt written notice of any Third Party challenge to the validity or enforceability of any Patent,
including any reexamination, inter partes review, post-grant review, opposition, or litigation. TuHURA shall keep Parkview reasonably informed of the status and material developments in any such proceeding. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) TuHURA shall use commercially reasonable efforts to enforce the Patents against any Third Party infringement that is material to the
Products in the Field in the Territory and shall consult with Parkview before entering into any settlement that would materially affect the scope or enforceability of the Patents. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">7. <U>Covenant Not to Disclose</U>. The Parties further agree that no Party shall, from and after the Effective Date of this Agreement, and with no limits as
to geographic or temporal scope, at any time during and after the Term, directly or indirectly and in any way, use (except in the exercise of its rights or performance of its obligation under this Agreement) or disclose, or cause to be used or
disclosed, any trade secrets or Confidential Information of the other Party acquired by it in connection with this Agreement. Each Party shall safeguard the Confidential Information of the other Party from unauthorized use, access, or disclosure
using at least the degree of care it uses to protect its similarly sensitive information and in no event less than a reasonable degree of care. Notwithstanding the foregoing, each Party may disclose or permit access to Confidential
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Information of any other Party to its Representatives who (i)&nbsp;need to know such Confidential Information for purposes of the receiving Party&#8217;s exercise of its rights or performance of
its obligations under and in accordance with this Agreement, (ii)&nbsp;have been informed of the confidential nature of the Confidential Information and the receiving Party&#8217;s obligations under this Section&nbsp;7, and (iii)&nbsp;are bound by
confidentiality and restricted use obligations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">8. <U>Relationship of the Parties</U>. It is understood and agreed that this Agreement is not intended
to, and shall not, constitute any authority for Parkview to act in any manner as TuHURA&#8217;s agent or bind TuHURA for any purpose whatsoever. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">9.
<U>Severability</U>. Whenever possible, each provision of this Agreement will be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Agreement is held to be invalid, illegal, or unenforceable in
any respect under any applicable law or rule in any jurisdiction, such invalidity, illegality, or unenforceability will not affect any other provisions or any other jurisdiction and the Parties shall replace such invalid, illegal, or unenforceable
provision with a new provision permitted by applicable laws and rules and having an economic effect as close as possible to the invalid, illegal or unenforceable provision. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">10. <U>Complete Agreement</U>. This Agreement, together with the Loan Agreement, embodies the complete agreement and understanding between the Parties and
supersedes and preempts any prior understandings, agreements, or representations by or between the Parties, written or oral, which may have related to the subject matter hereof in any way. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">11. <U>Amendment and Waiver</U>. The provisions of this Agreement may be amended or waived only in a writing signed by TuHURA and Parkview or their
successors. No delay on the part of any Party in exercising any right, power, or privilege hereunder shall operate as a waiver thereof. Nor shall any waiver on the part of any Party of any such right, power, or privilege hereunder, nor any single or
partial exercise of any right, power, or privilege hereunder, preclude any other or further exercise thereof or the exercise of any other right, power, or privilege hereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">12. <U>Successors and Assigns</U>. This Agreement is intended to bind and inure to the benefit of and be enforceable by Parkview, TuHURA, and their respective
heirs, successors, and permitted assigns. TuHURA shall not assign or transfer this Agreement or any of its rights or obligations hereunder without the prior written consent of Parkview, which consent shall not be unreasonably withheld, conditioned,
or delayed; provided that TuHURA may assign this Agreement without Parkview&#8217;s consent to an Affiliate or in connection with a Change of Control, subject to compliance with Section&nbsp;3(d). Parkview may freely assign its rights under this
Agreement without TuHURA&#8217;s consent. Any purported assignment in violation of this Section&nbsp;12 shall be null and void. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">13. <U>Survival</U>.
Sections 2 (with respect to any Royalty obligations accrued prior to termination), 5 through 19, and any other provisions that by their nature should survive, shall survive termination or expiration of this Agreement for any reason. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">14. <U>Choice of Law; Jurisdiction</U>. This Agreement shall be construed under and in accordance with the laws of the state of Delaware, excluding its choice
law provisions. Any legal suit, action, or proceeding arising out of or related to this Agreement shall be instituted exclusively in the federal or state courts located in Delaware and each party irrevocably submits to the exclusive jurisdiction of
such courts in any such suit, action, or proceeding. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">15. <U>Waiver of Jury Trial</U>. EACH OF THE PARTIES HEREBY KNOWINGLY, INTENTIONALLY, AND VOLUNTARILY, TO
THE FULLEST EXTENT PERMITTED BY LAW, WAIVES IRREVOCABLY ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATED TO THIS AGREEMENT. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">16. <U>Further Assurances</U>. The Parties agree to cooperate fully and to execute any and all supplementary documents and to take all additional actions that
may be necessary or appropriate to give-full force to the terms and intent of this Agreement that are not inconsistent with its terms. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">17.
<U>Headings</U>. The headings in this Agreement are inserted for convenience only and are not to be considered in the interpretation or construction of the provisions hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">18. <U>Notices</U>. Any notices concerning this Agreement shall be in writing and delivered, at the sending Party&#8217;s cost and expense, by (a)&nbsp;email
with PDF attachment if appropriate, (b)&nbsp;personal delivery, (c)&nbsp;certified U.S. mail, with postage prepaid and return receipt requested, or (d)&nbsp;overnight courier service, to the recipient at the email address or mailing address set
forth on its signature page to this Agreement (or to such other email address or mailing address as shall be designated from time to time by such recipient in accordance with this Section&nbsp;18). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">19. <U>Counterparts</U>. This Agreement may be executed in separate counterparts, each of which is deemed to be an original and all of which taken together
constitute one and the same agreement. Execution and delivery of this Agreement by electronic exchange bearing the copies of a Party&#8217;s signature shall constitute a valid and binding execution and delivery of this Agreement by such Party. Such
electronic copies shall constitute enforceable original documents. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">20. <U>Expert Determination</U>. Notwithstanding anything to the contrary herein, to
the extent a dispute is claimed, by either Party, to involve (a)&nbsp;the determination of the Net Sales or the Net Sales of a Combination Product(s), (b) the calculation of Buyout Consideration, (c)&nbsp;whether a Third Party license is reasonably
necessary under Section&nbsp;2(d), or (d)&nbsp;any other technical or financial matter that the Parties mutually agree to submit to expert determination, the following procedures shall apply: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) The Parties shall mutually select a single independent, conflict-free expert (the &#8220;<B><I>Expert</I></B>&#8221;), who shall have
sufficient background and experience to resolve the dispute. If the Parties are unable to reach agreement on the selection of an Expert within thirty (30)&nbsp;days after submission to arbitration, then either or both Parties shall immediately
request that the International Chamber of Commerce select an Expert with the requisite background, experience, and expertise. The place of arbitration shall be Delaware and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Each Party shall prepare and submit a written summary of such Party&#8217;s position and any relevant evidence in support thereof to the
Expert within thirty (30)&nbsp;days of the selection of the Expert. Upon receipt of such summaries from each Party, the Expert shall provide copies of the same to the other Party. Within thirty (30)&nbsp;days of the delivery of such summaries by the
Expert, each Party shall submit a written rebuttal of the other Party&#8217;s summary and may also amend and <FONT STYLE="white-space:nowrap">re-submit</FONT> its original summary. Oral presentations shall not be permitted unless otherwise requested
by the Expert. The Expert shall make a final decision with respect to the dispute within thirty (30)&nbsp;days following receipt of the last of such rebuttal statements submitted by the Parties which such decision shall be binding on the Parties.
Each Party shall bear its own costs and expenses and attorneys&#8217; fees and the Party that does not prevail in the arbitration proceeding shall pay the Expert&#8217;s fees and any administrative fees of arbitration. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[Signature Pages Follow.] </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF, </B>the Parties have caused this Agreement to be duly executed as of
the Effective Date. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="93%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>TUHURA BIOSCIENCES, INC.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ James Bianco, M.D.</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">James A. Bianco</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Title: &#8195;&#8201;Chief Executive Officer</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Address:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">10500 University Center Drive,</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Suite
110</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Tampa, Florida 33612</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Email: <U>jbianco@tuhurabio.com;</U></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><U></U><U>ddearnborn@tuhurabio.com</U></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>PARKVIEW HOLDINGS ONE LLC</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Vijay Patel</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Vijay Patel</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Manager</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Address:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">6135 W. Sitka Street</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Tampa, Florida 33634</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Attention: Steven DiSarro</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Email: steve@dmfunding.com</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Appendix A </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Appendix A begins on the following page] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="17%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="38%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="20%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Patent Family</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Application/</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Publication/</B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Patent
Number</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Issue Date/Status</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">DNA Vector and Transformed Tumor Cell Vaccines</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Whole cell and DNA cancer vaccines</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">PCT/US2015/018688</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">(WO&nbsp;2015/134577)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Nationalized in</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CH, DE, DK, EP,</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FR, GB, HK, IE,</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">NL, NO, SE, US</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">US 9,555,088</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">US 9,839,680</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">US 10,391,158</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">US 10,751,400</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Issued&nbsp;01/31/2017</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Issued&nbsp;12/12/2017</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Issued&nbsp;08/27/2019</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Issued&nbsp;08/25/2020</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Cancer Vaccine Comprising mRNA Encoding a <FONT STYLE="white-space:nowrap">M-Like-Protein</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Next generation cancer vaccine using mRNA encoding a bacterial antigen to prime anti-cancer immune responses</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">PCT/US2016/033235</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">(WO&nbsp;2016/187407)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Nationalized in</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">AU, CA, CH, CN,</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">DE, DK, EP, FR,</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">GB, HK, IE, JP,</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">NL, NO, SE, US</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">US 9,636,388</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">US 10,682,401</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">US 18/060,605</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Issued&nbsp;05/02/2017</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Issued&nbsp;06/16/2020</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">pending</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Modified mRNA for Multicell Transformation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Next generation cancer vaccine using mRNA encoding a bacterial antigen to prime anti-cancer immune responses</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">PCT/US2021/031204</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">(WO&nbsp;2021/226413)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Nationalized in</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CN, JP, CA, IN,</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">AU, EP, KR, HK</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>4
<FILENAME>d139552dex102.htm
<DESCRIPTION>EX-10.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit</B><B><I> </I></B><B>10</B><B><I>.2</I></B><B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B></B><B><I>Execution Version</I></B><B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">April&nbsp;21, 2026 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">TuHURA Biosciences, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">10500 University Center Drive, Suite 110 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Tampa, FL 33612 </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">Re:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Fee Letter </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This is the Fee Letter referred to in
that certain Loan Agreement, dated as of the date hereof (as amended, restated, amended and restated, supplemented or otherwise modified from time to time, the &#8220;<B>Loan Agreement</B>&#8221;), by and among TUHURA BIOSCIENCES, INC., a Nevada
corporation (the &#8220;<B>Borrower</B>&#8221;), and PARKVIEW HOLDINGS ONE LLC, a Florida limited liability company (the &#8220;<B>Lender</B>&#8221;). All capitalized terms used but not defined herein shall have the respective meanings given to them
in the Loan Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition to (but without duplication of) any fees or other amounts payable by the Borrower to the Lender under the terms of the
Loan Agreement and the other Loan Documents, the Borrower agrees to the following: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Borrower will pay a fully earned and <FONT
STYLE="white-space:nowrap">non-refundable</FONT> closing fee (the &#8220;<B>Closing Fee</B>&#8221;) in an aggregate amount equal to $5,000,000.00 (which amount equals 10.00% of the aggregate principal amount of the Revolving Credit Commitment as of
the Closing Date) due and payable in full on the Closing Date; provided, however, that the Borrower may, at its option, elect to pay all or a portion of the Closing Fee in shares of common stock of the Borrower at a price per share equal to $2.662,
which is the average of the daily closing price of such common stock on the Nasdaq Capital Market for the ten (10)&nbsp;trading days ending on and including the Closing Date (the &#8220;<B>Share Portion</B>&#8221;). The shares of common stock
included in the Share Portion shall be due and issuable within three (3)&nbsp;business days after the approval of the issuance thereof by the stockholders of the Company in accordance with the rules and regulations of the Nasdaq Stock Market LLC,
provided that if such approval is not obtained by August&nbsp;31, 2026, then the Share Portion shall become due and payable in cash on September&nbsp;1, 2026. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All of the foregoing fees are deemed fully earned when required to be paid and shall be nonrefundable when paid. All amounts payable under this Fee Letter
shall not be subject to counterclaim or <FONT STYLE="white-space:nowrap">set-off</FONT> for, or be otherwise affected by, any claim or dispute relating to any other matter. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This Fee Letter is a Loan Document and shall govern in the event of any inconsistency with the Credit Agreement or the other Loan Documents with respect to
the subject matter hereof, as the case may be. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This Fee Letter may be executed in any number of counterparts and by the different parties hereto on
separate counterparts and each such counterpart shall be deemed to be an original, but all such counterparts shall together constitute the same agreement. Receipt by telecopy of any executed signature page to this Fee Letter shall constitute
effective delivery of such signature page. This Fee Letter to the extent signed and delivered by means of electronic transmission (including &#8220;pdf&#8221;), shall be treated in all manner and respects and for all purposes as an original
agreement or amendment and shall be considered to have the same binding legal effect as if it were the original signed version thereof delivered in person. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">THIS FEE LETTER SHALL BE GOVERNED BY, AND SHALL BE CONSTRUED AND ENFORCED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF FLORIDA, WITHOUT REGARD TO CONFLICTS OF
LAWS PRINCIPLES. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Pages Follow] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Very truly yours,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>PARKVIEW HOLDINGS ONE LLC</B>, as Lender</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Vijay Patel</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Vijay Patel</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Manager</P></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Signature Page to Fee Letter </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">ACCEPTED and AGREED as of the date first written above:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>TUHURA BIOSCIENCES, INC.</B>, a Nevada corporation, as Borrower</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ James Bianco, M.D.</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Name: James Bianco</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Title: Chief Executive Officer</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Signature Page to Fee Letter </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>5
<FILENAME>d139552dex103.htm
<DESCRIPTION>EX-10.3
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.3</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.3 </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TUHURA BIOSCIENCES, INC. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>WARRANT AMENDMENT AGREEMENT </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(2022 W<SMALL>ARRANTS</SMALL>) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>THIS WARRANT AMENDMENT AGREEMENT </B>(this &#8220;<B><I>Agreement</I></B>&#8221;) is made and entered into effective as of April&nbsp;21,
2026 (the &#8220;<B><I>Effective Date</I></B>&#8221;), by and between <B>TUHURA BIOSCIENCES, INC.</B>, a Nevada corporation (the &#8220;<B><I>Company</I></B>&#8221;),<B> </B>and <B>K</B><B></B><B>&nbsp;&amp; V INVESTMENT ONE LLC</B>, a Florida
limited liability company (the &#8220;<B><I>Holder</I></B>&#8221;). </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>R<SMALL>ECITALS</SMALL> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>A.</B> Pursuant to the following Common Stock Purchase Warrants previously issued by TuHURA Biosciences, Inc., a Delaware corporation
(&#8220;<B><I>TuHURA Delaware</I></B>&#8221;), to the Holder, the Holder was granted the following warrants to purchase the following number of shares of common stock, par value $0.0001 per share, of TuHURA Delaware, at the exercise prices indicated
below (the &#8220;<B><I>Predecessor Warrants</I></B>&#8221;): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="61%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><B><I><U>Predecessor Warrants</U></I></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B><I><U>Date of</U></I></B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B><I><U>Predecessor<BR></U><U>Warrant</U></I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B><I><U>#&nbsp;of&nbsp;Warrant<BR></U><U>Shares</U></I></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B><I><U>Exercise&nbsp;Price<BR></U><U>Per Share</U></I></B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Common Stock Purchase Warrant #1 (Warrant No.
<FONT STYLE="white-space:nowrap">W-403)</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>August&nbsp;31,&nbsp;2022</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8,522,729</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.66</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Common Stock Purchase Warrant #2 (Warrant No.
<FONT STYLE="white-space:nowrap">W-404)</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>August&nbsp;31, 2022</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8,522,729</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.66</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">B. On October&nbsp;18, 2024, the Company completed a merger transaction in accordance with the terms of the
Agreement and Plan of Merger, dated as of April&nbsp;2, 2024 (the &#8220;<B><I>Merger Agreement</I></B>&#8221;), by and among the Company (which was named Kintara Therapeutics, Inc. at the time), TuHURA Delaware, and Kayak Mergeco, Inc., a direct
wholly owned subsidiary of the Company (&#8220;<B><I>Merger Sub</I></B>&#8221;), pursuant to which Merger Sub merged with and into TuHURA Delaware, with TuHURA Delaware surviving as a direct wholly owned subsidiary of the Company (the
&#8220;<B><I>Merger</I></B>&#8221;). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">C. As a result of the Merger and pursuant to the terms of the Merger Agreement, on October&nbsp;18,
2024, the Predecessor Warrants were converted into and exchanged for replacement warrants (the &#8220;<B><I>Existing Warrants</I></B>&#8221;) entitling the Holder to purchase the following number of shares of Company common stock, par value $0.001
per share (&#8220;<B><I>Common Stock</I></B>&#8221;), at the exercise prices set forth below, with the Existing Warrants otherwise having the same terms and provisions as the Predecessor Warrants, including the Expiration Dates (as defined in the
Predecessor Warrants) set forth below (the &#8220;<B><I>Original Expiration Dates</I></B>&#8221;): </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><B><I><U>Existing Warrants</U></I></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B><I><U>Date of </U><U>Predecessor<BR></U><U>Warrant</U></I></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B><I><U># of<BR></U><U>Warrant<BR></U><U>Shares<BR></U><U>under<BR></U><U>Existing<BR></U><U>Warrant<BR></U><U>after<BR></U><U>Merger</U></I></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B><I><U>Original</U></I></B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B><I><U>Expiration</U></I></B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B><I><U>Dates</U></I></B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B><I><U>Exercise<BR>Price&nbsp;after<BR></U><U>Merger</U></I></B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Common Stock Purchase Warrant #1</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">August&nbsp;31,&nbsp;2022</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,524,716</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">August&nbsp;31, 2029</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.69</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Common Stock Purchase Warrant #2</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">August&nbsp;31, 2022</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,524,716</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">August&nbsp;31,&nbsp;2029</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.69</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">D. On the date hereof, the Company desires to enter into a Loan Agreement (the &#8220;<B>Loan
Agreement</B>&#8221;) with Parkview Holdings One, LLC (&#8220;<B>Parkview</B>&#8221;), a Florida limited liability company and an affiliate of the Holder, under which Parkview has agreed to make available to the Company a loan facility in the amount
of up to $50&nbsp;million in the aggregate upon the terms and conditions set forth in the Loan Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">E. The Company and the Holder
desire to hereby memorialize their agreement that the Company will extend the Expiration Date of the Existing Warrants from the Original Expiration Dates to April&nbsp;21, 2031, in consideration of, and as a condition to, Parkview entering in the
Loan Agreement. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>NOW, THEREFORE</B>, in consideration of the foregoing recitals and the mutual promises, representations, warranties, and covenants
hereinafter set forth and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>1.</B> <B>Recitals</B>. The foregoing Recitals are true and correct and incorporated into this Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.</B> <B>Amendment to Existing Warrant.</B> Contingent on Parkview executing and delivering the Loan Agreement to the Company, the
Expiration Date of each of the Existing Warrants is hereby amended to be 5:00 p.m., Tampa, Florida time, on April&nbsp;21, 2031 (the &#8220;<B><I>Extended Expiration Date</I></B>&#8221;), and the &#8220;Expiration Date&#8221; of the Existing
Warrants shall hereafter be the Extended Expiration Date. Notwithstanding the foregoing, nothing set forth in this paragraph shall affect any terms and provisions of the Existing Warrants that would result in the termination of the Existing Warrants
prior to the Extended Expiration Date, including without limitation the termination provisions set forth in Section&nbsp;2.4 of the Existing Warrants. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>3.</B> <B>General</B>. This Agreement shall be governed by, and shall be construed in accordance with, the domestic laws of the State of
Delaware, without giving effect to any choice of law or conflict of law provision (whether of the State of Delaware or any other jurisdiction) that would cause the application of the laws of any jurisdiction other than the laws of the State of
Delaware. This Agreement shall inure to the benefit of, and shall be binding upon, the parties hereto and their respective successors and permitted </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
assigns. If any provision of this Agreement or the application of any such provision to any person or circumstance shall be held invalid, illegal or unenforceable in any respect by a court of
competent jurisdiction, such invalidity, illegality or unenforceability shall not affect any other provision of this Agreement. At any time or from time to time after the date hereof, at the request of a party hereto and without further
consideration, the other party hereto and its successors or assigns, shall execute and deliver, or shall cause to be executed and delivered, such other instruments and take such other actions as such party may reasonably request to effect the
transactions contemplated hereby. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>4.</B> <B>Counterparts.</B> This Agreement may be executed in any number of counterparts, each of
which shall be an original, but all of which together shall constitute one instrument. Facsimile and/or other electronically transmitted signatures shall be effective for all purposes. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.</B> <B>Continuing Effect.</B> Other than as set forth in this Agreement, all of the terms and conditions of the Existing Warrant shall
continue in full force and effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[SIGNATURE PAGES FOLLOW] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>I<SMALL>N</SMALL> W<SMALL>ITNESS</SMALL>
W<SMALL>HEREOF</SMALL></B><SMALL><B></B></SMALL><B>, </B>the parties hereto have executed this Warrant Amendment Agreement as of the Effective Date. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>COMPANY:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>TUHURA BIOSCIENCES, INC.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ James Bianco, M.D.</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: James A. Bianco</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Chief Executive Officer</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDER:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>K&nbsp;&amp; V Investment One LLC</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Vijay Patel</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Vijay Patel, Manager</TD></TR>
</TABLE></DIV>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>6
<FILENAME>d139552dex104.htm
<DESCRIPTION>EX-10.4
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.4</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.4 </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TUHURA BIOSCIENCES, INC. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>WARRANT AMENDMENT AGREEMENT </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(2024 W<SMALL>ARRANTS</SMALL>) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>THIS WARRANT AMENDMENT AGREEMENT </B>(this &#8220;<B><I>Agreement</I></B>&#8221;) is made and entered into effective as of April&nbsp;21,
2026 (the &#8220;<B><I>Effective Date</I></B>&#8221;), by and between <B>TUHURA BIOSCIENCES, INC.</B>, a Nevada corporation (the &#8220;<B><I>Company</I></B>&#8221;),<B> </B>and <B>K</B><B></B><B>&nbsp;&amp; V INVESTMENT ONE LLC</B>, a Florida
limited liability company (the &#8220;<B><I>Holder</I></B>&#8221;). </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>R<SMALL>ECITALS</SMALL> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>A.</B> Pursuant to the following Common Stock Purchase Warrants previously issued by TuHURA Biosciences, Inc., a Delaware corporation
(&#8220;<B><I>TuHURA Delaware</I></B>&#8221;), to the Holder, the Holder was granted the following warrants to purchase the following number of shares of common stock, par value $0.0001 per share, of TuHURA Delaware, at the exercise prices indicated
below (the &#8220;<B><I>Predecessor Warrants</I></B>&#8221;): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="58%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><B><I><U>Predecessor Warrants</U></I></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B><I><U>Date of</U></I></B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B><I><U>Predecessor</U></I></B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B><I><U>Warrant</U></I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B><I><U>#&nbsp;of&nbsp;Warrant<BR></U><U>Shares</U></I></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B><I><U>Exercise&nbsp;Price<BR></U><U>Per Share</U></I></B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Common Stock Purchase Warrant #1</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>April&nbsp;2, 2024</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">367,647</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.02</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Common Stock Purchase Warrant #2</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>August&nbsp;20,&nbsp;2024</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,941,176</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.02</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Common Stock Purchase Warrant #2</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>September&nbsp;18,&nbsp;2024</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,044,118</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.02</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">B. On October&nbsp;18, 2024, the Company completed a merger transaction in accordance with the terms of the
Agreement and Plan of Merger, dated as of April&nbsp;2, 2024 (the &#8220;<B><I>Merger Agreement</I></B>&#8221;), by and among the Company (which was named Kintara Therapeutics, Inc. at the time), TuHURA Delaware, and Kayak Mergeco, Inc., a direct
wholly owned subsidiary of the Company (&#8220;<B><I>Merger Sub</I></B>&#8221;), pursuant to which Merger Sub merged with and into TuHURA Delaware, with TuHURA Delaware surviving as a direct wholly owned subsidiary of the Company (the
&#8220;<B><I>Merger</I></B>&#8221;). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">C. As a result of the Merger and pursuant to the terms of the Merger Agreement, on October&nbsp;18,
2024, the Predecessor Warrants were converted into and exchanged for replacement warrants (the &#8220;<B><I>Existing Warrants</I></B>&#8221;) entitling the Holder to purchase the following number of shares of Company common stock, par value $0.001
per share (&#8220;<B><I>Common Stock</I></B>&#8221;), at the exercise prices set forth below, with the Existing Warrants otherwise having the same terms and provisions as the Predecessor Warrants, including the Termination Dates (as defined in the
Predecessor Warrants) set forth below (the &#8220;<B><I>Original Termination Dates</I></B>&#8221;): </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="47%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><B><I><U>Existing Warrants</U></I></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B><I><U>Date of </U><U>Predecessor<BR></U><U>Warrant</U></I></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B><I><U># of<BR></U><U>Warrant<BR></U><U>Shares<BR></U><U>under<BR></U><U>Existing<BR></U><U>Warrant<BR></U><U>after<BR></U><U>Merger</U></I></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B><I><U>Original </U><U>Termination<BR></U><U>Dates</U></I></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B><I><U>Exercise<BR>Price&nbsp;after<BR></U><U>Merger</U></I></B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Common Stock Purchase Warrant #1</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>April&nbsp;2, 2024</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">65,772</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>April&nbsp;2, 2027</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5.70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Common Stock Purchase Warrant #2</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>August&nbsp;20, 2024</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">526,176</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>August&nbsp;20, 2027</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5.70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Common Stock Purchase Warrant #3</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>September&nbsp;18,&nbsp;2024</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">723,493</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>September&nbsp;17,&nbsp;2027</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5.70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">D. On the date hereof, the Company desires to enter into a Loan Agreement (the &#8220;<B>Loan
Agreement</B>&#8221;) with Parkview Holdings One, LLC (&#8220;<B>Parkview</B>&#8221;), a Florida limited liability company and an affiliate of the Holder, under which Parkview has agreed to make available to the Company a loan facility in the amount
of up to $50&nbsp;million in the aggregate upon the terms and conditions set forth in the Loan Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">E. The Company and the Holder
desire to hereby memorialize their agreement that the Company will extend the Termination Date of the Existing Warrants from the Original Termination Dates to April&nbsp;21, 2031, in consideration of, and as a condition to, Parkview entering in the
Loan Agreement. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>NOW, THEREFORE</B>, in consideration of the foregoing recitals and the mutual promises, representations, warranties, and covenants
hereinafter set forth and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>1.</B> <B>Recitals</B>. The foregoing Recitals are true and correct and incorporated into this Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.</B> <B>Amendment to Existing Warrant.</B> Contingent on Parkview executing and delivering the Loan Agreement to the Company, the
Termination Date of each of the Existing Warrants is hereby amended to be 5:00 p.m., Tampa, Florida time, on April&nbsp;21, 2031 (the &#8220;<B><I>Extended Termination Date</I></B>&#8221;), and the &#8220;Termination Date&#8221; of the Existing
Warrants shall hereafter be the Extended Termination Date. Notwithstanding the foregoing, nothing set forth in this paragraph shall affect any terms and provisions of the Existing Warrants that would result in the termination of the Existing
Warrants prior to the Extended Termination Date, including without limitation the termination provisions set forth in Section&nbsp;2.4 of the Existing Warrants. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>3.</B> <B>General</B>. This Agreement shall be governed by, and shall be construed in accordance with, the domestic laws of the State of
Delaware, without giving effect to any choice of law or conflict of law provision (whether of the State of Delaware or any other jurisdiction) that would cause the application of the laws of any jurisdiction other than the laws of the State of
Delaware. This Agreement shall inure to the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
benefit of, and shall be binding upon, the parties hereto and their respective successors and permitted assigns. If any provision of this Agreement or the application of any such provision to any
person or circumstance shall be held invalid, illegal or unenforceable in any respect by a court of competent jurisdiction, such invalidity, illegality or unenforceability shall not affect any other provision of this Agreement. At any time or from
time to time after the date hereof, at the request of a party hereto and without further consideration, the other party hereto and its successors or assigns, shall execute and deliver, or shall cause to be executed and delivered, such other
instruments and take such other actions as such party may reasonably request to effect the transactions contemplated hereby. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>4.</B>
<B>Counterparts.</B> This Agreement may be executed in any number of counterparts, each of which shall be an original, but all of which together shall constitute one instrument. Facsimile and/or other electronically transmitted signatures shall be
effective for all purposes. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.</B> <B>Continuing Effect.</B> Other than as set forth in this Agreement, all of the terms and conditions
of the Existing Warrant shall continue in full force and effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[SIGNATURE PAGES FOLLOW] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>I<SMALL>N</SMALL> W<SMALL>ITNESS</SMALL>
W<SMALL>HEREOF</SMALL></B><SMALL><B></B></SMALL><B>, </B>the parties hereto have executed this Warrant Amendment Agreement as of the Effective Date. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>COMPANY:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>TUHURA BIOSCIENCES, INC.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ James Bianco, M.D.</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: James A. Bianco</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Chief Executive Officer</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDER:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>K&nbsp;&amp; V Investment One LLC</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Vijay Patel</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Vijay Patel, Manager</TD></TR>
</TABLE></DIV>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>7
<FILENAME>d139552dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TuHURA Biosciences Announces $50 Million Credit Facility and Royalty Transaction Extending Anticipated Cash Runway into 2028 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>Credit facility anticipated to fund development of pipeline, including <FONT STYLE="white-space:nowrap">IFx-2.0</FONT> through Phase 3
results and <FONT STYLE="white-space:nowrap">TBS-2025</FONT> to key efficacy measurement milestones </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">TAMPA, Fla., April&nbsp;22, 2026 &#8212; TuHURA
Biosciences, Inc. (NASDAQ:HURA) (&#8220;TuHURA&#8221; or the &#8220;Company&#8221;), a Phase 3 immuno-oncology company developing novel therapeutics to overcome resistance to cancer immunotherapy, today announced that it has entered into
a&#8195;loan agreement providing a credit facility of up to $50&nbsp;million in funding to support the Company&#8217;s pipeline, ongoing clinical trials, and general corporate expenses. The lender is an affiliate of the Company&#8217;s largest
stockholder, K&amp;V Investment One LLC. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the terms of the loan agreement, TuHURA will have the ability to draw down monthly on the facility on an <FONT
STYLE="white-space:nowrap">as-needed</FONT> basis to fund monthly expenses for ongoing clinical development and operations. The facility bears a 12% annual interest rate on outstanding funds drawn, with interest paid monthly and principal repayment
due at a <FONT STYLE="white-space:nowrap">5-year</FONT> maturity date of April&nbsp;21, 2031. The loan facility is secured by the assets of the Company and its subsidiaries. In connection with the credit facility, the Company granted the lender a
low to <FONT STYLE="white-space:nowrap">mid-single</FONT> digit percentage royalty on annual commercial sales by the Company or its sublicensees of products based on <FONT STYLE="white-space:nowrap">IFx-2.0.</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#8220;We are gratified to have established this <FONT STYLE="white-space:nowrap">non-equity</FONT> based source of operating capital on what we believe are
attractive terms for a company such as TuHURA. This agreement allows us to fund operations through anticipated key milestones this year and beyond through anticipated <FONT STYLE="white-space:nowrap">top-line</FONT> Phase 3 results of our lead <FONT
STYLE="white-space:nowrap">IFx-2.0</FONT> program. Importantly, we control the timing and amount of funds drawn under this facility while preserving the ability to be opportunistic in securing other potential sources of capital, including corporate
partnerships or equity financings,&#8221; said Dr.&nbsp;James Bianco, President and Chief Executive Officer of TuHURA Biosciences. &#8220;We believe that it is unusual to access such an attractive source of capital in advance of a BLA submission or
pending FDA approval. This funding is a testament to the conviction our largest shareholder has in our strategy and in the potential for the clinical and commercial success of <FONT STYLE="white-space:nowrap">IFx-2.0.&#8221;</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Additional information regarding the credit facility and royalty agreement, including the terms and provisions of the loan agreement, can be found in the
Company&#8217;s Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> filed today with the Securities and Exchange Commission. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About TuHURA Biosciences, Inc.</B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">TuHURA Biosciences, Inc. (Nasdaq: HURA) is a Phase 3 immuno-oncology company developing novel technologies to overcome primary and acquired resistance to
cancer immunotherapy, two of the most common reasons cancer immunotherapies fail to work or stop working in the majority of patients with cancer. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">TuHURA&#8217;s lead innate immune agonist, <FONT STYLE="white-space:nowrap">IFx-2.0,</FONT> is designed to overcome primary resistance to checkpoint
inhibitors. TuHURA has initiated a single randomized placebo-controlled Phase 3 registration trial of <FONT STYLE="white-space:nowrap">IFx-2.0</FONT> administered as an adjunctive therapy to
Keytruda<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> (pembrolizumab) compared to Keytruda<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> plus placebo in first-line treatment for advanced or metastatic Merkel Cell Carcinoma.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition to its innate immune agonist product candidates, TuHURA acquired <FONT STYLE="white-space:nowrap">TBS-2025</FONT> in its acquisition by
merger with Kineta Inc. on June&nbsp;30, 2025. <FONT STYLE="white-space:nowrap">TBS-2025</FONT> is a VISTA inhibiting mAb moving into Phase 1b/ 2 development in <I>mut</I>NPM1 r/r AML. In addition, TuHURA is leveraging its Delta Opioid Receptor
technology to develop <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">first-in-class,</FONT></FONT> <FONT STYLE="white-space:nowrap">bi-specific,</FONT> <FONT STYLE="white-space:nowrap">bi-functional</FONT> antibody drug conjugates
(ADCs) targeting Myeloid Derived Suppressor Cells to inhibit their immune-suppressing effects on the tumor microenvironment to prevent T cell exhaustion and acquired resistance to checkpoint inhibitors and cellular therapies. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For more information, please visit<B></B><B>&nbsp;<U>www.tuhurabio.com</U></B><B></B>&nbsp;and connect with TuHURA on Facebook, X, and LinkedIn. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Cautionary Statement Regarding Forward-Looking Statements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This press release contains certain &#8220;forward-looking statements&#8221; within the meaning of, and subject to the safe harbor created by Section&nbsp;27A
of the Securities Act of 1933, as amended, Section&nbsp;21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. These Forward-Looking Statements are based only on our current beliefs,
expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and other future conditions. In some cases, you can identify these statements by forward-looking words such as
&#8220;believe,&#8221; &#8220;may,&#8221; &#8220;will,&#8221; &#8220;estimate,&#8221; &#8220;continue,&#8221; &#8220;anticipate,&#8221; &#8220;intend,&#8221; &#8220;could,&#8221; &#8220;should,&#8221; &#8220;would,&#8221; &#8220;project,&#8221;
&#8220;plan,&#8221; &#8220;expect,&#8221; &#8220;goal,&#8221; &#8220;seek,&#8221; &#8220;future,&#8221; &#8220;likely,&#8221; or the negative or plural of these words or similar expressions. Examples of such forward-looking statements include, but
are not limited to, express or implied statements regarding our expectations, hopes, beliefs, or intentions regarding: our ability to draw down sufficient funds against the above-described credit facility, our needs and expectations regarding
</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
existing and future capital resources and expenses and our need for additional capital; the anticipated development, regulatory pathway and timing of our
<FONT STYLE="white-space:nowrap">IFx-2.0</FONT> Phase 3 trial; the development of <FONT STYLE="white-space:nowrap">TBS-2025,</FONT> our other technologies and product candidates; and the anticipated regulatory pathway and timing of the foregoing
development programs, studies and trials.&#8195;You are cautioned that such statements are not guarantees of future performance and that actual results or developments may differ materially from those set forth in these forward-looking statements.
Factors that could cause actual results to differ materially from these forward-looking statements include, among others: the risk that the Company may be unable to satisfy conditions to drawdown or maintain compliance with the terms of the
above-described credit facility; the risk that funds available under the credit facility may be insufficient to fund the Company&#8217;s operations and development programs to the extent anticipated; risks associated with conducting the ongoing
Phase 3 trial for IFx.20; the risks associated with continuing the development of <FONT STYLE="white-space:nowrap">TBS-2025</FONT> and our DOR technologies; risks related to patient enrollment, trial design, data outcomes and regulatory
interactions; uncertainty regarding the timing and likelihood of regulatory approvals; potential conflicts of interest arising from the credit facility with an affiliate of the Company&#8217;s largest stockholder, and the other risks described from
time to time in detail in TuHURA&#8217;s Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended December&nbsp;31, 2025, as filed on March&nbsp;31, 2026, and TuHURA&#8217;s other reports and filings with the SEC
from time to time, which are available on TuHURA&#8217;s website and at&nbsp;<U>www.sec.gov</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The forward-looking statements and other information
contained in this press release are made as of the date hereof, and TuHURA does not undertake any obligation to update publicly or revise any forward-looking statements or information, whether as a result of new information, future events or
otherwise, unless so required by applicable securities laws. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Investor Contact:</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Monique Kosse </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Gilmartin Group </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Monique@GilmartinIR.com </U></P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>hura-20260421.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2606 Build:20260317.3 -->
<!-- Creation date: 4/22/2026 11:38:43 AM Eastern Time -->
<!-- Copyright (c) 2026 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2025"
  xmlns:hura="http://www.tuhurabio.com/20260421"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  xmlns:srt="http://fasb.org/srt/2025"
  xmlns:stpr="http://xbrl.sec.gov/stpr/2025"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.tuhurabio.com/20260421"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" namespace="http://xbrl.sec.gov/dei/2025" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2025/naics-2025.xsd" namespace="http://xbrl.sec.gov/naics/2025" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
    <xsd:import schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd" namespace="http://fasb.org/srt/2025" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd" namespace="http://xbrl.sec.gov/stpr/2025" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="hura-20260421_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="hura-20260421_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.tuhurabio.com//20260421/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>hura-20260421_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2606 Build:20260317.3 -->
<!-- Creation date: 4/22/2026 11:38:43 AM Eastern Time -->
<!-- Copyright (c) 2026 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Two</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>hura-20260421_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2606 Build:20260317.3 -->
<!-- Creation date: 4/22/2026 11:38:43 AM Eastern Time -->
<!-- Copyright (c) 2026 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.tuhurabio.com//20260421/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="hura-20260421.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.tuhurabio.com//20260421/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="24.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="25.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="45.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Apr. 21, 2026</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">TuHURA Biosciences, Inc./NV<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001498382<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Apr. 21,  2026<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">NV<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-37823<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">99-0360497<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">10500 University Center Dr.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 110<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Tampa<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">FL<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">33612<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(813)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">875-6600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, $0.001 par value per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">HURA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.26.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d139552d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.tuhurabio.com//20260421/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="d139552d8k.htm">d139552d8k.htm</File>
    <File>hura-20260421.xsd</File>
    <File>hura-20260421_lab.xml</File>
    <File>hura-20260421_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>19
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "d139552d8k.htm": {
   "nsprefix": "hura",
   "nsuri": "http://www.tuhurabio.com/20260421",
   "dts": {
    "inline": {
     "local": [
      "d139552d8k.htm"
     ]
    },
    "schema": {
     "local": [
      "hura-20260421.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/naics/2025/naics-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "hura-20260421_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "hura-20260421_pre.xml"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 4,
    "http://xbrl.sec.gov/dei/2025": 4
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 24,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 23
   },
   "report": {
    "R1": {
     "role": "http://www.tuhurabio.com//20260421/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "duration_2026-04-21_to_2026-04-21",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d139552d8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "duration_2026-04-21_to_2026-04-21",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d139552d8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.tuhurabio.com//20260421/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.tuhurabio.com//20260421/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "terseLabel": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.tuhurabio.com//20260421/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://www.tuhurabio.com//20260421/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "terseLabel": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.tuhurabio.com//20260421/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://www.tuhurabio.com//20260421/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.tuhurabio.com//20260421/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.tuhurabio.com//20260421/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.tuhurabio.com//20260421/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.tuhurabio.com//20260421/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.tuhurabio.com//20260421/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.tuhurabio.com//20260421/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "terseLabel": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.tuhurabio.com//20260421/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.tuhurabio.com//20260421/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.tuhurabio.com//20260421/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.tuhurabio.com//20260421/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.tuhurabio.com//20260421/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.tuhurabio.com//20260421/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.tuhurabio.com//20260421/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.tuhurabio.com//20260421/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.tuhurabio.com//20260421/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.tuhurabio.com//20260421/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.tuhurabio.com//20260421/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "terseLabel": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>20
<FILENAME>0001193125-26-168395-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-26-168395-xbrl.zip
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M)?' FJX;< K+T+I.K^(M*?AV=OQ!FNG@V]9,6:R /N>A;6"=_]#QJE=04;/
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M>A\ ^#A,- DIAWD65<-RJ5@FOE*.L\+"?:X;?$9=#R^8Q5T'$>Y<Q-L_^!R
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MW!T0?;I']V+Q;^+DC7!P<4$@E)FJ0$E1Y6?Q&3Z&A<<H4\QCFS[$AB/8Y S
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M50Q4(7[)&X:1%Q?^!%VWB$0Z'I-N SSJ%*1Q6.(JTS%V+UHIV3B[2.V_>MJ
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MH%"G\1G[EPAB1W0E?^JA,WH ]TF9?>FS.*L* (@B Y1QJ!0(F\,X.+%T-MZ
MU>TLHW=K,JV2 O'+0)]LCX' NMVM?SRK8:^O)R,*3\,X8OKBSE.%53EFGNU'
M$[L74$AD/9PX_P!G"XW/&3BLN4C<%%V<@10'8G"W($],?'B71[#177,-68&7
M, +\SBDO$N *'L$U XB,X^F4XA#MH #-<!0<G&@!A9WD4V -+*?QQ17-\[%(
MTF+QH-/' 9>ZLC!+8)GB%NP:0#1 S7V8D<@F I>E =81"3(K.9)2\R;Y\P8A
M(+8>E'6*2S%-,XLAS(AP]=8E,;,DYB88.19%;I\N>)O?4_'(6R^*3X";Y&-:
M5?L9+ CGI%LF\<W]?!(B;CN0QZC/N&!1T "52XTJO'!)H/!X4L3A/*^6&$ ,
M#@MI0RC+X?#T9)ID%ZPP[@EOXDMF+QH@ X9"6CQ"T&$/-.T-E_7#W5H]YI"8
MT5(ZG[;/3PO">A"*"RNEAFCP&<2,4K5P>^:8#;=7VZNM$<&^89)CVHN2-2HX
M4FUC6<126U!H>\[G'ZI/H!!%:H?E>Z"!(?F^!D <$_R+']GJPF",IXMOWI]$
M*+J=B\Z&/:SSYUW2JZ>4G-@PA1O;,BL(2"_SN)!('N_X'($(F=[BFX 1$5%C
M. ED 7!1]%'B'R*-&C \@=-'Q0N_J%_  4?@S#MZ$IE\40X)NK,%UU,KFL"1
M/EI+W]9/2]_MAN#Y1O7 \@L_J#[2'/6+*)V+Y,\)-]9Z#(-K$'T #YT<:YF&
M^3VG_837L+Q=^8*L=V5PL2)_M?9%/_@"$'U2)64\34A0%<6VAAFT_3EDL>ER
MH&17NQ?K\D)+.J!A"!+'=&RPS24AD- AF&VG-O1SZ1HT5\W3\I9-0, HE[#&
MSMI2Y_]N+ZL:/>^8R6*F7.<D_R![!W((\*]2&+_0E!J )I:A;B<9M;.@# J2
M*PN-FZ<@S"780[RJ5W&=P>*"B1O!H9K4;-G//MC^YA4VA[W6.NO6KL"HMASZ
MDN@S%%*G.H^S!V#.:6?T,P=$S'#>W6%H6QT/!]5UQEE<H/#2;^5L.*]XG]S4
M@8=^HT;V3ANAL9J))2? F)'?E<S(??S&U5Z%0BTHLR/HTA'P \"]'PQ15R/(
MSLU1XGK$[ % ]DCIF#9M R0?$'5J@]WY:'.[]*D%83&0ST1:IG)LW[ 2&PB&
M2Q%6_]V+"S@TK&EF+ RZ73?&(+@:>9L+O 8% 5W D! RZ]\M!3%3A'+X'$27
MZM.LC$.KQM?SK^@2.) Z$.L':/$7XF+A)-Y12$&MX1<.OD,KRY .@4-&T0Y1
M6G4%_H0S;M7W/5W%LCITO.1H8L&8PDQL7'=&>-XH0$-C=""+-G*U (T'WD&0
M6E^E)CJ9LXKIP&@LGM?<=FC#DW&N^"M>^M+S=4&7",1Y5M]!7$V'UHAM+H6-
MC 3"]'P2EI1*8O@-@'26G+' AX>>1R[*N!$Q-_>"*#\CS*/BP3H7VKP+[$AL
MT?H]AY$UCE/074JA8<<E6ZPY%QW@Q_J6C8S 'Q<7:C[#)1/Z95[&V%/!REQS
M(+7+N2CCM#*7=QL*A3<@G.4*ZM5!0ZE "Q1%X*!3W+DK \Z*<39MV#)&S=J%
M+2Y<,G.N5_37T$!Q8>842ZQQCXY,%'PM\W99)>B/)=#L3"DV]RL0(3PN<G9$
MS@R-/[_A]:@;WLZR,0S2T<#MDM.6%"_XV;='+-X@EC!OA!-2DE4D46@NPWP^
M2Y)"$I(88'-<R00Y)8(_="D7-"$K#X&?!;NXT >Z],-MA :SVU'[XIL\HC-1
MP@^$@+5&"7-&VF5)T11 :0N1!3:X%>Y5$EC(P":9^,%L;3'VHL X@?H3,+)4
MJ*=17'Z95P7E;<2IF8*"[XIL&,ML-2_(((O086C<)6@"!>BNR&^$=NQ:;07.
MC*1\&_H9159X-O+'&\GW]*=][\Z1I157YIKX&_ABA$R,OS5Q7$NQ)P3<*#M%
M"LQ(T@M[$GS+O)]"@X$YE"9C7N?U2$;*O%_%HUJ>#44&9)S60EI5[-8>EC5?
M@_BIQ=Y?XU^7<O36F/M+HNRYC E[Z;[0)+!6I@$V8X@5"[>F[T\"\,+I_0""
M*YDM4+PYD?LF5>_; O=) Y!<*UL,<<A^59(PLOR!\)K6X/Y&9F*[GZRE9@2G
MWA+LU1,?Q4M)42!8DPD3<;E\$^BK(4>*G&J)*'&>3U,3AF(32-FK2DSX4HD^
M1;"+0(2%[QZ&<#(GIEC$J-L23A[ +B_;)MS[19;/);R/<;]GEVV7U(_;%#Y_
M^'XOW2ZJ E<$7%))2M'M6A,SC/[GY<)XN3]&:4$%%@\,'L:)*&+3.+>$-QS
MBUEJJF&2I?O[-><D+$HX\!6:2S<T9I\I-Q9MTF\=CWLHY+TUTM(/>;SB.LMS
MG9SIE0G,-!8_DAIH6"6!<S;GSA<7FI=.\3">LEJ'@:5ZS*,\7I;:S%%S*A,'
M@3[:*+05?IP',X3EP8T4&--H[(:MP%@K%$%>-*D8Q?ZAM*#JWF?F'%3M'(B5
M<]:7\[HM+OC(\E"0NE5O]NS5EQ;;FLGWAZ,W0>\VH9ME:#LB&<WQ7*\;%HNE
M92XRR6N8H&1KDQM,Q*(_%EG0&ADR=6L\2C 4^5ZS&;,<H;]2,8U"1K!R2GT$
M?]^P,T\:D;@V@-PB2S36'3"Q!B:L$Z!NKEU&MEY4E$D 6XM3]E^$Y*K%J'X*
M9<UUJ4UZ24%E1+/IE*I>D"6>PU7Y&@9Y%D9>9@#*91B[1(I]K LJ,3K0<*NC
MRY;V<*A6*\#.9S\W8+1;#V63QLPCN6?^OKP-,W9<@I\V?ORA[*M-(_=0Z0J5
MW%1I*FU1%0>LIGC?@]EI&Y!Z8L*E5'4H@H07DX]F+RI1@:8VED$B)E@&SP_%
MUW!#4W @MHFQ%&JAU.(QDF&8!Y.UAAJ]4S@M6\3Y$V4*G=%^*,PPTD/R&;!-
M H2?O'2A\#4#H(N49F?55)/]HI;CC 8+:]&WIH_9ZAW6[NWJK%YA^&[9K,B+
M?&A8B2JA6/ _.;[7=Y\#A16Z28N'A6B.V :U/4[8 R !QK49S :0$YRB><'
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M+<@Y<=E6^Z"^Q)H;0]P[X4B?5AB[?)F>U#8Y04*5BMWZW]AD"??-Z;R!=QC
M>- V1+?GV#"&@Q.885$:ZF->X@!&M"@1F8B=<D0(E5%)D<R>:2&8+C'"S^61
MYO)4P\XC/O7)L$ERB0=D_3"U&(N *TWQ/I&AFDL3R*!(59NV7!=A'ZL%Y-5/
M"\CWD-J:[M+P-QG/"X)SHW8]^6BL>I]J-D:BQ<!T2YV#D,UN;)R;C.J?R+U^
M>?MK4CF*WFJ)&3&$M)&I-#\LW.7E-46;6G8:"%I5[K4TF[-58\29M[TY02ZU
MB.$7LW4J<I?"/YNWSWHOYTDP9:NG\M^UCOA2_-1B'?!M:KY7ND?"$&VZ*-&O
M[+6\$SM]F[./-,X(8R!0I7<R$7P7^(TOR/YF_9)^!3U2:EQU=$D<"&<J%E/;
M!.J=@QY-XWR3$$<3\W8.*RTR3-2\^X-]M<HY)#B;R&5\E)_'.L6'4F 3+6E<
M*>J2^!+3@9 TA2G60XYL"SYW)"P :"LEX7FS+TK0JU$- 3M?QDQ +IL\+KA$
M*@\OKC'06A+J/D$,N%8]E=QRK.9PN*8+RZRO@#S %?V OO5C$21%5V:C0G(R
M(?V]/B=+O<X58=P3,Z$[+NB5GM>"'PSV&QG5A)E,DW"H:ZNY9.\4I"DG*=D[
M*<"$>WA)>0J)8*D2L=\"<6-!5&E E6P"HJMQO!12D@G^8J#(**7--<Y>CUW,
M/2@&&^NB&4RF"5;QME!E=((Z9:^7#IEU!0.J3 89!?@PD9=APUKDDY I$;A:
M' 'B/JVFZ*..Y+BG.,2T+ 0?8CHW;Z"&;R[S?/K"$]C2V>IX,-8%"AY'P'%Y
MU<3#&J5GC-]:VE9:5Z?1,>[CYC;HYCJPW<B>[.<0PUF=/N<CU@S=$ -1."$6
M0)V>0N[ ER9<@(:.A0Q0F#SI!\G6 K[82A]377V3((V"-8;78LVQV?@;H] ;
MB<0:7FI12V04 T8/>**]HH.,^&CV);\WQG30PG/C<\:YS6M\(?3MW'7(!XX<
MO\8*T-_,9 H7GG!+ 1PVYB @*V-==TL!E5^A5#ZOF5-NU7 [IG&JVTH1];DD
M(O\:,]X'@'(-X6,+$@0T'4I[*-K("[OM62"QL4\L<E:YI9]>D@1^APS5HYU>
MA2N_7&_$ &HX'H##X@(^H#:B9GV!"843!L 9&D6;:9J^H5LPQ1V;$5^UW TG
M9[?&2]7+>M=,SUX\E]L7TR;SE5L66A=2SYR(PZ)D0*(<UP#24;"X@!HY8B96
MR7"AU&-K62;*('N<$71XI3.UR&I9&"[F21Q ,T'K;2'K7M(R,8YX3LO?K:5H
MN1'ZC-%/B5VS=^1.#5A<F-U%0T:5/7#>+<FDN8,#AM!4XFU\2:RVN(U-YX%*
M*R) (.1E<73W$NW&EB <QNF&G#&PN""K*]2FRZ"UK="\P&X?,B^+!EX.U#/8
M=YY5IV.U\:KICO0X#D$4%Z\$U!,=KQB3O52"B8-&;'&C*$<S[;$&BD9Y8("_
M#X+&,<,[XTP<$'OA^1OU=T]&;:5J?H$]T"/Q7*_0ID7:])P FH/$$XIP#:0M
M#)FE,3.,%D1AP][Q,Q2SB%E4F'T4#JUKPLM4,KG.B _,66JR3OM68J,92HL:
M;$/$,@.9SW1$*6[(A&GQU(&A4$G&K07A-;,7#E?B0KPD$N2Y/LN&G"*"=2O8
M3<#,3B9JQD1+%4F9Q'>)7++OQQNAM+'^TT#W76C,,4J?12@<(0:#7(O>&XGP
M[^Q\4 ?O5?]#5QUVCOJ][K'ZT#WJ;O^A?M\_^-S;_VWOCT#U8'?[_=[!?F</
M/W;V=]6G@[V3_7[GJ(</^@>+"SC"^Y.]O>YQ7W7_@>^KP^[1QUZ_W]U5,-Q>
MYW.@/G=ZGV"&WM%1]]/!3F=[[P\8[ \:$(961[W?/O1A--4_ZG7V\%=_/SGZ
M Z:GM_:ZO\'#PZ.#G6YW%U:F8/9C_//@I(][.#A21]V]#LZ'0WSH':O.;T?=
M[D=8RWV03 YQ>"]R+ A_%4=*SKJ<Q-6$O-^(]IP")@%=D@E6"P6CSE1$FC!>
MW83)%#8&C,*/D =[%1"'+NME<4%4H%K,NU^I&1U3 "8K7GRE4",NX6&"STQS
MOQJUM-7>V-+6+*9!I U'N0?)X 4;NS[HD#1E=_IC>3(;;$8K!SJO<Z^@V)E.
M8ZFA(#=C]L?&)]-IPX6*6XN89>K"!H>^.\F3&HP*=_>PR:;5?8HGD"-!ELD!
M!@4'4>5I2SJ'QP:MAHQG8;-) U.IK+#-@GP[]3 K6%V74(T I20;^HBI50DG
MI:G#W?=8K@CX(XN?(U4+!+=!AE/*\Z#H %K"1>!2=UQEX)/5XU6,*T'S!D56
MP#J ^'/@F$3$<Q5<-K%/2U-B34+&;.(+55NG4J/(=;&$AU3K# Q^P #Q-):
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MZV1D_VTR"28[A,[GT*[KN/3E(UGG:$0VIF6)6"K2;"&[*_J=$;JFW*8SFT6
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M(NVF2?&$3-M)?OX.MC'L?H9&\6MP_P=02P,$%     @ !SV67-/PB0?V\
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M=?<&E*9:ACSFWIK]9]4$=-Z4 L?935+D&7H\8&*"K0G&YEHRUY+Y:,F<.\?
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MTMA>+ >\WJ1D8#."?);7N-FOHQO>=&,580UHZ<CJ0,$O?O[A.] QVG03!,>
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M/JC?LT_""S*:.IIAH\^B*[#+KK!Z9@*B/DPFZ%OQ([M@D!C6@H.XKM!)(S&
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MF(Z <]1",=G3Q_E,LAKO>T1CP/@P&Q<C>3E.^E LR?[6F$X1+/N?1O'1N^J
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M3=UA#R/>?YB'PNA'K.!&L?ZOA$="EK=0EZS!PMTD>1KI3?2 T"T:HFCS@P>
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MG?R]P\20S+WCA'/CBB3*J1"7^(T$:CG8ZI@YU(] IF% 3[6,ZHV[Y]P-WDZ
M=(1ZW#1$P@$TXS92+-/OZ;H:NFQ,;'"QPV+A#LY42F+2.:,W(U*"D%E>TD3=
M@&1@7_?RFB!/X!%[+ %TA08@RU3)';YYR0?J+I<4K)Y3MP-$YWV#B)-U=[ID
MJ'L2B-4SGC41Q'109\Y+EF/49YJQCG:=Y/JH-3T6V#$]@VZ(F&0>2X;*D(XP
M-DMHKRNIIDGN(09'PJD4*A\1^A#]?;.U@9V_?L^;"F:0(M5I,@4(!JW%O&H(
MN&E7GA)_K-,^?82$&C2L85+ V:/YUDT9EH^*,^GTUB.0=F(&O81>,]!<ABM&
MULQNK,7:]=,;'$YK!>1!>3V\;0O7:Z&Z#3ROH'R)JD::&(Z$H8Y%C$@K2&L]
MW_Z+5P&.*R#=C4E=6');(\O<TUG((4VA\TW.?0-UL$RE1$L&D_NGX;HA>2>H
M"QXM&JEA5)^;[MU("CFD.('6;*Y'8NJ/R.T]TN\1H7_GK=%PI_WJ#9GRFGCG
M:R*&$^;NR&Z7(5)]PCE"%YG:,-D#>B1<-4=UJ/K1#UU#^*FWC-2SPR,18FBK
M[3,LS^>MA$ONKGA2>E/5W7 IR&^EZ(,*!)#)$9UJ;M+L$IS0\Y!:2-B24,_G
MV-Y'>K28#.'GC)JN6B\'Z0:DKX*AO%-2L K3*WO%;A2]23A_W/P:'JXO:#$"
M]GL-5CVO+VC>X&%IQ'<7:JS=1I-9CB^I!8HKZTY+(6,0#"&5^>N9%#F$TK,:
MVT5J)G E@1)N<$%=</'!9%,7R8V F3S"(^9K-7_G$]I II B-]2T#J&CL>$Y
MPD4GG_X(4858:U'@03#4-<MMTECWO*?*CM9 G7(.W;XZ5E\7OHINKNEWM"@[
M]+Z/-V]2"?G"@,<$5Z40E)-PEV"J<9]6CA&8#F_<3.N*DB&&H2S%'LP5G[K&
M*:.IX^Z;TI3;?Z@]#FRW:V8<P#]-E0Q]V/E[4J\##+P/4^Y#44O SID?LKB;
M;:GQU8K8=KY"\0FE#53'C[UV%-Y@B6--^XCTB5$]L4X>2=DO=:>PIH<W)+%[
M[@4>W7L!"-X7D,-G^%]5"4!)XY3D;4::^!/GT_&YV5APNRM1=W ZLES9N7\0
M2>P/P**"P,R*$^SW=!,E[!']H\XUF%2WW=9D=%AM?L7=E6,5I4S]VBU)8G!$
M=X9\U?&V9<&<$D+QO_C[S16.:^VLXUI/HV<?Q99@NW(PCY&0)FBI!YW"U 9,
M8Q!R"3Y12-?L58+0UT.AFS3\!TR>(8<;MIFCA)>4[\O-8@ZU7*N4X[X81"A+
MNX6FH?"J_(H-73HX^633I!U1S%R79#O!R(7I((M2\N T?P#'G[A$R@_W2!IM
MD3";)AJC.RBIHB)-T+XUG3>:3HK?5\-O2]1%D4,<I;7KB0@:IZ3^YZD0YFR0
ME4$U5\['F].S2:^VL#H5[/2@\[%M:("#<TDPN@GRQ5;,/U613W_.[M;VWD)]
MV<]90O *'#\V"R?VS'C*^DVYV"]Q$-_)>*@?L!E<'+5#N8M][XN#X.S@\OSD
M]#(X.+R<^KYL8V'Q<@56QA5\2D[D ;Q_,HQPVY_1*4H?FOX_*KC,\Q2K0FR4
MD)JS$.*30,^G ZYT0>.R@!DJQSKQM[N]O1-L2'7\R0E^=%8/MH*/6_>; CO;
M+Y\]?Z'-@ U,@>G&IPAW/@77?* *D;T7(3UK<Q%E4)S*T$4,\)?\1Y*YL/WP
M@T WM3$E,'+9%GW[!ZM!S83>9FPQ7-8=G"U8ZHQ>;;]GW5K+ LT]I"2\PFU9
MV[?X>89C\F+*K,E'>-C2K'W7+&+*^Y(BZJ,D2VR9O($#)KJY:41-D8DF,-7-
M6\"U!K&M*3.#W;32&JO!*<VOM2G?25(]6\$?(/[41(2B(S R&#Q9@1(.9[\/
M=D$&)G>#G9]_0O&?G$-/XZ@<UMSW<J2P2"=3')7-5(W>"(V$ YVW.1(^R/:5
M.YH>;_['I?G<:<YA'$]3/-S=\W64IVE^:P$+D^L"<?-R%TV-2/$>$L<M_2P]
M2'MIFNKOG+@K=:EP:'1MWEF@M"2QIO5*U;@KW<D\4Z(R[EK(.KBA&L/72.@;
M*RD2/?2V#YE;-B=HFVHX)?ZQWWS!>ZVHY/L5KAOZX!M&95=]G,[$/R3GON%P
MA]#K%@)DYITA.]EM^."T> C9XW*[.UA@LZ</IK! ;3(+IOA2>EKEEWY2KELD
M]%;I*(MSD4:2O0+=7OK-O/5&P2(MDA?IA-?8*-*#KF.;V (G]TO>?!CYE( /
MFJ1%A<';+*A+<?';-.3=+VD">1W-,!+.CR&+!"A\-OT%-LWT8\B+1 J+?-?2
M;:&,_">:,K01D\3AM=G+#_!FA&S2Q"2AAIA*2>"%:1IRSZOH6WDT)\*D%YN;
M-NZ)8;(6Z,-&\_TV'R5U-HDP>'SC[N?6]L5COMT6Q3:I8B +U2[AGROKB>^N
M/?%[+(M'61*4'.<=1=%B(0RFJ"WI2_I7H29I-*1_DB84RXS[B8&XHO#I\KI.
MR<Q-$V;3=UW;84&'&18VM$7[%A;[!@I GP/2$MI!\[;.%4G_WK1TIU:%! _H
M4)$:0_"]AWOF:Q"OS8\0/$HEA/V3$0O2^53WU\ B<9-%CTJ,JQHL81A(4%D4
MF@G[<V^)68'U'V._#C;!+Q(+!G/2IO"&"T+8#L5EX\H0QT!G, OE@U*":_A?
MA2W;">_@NWC.%W[1R1M]74LJJKQ#)&!^$V/L<7]193E=T+"LB?^_<7,-=74'
M*5FZSG&2E,3.<AM#<-&K.-QL]/5ZB+5DV,IAS<M1)/6QH&$8H<51,*$M2S(D
M2"66A!9,BS<@S;@@E\V/X%DI& MD -#/L949;!$:V)@2GY7RHN-(,H>)DLS@
MVJANUDU"NU 59QRAA-/U-J0.>BB83N<:]S-07((U19L=S%3K=$B87, 7AL_.
MPZ95IOS<V/=UA@J">LTX0TQT"W*V:;V[^'UM\0W=;]U\4C,!P% 1'_&!I&N1
M[SXY]<:2;+#5IZU;HC9$SD)X80>?H'TN[NWJPJX&O-A)O'@U%L,&0">;E2W-
M&3G.:+N*7AJ2XTTY>6R[2W*G(92\71R?U)XEW'P//6&,<7+>3)\3MLP7-%[4
MG!MPA01?[%<+>@$2\\0)3F4QY8&_'!R</8C'!)>;^],3Q*)$YE)XRB J$['"
M8;XRWD/Z2WR$$#MI7X('HTNY=#+?N$(1:#\ZU,W[NTW[I*PZZC H> TPCR!-
M['GB9X:_?HP J<W@ Z83,,V!V-;2;4[<@(6'71T9*4-JZG&DF0;A<>0SOML1
M[.E;W*A$?J 94@FM4M V)1H+S>8,OQYQF]G@3[ HRI@]:;,02,JP^3-J(.1+
M(Q,&3920S8O0J:4E;>[!(AUG6'>0(XWQ\!LXHW/*]-&###J".S9Y3:@&#%)@
M8TK#'9W#(Q-DD9!!F5X:@Q+UL_,07VO*BV>PF/)+?AF*N1(VCEO[DLYSKIHY
M1"&V$+A6-)2-+5@FW<]<"#6JTCY'*UY,7TGW4?J>V]SKG!."B*@0Z]H)Q*^D
M%[BW]@+G.)UOW[\[.+\\.?QX')R<4(72#,7X1 .X_/4X.#S][;>3R]]@TH*#
M3T?!Q].#3Q?W#>>ITQ2V 'M6\F_KGE'^L*S A4^BS.:(N("QDRGH:.RLJZ+P
MT_(^VH-&&WBM4%W+(*[-47X_/4"31Z'=2$T0S8B0H=N[QB+:6[;1FH,[%A-Z
MULH%1X\:IU?.")9\OP?6RWT_+E$_#^A7%$0A0^=NZE,-LP3UKA1W"H.@FK',
MN15'_%RDE71JGK+X#ZB/_&$A@$MW+C7<$S'^1(SGK.^4&9)SL0E">&,03L3G
M*G)-$.:2ZB-A.F[ 8>+'H+VC:WVFB8NE^FA,<PL\ #ZQM$UWJ9UF'OKL"">J
M">_@'?:PH9$9[>#T^ 470AXV.\.[ZV1XSXI\J$!+"%:N]6KOM91[R=_+Q@:4
M?>68S>9&_5['3LPY,O%>5V <P2T>I:JL>(D[7+7%6.K:&E5MR+A7( \(N\;F
M_9!- ZG?!%[7^GR,:/"!]#FY:08,0/M)*(SB CO;/V]O]WO1UGB+EN7O>?$E
M.*0"&M+.(!X;.]NZ9QL8.3ZXTD8E[#"89^48(UQ&\Z! 3A%&(^VBT[MH</!1
MNN"*F\L%_[D3OF1BG(:I[>ASCW&HHGIQ:G0$RQE?\7=4 N2%>1Q;?@R2>RV@
M5[*#6W.=E%.+$C<DBX@CX56WN)*IC34W76WD5=JPR\4%9(VS3ORDATRV+EK"
M]GAF9OW1A*U#BT(X5-8PD?!;GA("X):82\V:>>T%M=M%O><M$8?_+!/=U*<V
MU?+ (F"$C277UF::(6FL!2U/J!\X<PUYKX1VQ:.;/(EU36><UP,W$VGU+LPT
MUB"IKK$;Q"X]8G,+90)ULCF'8%$J8LRUR5V=A2^H&5-SHB4:0P$0?A1FW\&$
MV=@1X6X)X 3#)%&JD)>#![*,2GQ/*W'W\"4E+@C+3I%U]+"KT_FNGQ$ C5I"
MT T4V 5;M-_;V-.3Y2CM4L(1FC>SP2C4H91-<H:B#/0#S>U^K^K'\IV.9!(%
M+Q'SQS)OK-<'FY]-[8#*O(V/I]S7PR;6">T9HH%DI L/KA+ZE43S!$&JDU*,
MX=%Q]/(>DX-X&,0"X_MA;5<LDTFI^<:DM-0<A6U<.P\)@'#T4Q[)C/N.GIMI
MUQ]D=[9FBQB6S10V3BC2"9KC%(XAX6?33"_7))%X?HM.*]E)TMUT1*$)B*%$
MDQTYMS%!FF=<#:^-6Q(57)@H@\<QSU6_-VLY.;2E [#P5EK>!>_ED(7>)\/V
M7&O2LI"FJGCI=' _,^>A\1YTE0+%S892DV2R)'R>V71<)2@4"VV@G(IS<T3Q
M2BKD)O_2,:Z-P5WG]I;B%6.XH$;U##J.XG DSPS(E])-T^O!O!]7XU;6(E_A
M"-G^.D+VQ &A?:12DIPC<B.CBGH3'#,?'>T*[#N_-)&ASU-V;C"U76WG(4JD
M!]Y>;"99V^9COU>2<KA[-L+=-T$\-+*)O'S^ETVMN+R6ML+"G4;@]_B=::TR
M:?[([Q0K+PENA&NG?Y[>F]=8[I^-Y1[*D^[[C3U.=")L<.<6/NGY<D^Z+I-_
M^F';LA*2]J1UCJR+UN+;AR&<(I4IC9@ZBGY/)*@A/7F6FMRW1Z/A213CKF<,
M<XNR9M.L?H)B.#OS03-EU_!^M#T<-\_0_M-X>VLTD07CM.BU9_] L<6D\]J2
M(K=$WZ[MA?\<)^@MZ(H@::BG?ZT]=1U@PFED"3'G]CW!*E!@S[>Z(G 4]:4I
M%./ISD5MR KI'@$J ^O<CR8PE%J'4[CT1_OX,RIZ'&?0(Y,SH92NK&]7@4T9
MO-C:WD&-AQ-&_QYL=D04VB/H?$(CNVYL*%CF!S^[T'1XJ-@F]0 67F-/)*TI
M7$K'AR;'>HSARB+/X-(CS/+_$J$]I=%DYZHJ$G4#0[VX*V&HC95$RPMT4)T9
MTT8RX$C.RL']>_6X<<.%MXQB#""7-TE>EWBS*(GYA$ 3]5F=X0?=H0RXJ1>P
M]:J]%H_BD$BT5CZR"[B))D&0FAL)E4A=UM1<'0%,0Z$MX3INC"@+^LYEI_UV
M/EK#=.<6TML8"]W-F7<&#S*AA*;;)>P@KL]]-%LZBHJ-1$U^:/%+-'3L%XE0
M^E1?#5N%.(A0W"?H9#%W/\_"E,AL1] 8*8Z;],+=Y^*/)RJX-S[S7,=G3B?2
M)>/,>O;->'J_YWF"+G<03ED'#SFG:31&I0R[DU7ZM.HZS<B1=*/A<FY-"[XV
M@MP[/V.8>$J,.\(8$MJ.%#\*NL-'[#U*=Q?$Y/-!(,-@+<"^XYVU> B6810;
M'Y!F7AN) >:Z\"_Q(P^=VG+>\8<PD+Z&>!/>)EQGT4%5+X&;5F!F*S@9V=>Q
MD8$K6*K,95MPO&T=T_4F%$_06JLC5DVRJYE^HAT\:%10#X<"CQ,%IQ'B^C1W
MAC+Q4(*KZ,,_7_OP3^S#OPC^[[F"K76CXO]WGZ?^PY F+Y=Q4*^XD!GVW-)$
M-(X- [!6+E%A-4/^ &]7ZSN#!G2 RW[ZDPY%YEF:H'L;91D<:%Y^3,\/<J8O
MAU5[XCA=&NN 8$USUM@)$1>49E.BH&0O4JT?JNP-.<RQ] P;DYOB%3MC5T5D
M^I>5%#TQ)&],H!QHT@9F]->,#!KF:7"[80L PN[#AKYC7M (D70#QK;9N?[>
M@@4=ZU68>#?G%2QL>. )@A@(OL.'N%EXW\FUY;&(!CD&M](:*:B_VBC7B[]L
M^G$ Y^2+%2Q6W(4MM<OE($!< A$-9* EDTM'2MFB WT,RM-L!TD>"$X@#<99
MY8XULTP;]RX:AVUX38P]\"TKX^VD[AD-NV;1[7D6VDVM8U6<5[LWNI/EV3,Q
MUW2 ARI] B?]3Q2=.'/B-"]^NP\W[;3EF<..KE>@WVM:7FB"@@&.A3+Z%^86
MTOY)=%]K,[ A7+D,"14-R9:W-#D5%IK%-L?8Z^"#XEZ>RW&&>6$;"[TTWI5V
M3U'(D/.^R 0<_B Q+A3"+G#AM"3C;D.R!TJK^Q"6 _X*YL>%K_@@'K--=[:$
M:_3>-"R^H;WU=#_ AA0=?)+OL=G0(@DKO NZBB410O)(O(Y1O&LK'R'8[QU1
MF2"2+(IC;P"3#+"_Y[:+W^I-Y.14L:%W@J_Z/<\M\_KQX)&1JDIP6)BF87VI
MZ?H>TG0G:$@2KO-'NJ<K2:%+85HZ^F'D5/Q5KK)82:?MQ=II>UH=OK--78:<
MHF%S:J%8DGY?%O6.U8%.A3,7YNC1HMPW$),NJ(:KYRA%>X?V$_QK[\5SM+GV
M7KP(,-=BFET1L(+/W5#O30Q;$X\VF%<#WMV4GU%I-"D1VH!CT^6I_@A19]P[
MIGL/H+T7VVY[XSMBL3#PP-EC,RLJ+$84]O'M&ITDAA\VJ.&T$X,#=U-P:/':
M.T424N]N]Q!.O;\QN#FT)S\3>W Y</7D&!NF=3YFKW+LLQBA1O>[#/M88NDY
M; T^(ZUDL#M^!I[?UJ<@(>G*E52F$*%5=N)Q* S!RD=P /5YD^[$><>IHS,7
MC:K)$,G^&>0TIB):KFI$BK6E,#QW=MR@SK(4->WL+F&H:6=OF::J.[^RLZ_S
M*W:H^,E,6=O=?^K:/5N\]T.+!R\/_N?X(NSW_GYR_/$H.#L_O3P^O#PY_112
M&=_)QX_'O\"/+O]^S^A^C(#M82D?T<XNCY7@LMUJ]"TW2,J=O+*047B-BDT$
MB)N@686<ZV9[TV@X2/E2JS[2W2/,E%&M6"K&AHLWB2WZV./)#31+-TVH4X/O
M]GER3I,TNC6Y)&?8R:P?, B$6JPX#W>>2H$>%ZS"::[LY^\]C%]_]^(F%F4*
M8R5ZV@R,&Z'F@+>]1-Y?-VDEWG";2,.9+B>)R,4,8.'DDG,DF#>MK!")R;1:
MZN,6U3'B4T@&-BR\8-;E3C0H-RS&)JA>FG>P6 *-C]GT*DVEG*F<5G"B0VTZ
M0$OX?5,#=1W%&BSOB6>_Y\HGE</ARS'OSO>Y[G.0AV33VI"XF(FQM EWY;]-
MQ]RC^0QW)?R-=$E&S Y/%=(\2ALA_4.5FD1ZH5)U@^'K;K+J+L18<^>NK%/^
M<NV4/[73\8=+DJKQ,@ZY')PHK7.8D'*8-K&,B/V>ORT<:2>B(CK)6._/6:X7
M&[R_-)ZK__Z:Q\GUTL+N8"FYT'P W!98^:,S(^S4CJB&2;Q:1VMH,Z)Q+,$(
MG/.@_:7FIY<^(E55)(.Z,L?"_6<!)U!083<./?V2UMKP6QQVG)4->\*80'YW
MEH;[>9^)U$7?[WC5*.R80\V'7U1%K<RRD@A@!'GN(7,<WIY*AU8QB]S-Z6_S
M<)+II'.AO0;@% NYLNX&I5O&F-7A7@6%0S-VSW[!$B,,#C-UF+)I-*=KKG<^
MV]98=WI:+6%/$\[E0,TZO7]VXD%HDQ$&'<2!/V[T^A5\:\1C_J=P"+E-/W%8
M(T-.=>?Q+&K9='%N@EAVV6E=46JQW ;1582LQFY"'2,B/FC-15,Z&>/AS";@
M/XZZ#,%BS*4I.%:.%K$)2;R[!D//\M;>:43$V"U(?L+<W?KV  A;\SVK?I[P
M')JO"2G56$R)^&XBY%!D'TXJW?9.=S2;<C8X\$Y7AD/B,9N8_(_9,K YZR*3
M-NGM7]E.),HI _)VA]M44C,@4J]J]TT7+QZ*T"/.W)M^10SV[$ :8@4Z=H<0
M,C<;<-0U*\A045H#'M<*TY/Z_&$18_5B>F?B+\B&3QSEUQ;#CG.";]'TCR/)
MVW>Y+5.D-;3,8FB%H" 9DF8<_H:I0/>.4^[QAC.1)JK&3_GZ3:,^.WV[#20-
MI3(9'WY/B0.:@NK.!@DXQ(U*OLL-0X!^LZ2R?1!WTH[P8DBY<(&@&*T;]:)A
MH[IIKQABFS(-_?_^;EMPTC[+1\_XI&TTVS+G;J.WNQ.\,"'L#8<^TX/2D$@\
M['@4WD)GNOQ9F;[NG;PAG4(0VC+;*6!WF_*U2&QC%:%5Y2C/*7)&L!J_(Y%I
M/N2P]$N;)&U0]'L/FZ;-ANIN<5[HS_T*&WZ;!\ZHF?QIALQ4^H8&;X/I/NF<
MT6J3]%R6\Y@QJB -<67D'55LCBTP<^Y;FL8^5PK[G)/711UQ' 2YN%5C<B-F
M3: FZ+I/X/T[CX[Z9[#7325;7B9BI&(.#5_;AEY$#^LQ8D#+Z;O0))SE^$S%
MO])QB48;+0NYT_:JS@\V[V9)"3IU75.%F8@;C8):E] X.$<'<G'-)3F-Z>_W
M8-VE,?04YG]:\8:Y2:$;2R:,9V,%SV9CP324Y_V4$,=J9%MOBCS*CU1I#DOD
M+*'B^Q&:$L1@T&!=\^^LF[:N;)#FU3I(\\2)C]UERJR94>TM71)R#ZO[EV=0
M73G(/:?&ZS=0AU<MFN\WR$^ 1X5A*""%Y15_G33J$!O'L1QJ_5Y+Y3;Y.%@1
M33&9=-#)R60YOYW:)(\=1*I%<BYGQ8RDBTXL1HV0%:SD5!%VR"'8JL,4_)%;
M602GHQ%6(XVHF:2@#+#[=<X->>$6A,CI][Q,&GJYU'B'KN F"G14Y0YONOT%
M1:E8*0L1;TZ/!;MJ4$39\%HL+-,IM:0"+;&1_JSC*[=T7=M\DAO@MY-4'(^*
MKC9(?V')P3AL)I@-(9YI!N6<F>_WVDE2&8\TW6Q U#VH-3^2 U5B$'@'),I&
MG14J&0_@D>2O4W]S;;VSN6YNXB'QP<&,8K0T09WG==ETE#TDI(X+>8!(9MXQ
MHH*/+KFC0F?,SK>KNOBV9R_$+-_]R1$ OR^(O??P]-/1":;\+X*S\^/#XR/D
M\%U"K;D/<JVUYJ$E13W#H$0L- <GV"<MDI+U%O6DGW[OL /9>J5;<$"_=#@5
MF42 DJT@:AC?,$HC*5UK&N_B=L@(1(7>1A07:X&V:*,:>+3#]SK1K_;=V?"Y
MX=T]1>XG=3'L5E-[(7"4X+V6(X7?9$N.:UM4'KM5Y3HV92/3L:A^LTA:5]E\
M]&+?3A+2%]P[Z,YM-]""]6-%?!A8=#=34>1W6-'MSH][.$R?)]"_C;#^A$/*
MG -9?'N;+EX(3UR70SIU6PS;O6M*CXP6ZP111<#G%_6@3.(D*A)ER9?&>$3C
MFV:&@XE@R-1TRQ3/Y^VR"S>"2T=EYUBH:XQVF1UPQBHZKJ_7CNN3*ZDZTW).
M\<ID_&WRWN]U"CQI(DTQQA+.:;#JVN>Z0@Z*LG+C>IU/MGK.]6Z&:52[G5EU
M2MHSO?<U:]#CMY& W;V+^SWG:H.#-R3$CF$\S>\HU"CEUG5W6, +<X]>8(PE
M4@K#P]F5,DVSNI?$$BPV5B24SK%X?V5:;]FEOG^)8]/3!XUUFE]L"/J "?[>
M\^7U8\78G*Q3.:7:@6$M#%)3::]4AAX*T_V\\,D(%CNW%W7R']M(KKV92\&1
M>WU(8S/F'T!BU>1/\?:N[ADYH;@IV=.AX3Q#_]4-S=\Y\X-43JG[-PHNF<8;
M93ZJ,,^+6H!0"]D7VG01M=QMS, F-Z8C>F;YR:AQR1)4?PRYYNC*#<1P3#TI
M8C&P(NQ7#]->!N#:PHM*!J3IZNH,29+5%":92-FW3;6Y:"72K?!I4GC:U5;\
M4/LE<6:H;?5XDD9N]SNOV95K;G%KI &6*XH9R?PYA&$":1QR_(#I76V;-$='
M@]=$<7;=7=*YN?HZH:UH>/DPA\.CY-9S%3AUXGX1DV+&N@815@0PE0@9UE I
MRM1&)N[ED M00^H("6V00LT#"SCY#ZM6G6XMNOD3:3]V[NSD<<3CS>(%+[[7
MM_/@#@8?87:ZIAGPCMMC;'"%+_U'5(#\M.4"@S@5']@$18D-J0.Q6!C^0<-^
MZ7'/+=['4/=.&Y/!E1;=DB'&$M^\A)<;7AMO2Z;,[=A6(HY,IZN\W5JH1K,Q
M60(YW;GC;.<^QR9R.2+#8L?<X*$H/-IN%-;UY31&TVU#[C3]OJ9_'Q5%TD\M
M?WDG*1WN'P2?4'XZ;C)"M[P2]VC5"ENZ$4^%X2Q>/$8:&#HC9)*F7+!).E!'
M-#NX'MKZW4-#FI)NW=]IH.QY;,-4#B:T$5C%080:+\"R >M# 5]CCA,\D6(\
MI8+3_.W)._V(MW\[>1=8]G'](OT>"ER2W>3)T*RRP^[MKO'BE^N*EJM0[D(9
M)F+8$[_I#78@>OZ8B?CA%9 -_0C6%.MA)0:_$P:[V[O/WZRL8[RWO7:,GU3>
MKN\[/<C/0\"!J.H!8F&&JJGST"LFS*.#^T4V"#\^%SJ 2S1[L.%XH2KAR;"4
MP>XOV'5K[E1&!/Z\^'*<3= OS;<V^(Q0'Y&6[0CV:5Y,<LU_%+G54&''E/DS
MYN&FK)G8<7!3FQCGX<;7L+?^;IMO/G&9>S%&@[MGV"\VU! C\2/P_#!-H$,Y
MJXHJ [5XG4S\[_Q9UO$:IUSBSN]2W.G/\N27>5KK-M?<"Y:/NC2_931]%.<3
M$-EY1 >^=W)A=MT!LYCT>^S;D>^1QW==0L<.GJ[!<1TOLA',U6Y+=H.X3<@7
M3K0)$+'3R"LDB$X;%7#PTYSOMAZEWB@J=!=6^OF.*;QCRP2H$['QO)9!M&\V
M/7THF#AV5;)HC!9.E52IMG0X&4R][&0[2]ZG[%P@FQY"L!H""\PE8 8\?%EX
M56CF[:(THTK6>#.U0/(G&E&%6(I21K(D>2F:?H*0&_2F5Y2B8[;.I%*A"D9W
M9RG2)0C1)/>Z?!;%J>NX\DF2D1*(XKA ,N F/3)9VW36VAX-GO^#L^-$1C_D
MJ;KC?_XU&D_>!!^C(L8.[1\_GH7:0#?/\!RU!UD4/EK9@X[\FJ<I?.(^_%?,
M]M*3B14*#.1/<$C&47,@-F[\X$%HWVGQ)15_?D^$A(1=;W'/"0.M^?GPT(D/
MF>@XUY?180!^,0D!:%LL(S;QO<\9*>(+_$D)2UQI3_"RB+!VL/BB$5.2%?1_
M<)A/[KB9&E^UZ97Q=^>5-5;LW&E?@> T+O0?2)09TPY7V-R<XM@$8<(23HZ]
MX3_(RQ]21(Z$ ;>,.2(-;1[8&B/.+3"W&\4'<#@88M!VPB$*)#PI2IUT0J4)
MJ#FDP')&\4.N*M0MY)KX6Z_(H E+YL &^+:XA[&JM2/$85WRS="M]$=G?,+,
M-V/&K]%BAD3(FF!T46Q2ZA",DP7?+MXE_G*OU+NE4DE6U@5MY2%:.1&GEO"5
M82Z&\/XA!YH?HG?LV<@1UHRL#+ YNKF)O!S1<V09P]][G[[8VG[>KB-=8?]\
M9^V?/ZGPI_<#GAQS.C(F>JM4 #>Y5:RPX6O06"CQVHO$T*P8=3;M(8R,7\ 5
M"^[RN@B&=0EOJ@JA9.14258ES\9YINZ"-*);4,E7G4I(41Z&UH?3?\0V=R!C
M7G0/G1 7!\'9P>7YR>EE<#"LEB U,;X_2F(Z1E"#LHWGTQM&= 67FZUR7%.E
MWT-*$PP!4&UCI!>%(Z%8UX'N3V-=>"5A>QYN?=@ZWX+?[+QX^2;8V=[9WMK=
MVV[R;;Y7F8+C%^VFTUOM09^;=6N0< :=EQ]ZKDZBBU/RK-/VLO NBVVT73?\
MKE /G,1Y$+1\OZQD#X HMEKVNL>\P40E#HQTV1K$[#M=V*?!8$W-_8,AL/3J
MMGT8>0T/@KYNW*-6T*ESIQ-+\_XMT++'3EZO4&@UZF."=?,M9T51M^B);3)K
M<5K,PY5,R;4/;#  T]D4#:#20B(GDL2%2'F)5<^A8)28%\,=G3NX.Y..U8J0
MSC!]QX2KMZ=D1D(] /W<S4#NWFA%:(.C0OQ)$<&1(2^U/S'M8DS*T5/>AC=K
MYFP+>3&!;UA3*N$FT0EG?D)'Z]O[[MS /33C,T^V(D3T_\U+PDD[Y]T7[WD,
M-D$_!T=J%-4I98NE,^C(?"84>'Z:3O E+O(E<WL,%=VMM.W&FH+W=^\RER#;
MO&B'ON.P\PA3%L"S2OIQ8$;8Y#IHMKR@4MZDHE9P,_='XT;AO=HF1.R31(>=
MXP2%B%%+NM3X *RL(9CFX+O8/6[Z31./!9Y9*]RU:F]W[50^3777HHJ[SH_/
MSH\O8+H.N,(+25W_.#@_/_AT>7)\L9@RKTLB'*B'S5)\&C5"Q/-.?(M3H\6J
MVL^-6/Y29)#"DM)K#4HNA]<J)J>X=>N0P:?-*D2C8+PSOE' >&\B?!'NP7.G
M2HX0>!B>>T.L^T[XK-_[&-WZ!7)-GB[3&RDIN6C*8,["X :V5$QU5 SQ$PQS
MULCZZ, H,?65TW+ETC5<Y^WA[/>?:PT=\L%1C6#2S4GF6\83+^_>-:9^KSTH
M\GB\43'RCHI_;TWR$QUD)NPQ<%KNPX5_LMFECY":.>OP!@/M04L02*#)\E)#
M>>DN:];F+$=1DF(9+WS-O[LS'1K]89LJ7(>I"KL'(2)K6#D@\FBZA4@)GZ%=
M@X[8*Y['3@J@E!S (UZ#[BCE8G1+,W0T46,PS^*:[//<T,]$5U?8O0PM<^_M
M@ADOU^_Y;[=(7]YLS]W@C(L(I<B>I?5-<)P1'EK2ZDM#<-WB[Y.^%1-3AF;0
M,!8PSA$R2K10@ VV$3,<1E(PSEN(]YAQA_16DOODX,J"XJ7J!&\K10@/OM4[
M38-9\03A>L50)] %FZ(*2KQT>,^-++V3F3=5-N3]M6I?\)T(U=X\BSH(#W'"
M"(A.!3P&9.'J*L3M"L,DO+6!&,@VPI<B-2&O=>>]5R3YESF_GC\(:ZCC7G<;
M@G,2AKW<#N-9]P3ZE),)+^#?R!5]N"4<PYP2(P43ZL:SR*9I>^*!4AW<A2UJ
MT' 6?44'RXY'E#&E=H)4E^&^%1(KCU;"N;1C>9RED=.2M@<B'[Q=#G=' Z1)
M;>K KOT5=:7+0$T,S]X]M<TS2W:7 %Q!-;O>5%BG3Z Z#):OVHSXW 6Q S9#
MU%_V/B&Q;8%RDF61G*3I6N*%1V=.6&B7$HDWA5*T"TG9Q6),E%&X<T+'<&W(
MAA2.:<253ZX_B+(O13VIAG>XE<L\O0%#[P[/1A_X.$8;"?9"/2;Q*^%F:520
M[0.*ADY%#3:3Q^NL/DM]7I12$J:Y4ZY4AOGVE %,,"KY  G@$R81EMZD:'&;
MOI_NW3$"G->8A8>?@]8?*L4<Z9B>P+OPQJUPF)L+[0$SQ<3>TR8VJ+5#8J+#
M^)2]W@;<'ZZ]NQ#]_5Z'L$LG\ Z5;,3>GL2U5>\RT25+,'Q(>P/-Q9LD3[E%
M>B>V0S02OR@W?SJ=U<F""1SEWEP#$R290$'H[OP&! $1^YV*J!+GAN"B",[#
M:L.DT'H?4WUB+D@%H-2GN.'RV:]#NW3*.[E $-+"!/Y@R,J4JK=-.N.FW*_1
M=\&?+EUEIHU::NSQ<)-]A<-->^MPTQ,[&_O!!U-Z?6%*KY?&N4 -V5DP/HA2
MA@A=*Z?J;#;[142TX-V%.%8A<L:'TF3.\WSF 2P5&"L-FP83^3H8I?FM)=AH
MDVJX*8*0CGM$11O&XZ#.;!Q#$*'!AE,WAXA9T.7/D% =#%D_0+#) -E#T$G@
M.+Q77R*E09<X^Q-%2V JNYFJ+:*3 ISN M%J',X*N<];5PXJU-&+1[$ S%H)
M=SYD\KW;.]61K-N=,F7Y05+X/[EG*2JT FD]P@ZCJ]_[Y>#@;/%@4N&FF4*5
M\"22SU%.$?UI3W[D'JAN%1B="#\">Y:KLSOW GDEK5J:X76B1HZ$3:%:"K7D
MBB"'4W.H;?E%GW(%!+AK'F<+<H!R'&PX((H,+4E-U]WOS2CIP7WR#.YLFDJC
M) 11_&==5F,3\*: &_9S&$I955Z!+:?*F<T/%F2+/[>V>+\WQ4;RS/(+K-B<
MNELR9.&X46D^84*L85* A<>(5?;@;[33;?+.%.+$3Y"R&(,##8ONGC!EIT&W
M7 [/"\?A^6@H2[UI_91+# OI+K$F,377H1#?J-+^2>7>VNWC.@]=&<R<I<4@
MJ<AQQ6^F-0?".G/- VIP?(B83%5\U175FL8"@>>OTQ/$;T[@?C/##;ESG!"3
M.VDWP)D2V!&G!/R]4;/PJ^QBC9!L _Z39M-D33S>BF^3OS#PO!]4A":C!@KT
M0K)I 8I%$\YX!*=Q2FS@OI0X&$9=QV3C5AG&/#M)B?!(JIEPU>IROU*PFU#;
MK6.5*>T:FNZ0$U5.^4#S'9=Q/[YT]J- 8IJ;<19ZQM->= *6+FH&/R$]2%<C
MRF;FY7Y0M"'NTZ,&G:LW:A_&<Q#I%?:1]]<^\A/[R*\<*#7(WYGH\S<<]5D:
M7[DKKX3-O,L$C@;%%:TZ8Q)Q=)L3;M1RU?1+P4 <-:<C,C,GZQ:85N/^K?J]
M!]V+]:Y-X8EO:TELG/0O;5:RKOE1E-*1>TY)8C_J_&+]E3D=G/0[^MAC.NPQ
MRFAC\+:L"V&5GJB\W-K>70KO$=<_.*#")^><>A60[<'G=,0I=E6Q!Q>A\L8(
M;YJ451,1)]%@*1 GH0<[)-,QXZ9QTXKW8JD;!Z*[;TP)8;@KRHXJ3/19^QG=
MCVCU%K/DY$N2KAK*0KQ_HH7P-R<"46+#6-:P4+L/SGO6)10+JU"JTK7)7#[,
M=^4-;3@O7*1)R+&"4(H5&27#VP[I^%'YU$HO]!(L52Q+=?A$2T6JL>3N1NZB
MU5Q:T=G.+"D%*0$BKW[ 4N&#I!B6G[F,9NUK UW+;I(BUSX?*'K0] V\6@?>
MKV&YOPY=9&##.,4*:RIEP#L'W-7K?NC1]Y].RU&=HD]'/IB'F'"6/)J352.#
M/Y/NI)BL5!A*)DTD<+C8P<-U-O?;H"2F]0_/S-U=KU#C1?CYZB;):RRQMB@2
MO.NOT3^C(L8V$GIF*5^L&V/D%&E#L]E07>J.>6X(1]P)!T[./Y2_$#;/V5 !
MIO#70@/)B4R'^\0D6^\"7V(QSVCBKO:EA59,^#!#Y#?-'&Y,!MH)HR5I%C9'
M2@RF#(E4+?2Q,Z53<VJY00V\Q79 =3*0K9%R+-*'6!F,%K>C6;C,#E!FF^:O
MK76 -Q3,$*ID]C91VZ6I0H9!LZ0AO,1]K$>P-YY9R*,E/W)[XZ(^*)C:I &.
M[)A=HZ&5]YW6/5,<9]F=9UZ6FQ+_>I&F[[L5KFM_OO9WG]IL;8B5)MUULQ=5
MZR)I(Z2/ 2F]TGT%NR#",U5.R"C$KJ"M&[ E'#:QP=)A0&V1"% !I[4H7]SF
M RP[;>\65Y-/4=)=#52G;SGPB^[;<XLU<V?/9]<12LMHFCU2W!D;)'-!4YR4
MTHM\U.^9;N+._,#2/V"2\T*?NOY!VKA2:]<W][P&2,/4-Z&W8$0:(8,KQNR@
M&9QK/AKGK4B0)"/A-)07+II[7G26@$]]YXX9LN_]X#WAQ,Z#<\6X:L-SC3\P
M'XXZYRJBN'#'BH;4'1C\1RKNIPL(ML7)!QF:SR?>+EON@M1^TSD6MN:=K7+'
MZ*,&JB#_F6I,^#3S?(KX(=[,K,.B=[(B:R>*0=\)/= -K:_/#6_JY?^L8^:$
M<))J#\N.]7OWI,="9UNTA7Q:K^Y$K!HN3=>X\\?IVIEBD>5"@4>[ ;^-D="4
M[T(<4X[9U9K'?L_,6.'5L=15HWAI'H?&O7;:0@WK49=A'95E/1:[VAJ]LM<]
M,#U/4[?1VPZV+N^.NYKI7SB^179GO J_L< 4I2X;!$0,T\C]GMV4.#_869'
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M^O#3X*P8\&[[YZ9)=4XGZ-29US*R=1? >^/L,"W*C-]@YS,>\6.E>OQE8TT
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M2PR(\Q8*#*RG)F &(JH"1DL LDWHV>?<?S_F!*!H#$ ]IAJ6#!PH@G:XKK(
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MAHZQ6QR-RNH!6A^Q"$P4DH>UN18H 3B)#?]T/AP4<HEO(M5(X&[C.Z6I1!X
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MC G9]2YH>835$CJAJ&J+N&S?U"S#]@_<Q@%3)(&3K,/!];02+%![O(Q461>
M[C./N3=R<%VAX@[K05,B^E@$[[!LC/35SH9U9K;SMM N8+8-4Z6>TV?E6]S
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MA.29X\4[G^LYSI ^1=PW7!X*6BDDZP9(H[HW\%/7.&U.,9<A9S&V<0%I*&:
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MV=B?"&[YD56O@R(2_(VB&9;$AFTJ1SW%10)J'A33:H804/)$!<T\J.<-W2%
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MVM30$B%]VKV^NI/VB3MK#+/!A!1'PY[>E1E$;O5+5O_B%/,D@(^$EW?>&S!
M-<YSY[K/SK D*BIH?@R3LD$$*HG\GE:*HK(& P$)$-\J(GY[:T$/RWW"X_7E
M/,U^*YLSYY^\RMYC\12>[C6?6ANCJX=C))0'[YQZ7.$K4IM&RX+QDP:F'_\-
MD93++U<Q1<.X<D:/PND&&J'<IX#31P28B>IW%&1$)#K%GAP3QU"MRD4H*#HP
M&MD%,ZF[H0HE !!&60^X@(3HU5+HU.!".U8C;TG:14FS;2('@GHS$?8+V.U2
MA-DYJ[&N%ZXH2>"BADMZ--%0Q7,BU/#K,'Q3]<=>KQ</*IF!6CXV/Q8WI14Q
M$!6)XE65GCM.3'#&J3-AR24!BR"8%K4H;10UXK4I*\H7XL0,76HNB5!V*/O$
M?FTZ18+;<.-77-ZNVF((G+C.T0(A]( 083/DT@XGP"XH').^5.Y7A?S.D]E!
M'LVT+\1>4%*9MTL6P+T2_NH!$> 88S#9EP2FJX;4HV%^2Y)G-2,6(7]OTDN:
MNA%;L'%TI]"<F6Z#\HY=R'KZ&XK@@!L("PL@8&.W+4R:RD2\.^[-.'\>_=$S
M:787+Q$\AEYNB[0($ZKZM/)G-5ENC5%!"S57[Y1!'UW^=<8&H9X*4%;VW1-
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MC@^X$>AM/(\Z\O=VLQUII-0@!T$8)LR1L68ADZR):LHO4P5@*_>N4*_>_)E
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M;15E;OBANP^+CS!K47Z&$ 0[;R32G$YKY^DI_%^X!P @1T=A3C*D+O+ &T_
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M^9V @BG&C_8HW5]1@RI 8IJ2V3A4<'6 ^;V5R3&JS/FY73I[:SQ@Y5:#)MP
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MH=6A$DJB950.#(J@R/![WKG6J#.;Z0['!]X:YJ]2P_/A6#B^HC'BPR4)\VP
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MYEEL@L2??&.&[(EA3C>8=,I?D<*=$-*AR8JP;F"*T&53X)_-^4;3N &.!)=
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MX#R;H,#O8RV$E4-(X2,WH**)NF%G<&9KF@]>54AR0:#%YOK^*]=#%V0%9BL
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MHLA\Z8C,SJ8AW7\Z;=#["OY!L7YV>CSRTI=W<\D^*OMA2.N3I+CQE#81U4W
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M7G]X\P_WRU]/?WOWM_\/4$L#!!0    (  <]EEQ_W'3)- \  'HM   1
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MGW);9@\-G9[FQ.]]I=\_ZD>?7M+D3/C1V7V]""Q_<?P;+O([U_\!4$L#!!0
M   (  <]EEQI:D"M:P,  )L,   1    :'5R82TR,#(V,#0R,2YX<V2]5MMN
MXS80?5]@_V&JIQ:H1,O.IHV09)$V&R! -BV\V:)O"UH:VT0I4B6I)/[[#BG)
MEJ]UDJ)^,<F9,W/FPJ'./SZ7$A[16*'5190F@PA0Y;H0:G81U3;F-A<B^GCY
M_MWY=W$,US>W]Q##W+G*9HP]/3TEQ50HJV7MR()-<ETRB.-._]>'K_!'8SV#
M,4KD%F%X.CB%7VHABVPXH,TH_2D9]4$&N;<&!7>8P0D;#IE7A#3-1C]G)R.X
M^@R?N'5H%#R($OM872V,F,T=?)__  %UK95"*7$!-T)QE0LNX4M'^$>X57D"
M5U+"V,,LL;1H'K%(6JO/MLAL/L>2OW\'0.E2-E-DLBXO(I^'-@W/$R,3;6:L
M<(:Y186,E&+20B/RJ ?]=]P6ANK@)78)G'([":!.XO/SH8>8UX:ON7&U/YH(
M'2H4TGXR3'N( L42$#A9S).9?F0DV+3NY6)W%,/!8,2H(1PE&GL0*=1?!Q!>
M/*'>Z#O9@CR- B ].SMC0;I!J7#K$;36/[!&V-.VQFWGD@XW [6N,KNSXB4K
M;>Z<$9/:X8TVY35.>2W)0:W^KKD44X%%T*+V+U&Y-9UU#<?-#-T]+]%6/,>7
M59 :=5>Z* ,I^_/SW9?0P]&E!P"$MA9EI8V#IKOO=!YNW8$J^5W<%3?V1W$Z
MC$=I0L8B4#MI[^D,8&\FTO7,JX@L&^YH(G;?Q?"+V"_V>=]]G5Z=@<U!X>,_
M\_&GIT?%OS5H_@,F6MV_E4QO6KZ^)HJ+O!F&S?+XNJR0;^K-;MCX/!QVO#F=
M7A[TUN1B*)WUNX-A;P^\U^=[.0;#ZOALK\9GZSMXYDII%]SU^?"J$FJJVR,Z
M]'<WZR[P&*<0'H.,F]QHB8>?#%897:%Q@M[,U0QH#,P-3@E-4S;NQNLWR2<)
MC==.9<O!^E3Q8D80E'<K>AW6">?!=UX,7DX?'UPN3?M;<!%9RK[L3:7_.=S*
MX$O#)8BE5RV4;7_4O_>T7AR\]_- &N 77\>W!][%Y</(''_62I>+AN6USFO_
M^';_5ZKXI(C;XI9:RY2!5P2"7M QJ7\[2GW)LN-9('T+B]"_Z<#_Z%.YL]!?
M<E5 8PYZ]L[9II%-^[7%XC=U&=8YEWDMEUEOP:W&(>!FO8Y'KICMQ[6G7<6Z
M>\PV+W)[TK_PS5$S=FC[#U!+ P04    "  '/99<Z,0B"X$&  "X1@  %0
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MZ!+6[#;7=Q[ANLW;@7S+O)54]<XVWER99W5 -N>V!'*I$2R.L0&Y6(\(Y*P
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MP[V1JE[R.R[5EOZ5*^DNGOSB$;7G?U!+ P04    "  '/99<U$FVH<P$  !
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M.34U,F0X:RYH=&U02P$"% ,4    "  '/99<Y%Z.4+8[  !J%@$ $0
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M,F1E>#0Q+FAT;5!+ 0(4 Q0    (  <]EEQ_W'3)- \  'HM   1
M      "  3YU 0!D,3,Y-34R9&5X.3DQ+FAT;5!+ 0(4 Q0    (  <]EEQI
M:D"M:P,  )L,   1              "  :&$ 0!H=7)A+3(P,C8P-#(Q+GAS
M9%!+ 0(4 Q0    (  <]EESHQ"(+@08  +A&   5              "  3N(
M 0!H=7)A+3(P,C8P-#(Q7VQA8BYX;6Q02P$"% ,4    "  '/99<U$FVH<P$
M  ! +   %0              @ 'OC@$ :'5R82TR,#(V,#0R,5]P<F4N>&UL
64$L%!@     *  H >@(  .Z3 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>d139552d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="hura-20260421.xsd" xlink:type="simple"/>
    <context id="duration_2026-04-21_to_2026-04-21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001498382</identifier>
        </entity>
        <period>
            <startDate>2026-04-21</startDate>
            <endDate>2026-04-21</endDate>
        </period>
    </context>
    <dei:EntityRegistrantName
      contextRef="duration_2026-04-21_to_2026-04-21"
      id="Hidden_dei_EntityRegistrantName">TuHURA Biosciences, Inc./NV</dei:EntityRegistrantName>
    <dei:SecurityExchangeName
      contextRef="duration_2026-04-21_to_2026-04-21"
      id="Hidden_dei_SecurityExchangeName">NASDAQ</dei:SecurityExchangeName>
    <dei:AmendmentFlag contextRef="duration_2026-04-21_to_2026-04-21" id="ixv-387">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2026-04-21_to_2026-04-21"
      id="Hidden_dei_EntityCentralIndexKey">0001498382</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2026-04-21_to_2026-04-21" id="ixv-398">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2026-04-21_to_2026-04-21" id="ixv-399">2026-04-21</dei:DocumentPeriodEndDate>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2026-04-21_to_2026-04-21" id="ixv-400">NV</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2026-04-21_to_2026-04-21" id="ixv-401">001-37823</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2026-04-21_to_2026-04-21" id="ixv-402">99-0360497</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2026-04-21_to_2026-04-21" id="ixv-403">10500 University Center Dr.</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="duration_2026-04-21_to_2026-04-21" id="ixv-404">Suite 110</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="duration_2026-04-21_to_2026-04-21" id="ixv-405">Tampa</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2026-04-21_to_2026-04-21" id="ixv-406">FL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2026-04-21_to_2026-04-21" id="ixv-407">33612</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2026-04-21_to_2026-04-21" id="ixv-408">(813)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2026-04-21_to_2026-04-21" id="ixv-409">875-6600</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2026-04-21_to_2026-04-21" id="ixv-410">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2026-04-21_to_2026-04-21" id="ixv-411">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2026-04-21_to_2026-04-21" id="ixv-412">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2026-04-21_to_2026-04-21" id="ixv-413">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2026-04-21_to_2026-04-21" id="ixv-414">Common Stock, $0.001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2026-04-21_to_2026-04-21" id="ixv-415">HURA</dei:TradingSymbol>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2026-04-21_to_2026-04-21" id="ixv-416">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
